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ABSTRACT
THE MECHANISMS UNDERLYING COCAINE-INDUCED OVEREXPRESSION OF
BASIC FIBROBLAST GROWTH FACTOR (BFGF, FGF2), AN EFFECT REVERSED BY
EXTINCTION
by
Madalyn Hafenbreidel

The University of Wisconsin-Milwaukee, 2016
Under the Supervision of Devin Mueller

Drug addiction is characterized by compulsive drug use and chronic relapse
despite negative consequences. Drug-induced structural and functional changes in the
brain are thought to underlie these characteristics. One mechanism that may mediate
these characteristics are growth factors, such as basic fibroblast growth factor (bFGF or
FGF2), as they are necessary for cellular growth, survival, differentiation, and have
roles in memory, mood, and anxiety disorders. bFGF mRNA and protein expression is
increased following stimulant administration and is necessary for stimulant-induced
changes in dendrites and behavioral sensitization. Moreover, addiction is maintained by
cues associated with the drug, as they can can evoke craving and promote relapse.
Therefore, reducing cue reactivity, such as with extinction, could reduce relapse rates.
Inhibiting bFGF in the infralimbic medial prefrontal cortex (IL-mPFC), following selfadministration, facilitates extinction. Extinction of drug seeking can reduce bFGF
expression in IL-mPFC, nucleus accumbens (NAc), and dorsal hippocampus (dHipp),
indicating that bFGF may mediate drug-associated learning. However, the circuitry and
mechanisms underlying extinction and the role of bFGF is unknown. Therefore, the
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current experiments investigated if drug-induced plasticity was altered by extinction and
if bFGF had a role, in brain regions associated with learning or addiction (i.e., IL-mPFC,
NAc, and dHipp). We found that cocaine self-administration induced changes in
plasticity-related protein expression, such as ARC and pGSK3β, in each brain region,
and extinction could ameliorate some of that plasticity. Moreover, we found that
neutralizing bFGF in NAc prior to four 30-min extinction sessions disrupted initial
extinction retention. However, if bFGF was neutralized without four 30-min extinction
sessions, subsequent extinction was enhanced. In dHipp, neutralizing bFGF, with or
without four 30-min extinction sessions, facilitated subsequent extinction over days.
Overall, these results suggest that blocking the biological function of bFGF in a number
of reward- and learning-related brain regions can facilitate subsequent extinction.
Understanding the neuronal mechanisms by which bFGF regulates extinction at
systems and molecular levels will allow for development of new pharmacotherapeutics
to enhance extinction-based therapies for addiction.
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INTRODUCTION
Drug addiction is a chronic and persistent disorder (McLellan, Lewis, O'Brien, &
Kleber, 2000) that is characterized by compulsive and uncontrollable drug seeking and
taking despite negative consequences. Drug use and addiction are highly prevalent,
with an estimated 24.6 million people, ages 12 and over, reporting using illegal
substances in the United States in 2013 (Substance Abuse and Mental Health Services
Administration, 2014). Unfortunately, most treatments are not particularly effective
(Conklin & Tiffany, 2002; McLellan et al., 2000), as 30-60 percent of individuals treated
for substance abuse return to drug taking within one year of treatment (McLellan et al.,
2000). The persistent nature of addiction suggests long-term neuronal changes, and
indeed, the changes and mechanisms underlying acute or prolonged drug use,
withdrawal, and relapse or reinstatement have been intensely investigated (e.g.,
Epstein, Preston, Stewart, & Shaham, 2006; Knackstedt & Kalivas, 2009; M. J. Thomas,
Kalivas, & Shaham, 2008). In contrast, research concerning neuronal changes
underlying treatment is lacking.
A key feature of drug addiction is that it is maintained by cues associated with the
rewarding properties of the drug. Following treatment or abstinence, exposure to drugassociated cues can promote craving and withdrawal-like symptoms, which can trigger
relapse (Childress, McLellan, & O'Brien, 1986). Therefore, reducing cue-reactivity
would reduce relapse rates. One way to reduce reactivity is through extinction.
Extinction consists of presenting the previously drug-paired cue in the absence of the
drug reinforcer, and following numerous presentations, a new inhibitory memory is
formed wherein the cue is no longer associated with the rewarding properties of the
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drug (Millan, Marchant, & McNally, 2011; Quirk & Mueller, 2008). The extinction
memory is formed in stages, like other forms of learning. First, the new contingencies
that the cue no longer predicts the drug are acquired in short-term memory before being
subsequently consolidated into long-term storage. On subsequent extinction sessions,
the extinction memory can be retrieved, strengthened or weakened, and then
reconsolidated back into long-term storage. Extinction-based exposure therapy uses
these ideas to treat addiction, however, this type of therapy alone has had limited
success (Conklin & Tiffany, 2002). Thus, determining the mechanisms that underlie the
persistence of drug addiction, extinction itself, and their interaction, would allow for the
development of new pharmacotherapeutics to enhance treatment for drug addiction.

Self-administration paradigm
Drug use and addiction is modeled with rodents using paradigms such as
sensitization, classical conditioning, or operant conditioning. Psychomotor sensitization
is measured as a progressive increase in locomotor responsiveness to the same dose
of a drug, and involves repeatedly injecting an animal with a drug and then measuring
their locomotion. Moreover, sensitization is potentiated after a withdrawal period. The
psychomotor sensitization paradigm is a frequently used and well validated (Post &
Rose, 1976), and is ideal for examining the effects of drug exposure on behavior and
the brain (Robinson & Becker, 1986). Sensitization is also long lasting, as it can persist
up to months or years (Paulson, Camp, & Robinson, 1991).
Another paradigm commonly utilized uses classical conditioning to train animals
to associate one context with drug administration, and another context with vehicle

2

administration. When the animal is given access to both contexts, they will spend more
time in the previously drug-paired chamber, indicating a conditioned place preference
(CPP). CPP is frequently used (Bardo & Bevins, 2000), and is ideal for examining a
relatively simple drug-associated memory.
To better model prolonged drug use and the complex memories formed by
human drug addicts, the self-administration paradigm is used. In this paradigm, animals
undergo acquisition of drug taking, during which they are trained to lever press for
intravenous infusions of a drug, and these lever presses are often paired with salient
cues, such as tones and lights. Throughout training sessions, animals learn to
associate the cues with the administration of the drug. Mice, rats, and monkeys will
consistently and reliably learn to administer a number of drugs that are commonly
abused in humans and will not reliably administer drugs not abused by humans (Koob,
2012; Thomsen & Caine, 2005). Animals lever press for drug for numerous days,
allowing for prolonged exposure to the drug and multiple drug-cue pairings, similar to
human addicts. Additionally, drug administration is contingent on the animal’s behavior,
unlike sensitization and CPP in which the drug is administered non-contingently.
Once animals achieve stable drug taking during acquisition, they can be tested
under extinction conditions. During extinction, animals are presented with the cue(s),
without administration of drug, until lever pressing is substantially reduced. With
repeated non-reinforced pairings, the cue(s) becomes associated with the omission of
the reinforcer and a new memory is formed. This new memory serves to inhibit drug
seeking and the original memory that associates the cues with drug intake. As
previously mentioned, the new extinction memory is formed in phases, and each of
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these phases can be manipulated (Millan et al., 2011; Quirk & Mueller, 2008). Prior to
the first extinction session, acquisition of the new extinction memory can be
manipulated, such as with a systemic or intracranial infusion of an agonist or antagonist.
Likewise, following the first extinction session, consolidation of the extinction memory
can be manipulated.
The initial extinction learning can be further manipulated by shortening the first
few extinction sessions. Reducing the time minimizes extinction learning during the first
few extinction sessions in order to better manipulate initial learning and determine if the
pharmacological manipulation affected the acquisition of the new extinction memory.
Retention of the extinction memory is then tested during subsequent full-length
extinction sessions (i.e., same amount of time as during acquisition). Poor extinction
memory retention is demonstrated by a significant increase in lever pressing from the
shortened sessions to the full-length sessions, whereas good extinction memory
retention is demonstrated by no change in lever pressing (LaLumiere et al., 2010;
Hafenbreidel et al., 2014; Hafenbreidel et al., 2015b). Finally, following extinction,
exposing animals to a priming injection of the drug, a stressor, or a non-extinguished
drug-associated cue can reinstate lever pressing (Epstein et al., 2006; Lynch,
Nicholson, Dance, Morgan, & Foley, 2010). Overall, this paradigm allows for the
mechanisms underlying acquisition, withdrawal, extinction, and reinstatement of drug
seeking to be examined.
A number of brain regions have been implicated in addiction, extinction, or both,
including the medial prefrontal cortex (mPFC), nucleus accumbens (NAc), amygdala,
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hippocampus, and ventral tegmental area (VTA; Figure 1; Millan et al., 2011; Quirk &
Mueller, 2008).

Figure 1: Neural circuitry of drug addiction. A schematic depiction of brain regions and their interactions
that are implicated in addiction, extinction, or both (adapted from Otis et al., unpublished); however, the
details are still being determined. The medial prefrontal cortex (mPFC; right) is composed of two
subregions: the prelimbic (PL) and infralimbic (IL). The PL-mPFC projects to the core region of the
nucleus accumbens (NAc) and is thought to drive drug seeking, whereas the IL-mPFC projects to the
shell region of the NAc and is thought to inhibit drug seeking following extinction (Millan et al., 2011;
Peters, Kalivas, & Quirk, 2009). The ventral tegmental area (VTA) is composed of dopaminergic neurons
that project to numerous reward-related brain regions, including the NAc and mPFC (Wise, 2004). The
hippocampus (left) is composed of two subregions: the dorsal hippocampus (dHipp) and ventral
hippocampus (vHipp). The dHipp indirectly projects to the NAc and mPFC through the vHipp and the
amygdala projects to the mPFC, to mediate drug seeking (Fanselow & Dong, 2010; Hiranita, Nawata,
Sakimura, Anggadiredja, & Yamamoto, 2006; Kelley, 2004).
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Briefly, mPFC is composed of two subregions: the infralimbic mPFC (IL-mPFC)
and the prelimbic mPFC (PL-mPFC), which have different roles in addiction and
extinction. Inactivating PL-mPFC blocks cocaine- and stress-induced reinstatement
(McFarland, Davidge, Lapish, & Kalivas, 2004; McFarland & Kalivas, 2001; McFarland,
Lapish, & Kalivas, 2003), and attenuates cue-induced reinstatement (Hiranita et al.,
2006; McLaughlin & See, 2003), but has no effect on extinction (LaLumiere, Niehoff, &
Kalivas, 2010; Peters, LaLumiere, & Kalivas, 2008). Conversely, inactivating IL-mPFC
has no effect on cocaine-, cue-, or stress-induced reinstatement (Hiranita et al., 2006;
McFarland et al., 2004; McFarland & Kalivas, 2001; McLaughlin & See, 2003), but will
disrupt extinction following self-administration (LaLumiere et al., 2010; Peters et al.,
2008), and enhancing IL-mPFC function will facilitate extinction in the self-administration
or CPP paradigm (LaLumiere et al., 2010; Gass et al., 2014; Otis et al., 2014a).
Moreover, inactivating IL-mPFC after an animal has learned extinction following selfadministration will induce reinstatement (Peters et al., 2008). Overall, PL-mPFC is
thought to mediate drug seeking, and IL-mPFC mediates inhibition of drug seeking
following extinction.
Similar to mPFC, NAc is composed of two functionally different subregions: core
and shell. The PL-mPFC and IL-mPFC project to NAc core and NAc shell, respectively
(Groenewegen, Galis-de Graaf, & Smeets, 1999; Sesack, Deutch, Roth, & Bunney,
1989). Inactivating NAc core blocks cocaine-, cue-, and stress-induced reinstatement
(Hiranita et al., 2006; McFarland et al., 2004; McFarland & Kalivas, 2001). However,
inhibiting NAc shell only disrupts stress-induced reinstatement (Hiranita et al., 2006;
McFarland et al., 2004; McFarland & Kalivas, 2001), but will reinstate drug seeking if
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inactivated after an animal has learned extinction (Peters et al., 2008). Overall, these
findings suggest that the connections between PL-mPFC and NAc core drive drug
seeking, whereas, the connections between IL-mPFC and NAc shell inhibits drug
seeking following extinction (LaLumiere & Kalivas, 2008; McFarland et al., 2004;
McFarland et al., 2003; Peters et al., 2009).
A few additional brain regions are often investigated for their role in addiction,
including the VTA, amygdala, and hippocampus. The VTA is composed primarily of
dopaminergic neurons with wide projections throughout the brain, including PFC and
NAc (Aransay, Rodriguez-Lopez, Garcia-Amado, Clasca, & Prensa, 2015), and
inactivation of VTA blocks stress-, context-, and cocaine-induced reinstatement
(Bossert, Liu, Lu, & Shaham, 2004; McFarland et al., 2004; McFarland & Kalivas, 2001).
The amygdala is implicated in the emotional aspects of reinstatement, as inactivating it
will block stress- or cue-induced reinstatement (Erb, Salmaso, Rodaros, & Stewart,
2001; Hiranita et al., 2006; Kantak, Black, Valencia, Green-Jordan, & Eichenbaum,
2002; Leri, Flores, Rodaros, & Stewart, 2002; McFarland et al., 2004; McLaughlin &
See, 2003), but has no effect on cocaine-induced reinstatement (McFarland & Kalivas,
2001) or extinction expression (Peters et al., 2008). Lastly, the hippocampus is
composed of the dorsal hippocampus (dHipp) and ventral hippocampus (vHipp), and
inactivating either blocks cocaine- and cue-induced restatement (Hiranita et al., 2006).
In summary, a number of paradigms can be used to model drug use and drugassociated learning in rodents, including sensitization, CPP, and self-administration.
The self-administration paradigm is specifically used to model complex memories and
prolonged drug use in rodents, and can be used to investigate plastic changes that
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occur following acquisition, withdrawal, extinction, and reinstatement in a number of
reward-related brain regions, including mPFC, NAc, VTA, amygdala, and hippocampus.

Drug-induced plastic changes
Experiences, such as an enriched living environment or a learning event, can
induce plastic changes in the brain, such as changes in spine density and neuronal
excitability (Kolb & Whishaw, 1998; Sehgal, Song, Ehlers, & Moyer, 2013). These
changes can prime the region for subsequent plasticity (W. C. Abraham & Bear, 1996),
such as that needed for new learning. Commonly abused drugs, such as cocaine and
amphetamine, can also induce plastic changes in the brain. However, instead of
priming the region for subsequent plasticity, they hinder new experience-dependent
plasticity (Kolb, Gorny, Li, Samaha, & Robinson, 2003). Drug addiction is characterized
by preservative use and chronic relapse, and it is thought that the long-lasting changes
induced by drug use in reward-related brain regions might underlie these characteristics
(Pickens et al., 2011; M. J. Thomas et al., 2008). Here is a brief review of some of the
research that has examined morphological, functional, and molecular changes induced
by stimulant drug use.

Drug-induced morphological changes
Stimulant drug use can induce long-lasting morphological changes in rewardrelated brain regions, and these adaptations might underlie long-lasting behavioral
changes (Y. Li, Acerbo, & Robinson, 2004). Prolonged injections of cocaine,
amphetamine, or nicotine (20-25 days) plus an extended withdrawal period (24 days to
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3.5 months) can increase dendritic length and spine density in reward-related brain
regions, such as PFC and NAc (Brown & Kolb, 2001; Kolb et al., 2003; Y. Li, Kolb, &
Robinson, 2003; Robinson & Kolb, 1997, 1999, 2004). Dendritic length is also
increased in dopaminergic neurons in VTA in rats that were briefly treated with
amphetamine (three days) during early life followed by seven to 28 days of withdrawal
(Mueller, Chapman, & Stewart, 2006). Moreover, the increases in dendritic branches
and spine density are not limited to researcher-administered drugs, as they are also
observed following cocaine self-administration plus a prolonged withdrawal period (30
days) in NAc shell and PL-mPFC (Robinson, Gorny, Mitton, & Kolb, 2001). Overall,
spine and dendritic changes are induced in reward-related brain regions after prolonged
stimulant drug use and a withdrawal period.
However, drug-induced plastic changes occur relatively shortly after the
cessation of drug use as well. Twenty-four hours after a single injection of cocaine,
spine density is increased in VTA (Sarti, Borgland, Kharazia, & Bonci, 2007). Moreover,
four or 24 hours after seven days of cocaine injections, thin-type spines in NAc shell are
increased, but after 24 hours are decreased in NAc core (Dumitriu et al., 2012).
Interestingly, changes in spine density might be dependent on the dose of cocaine
given or the context in which the cocaine was given. For example, a low dose of
cocaine given in the rats home cage does not induce increased spine density in NAc
core, but if that same dose is given in a novel context or is doubled, then spine density
is increased in NAc core (Y. Li et al., 2004). Alternatively, when cocaine or
methylphenidate (i.e., Ritalin) was administered for a longer period, 15-20 days,
dendritic spine density on dopaminergic neurons in NAc core and shell was increased
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after only two days of withdrawal (Dobi, Seabold, Christensen, Bock, & Alvarez, 2011;
Y. Kim et al., 2009; K. W. Lee et al., 2006). In summary, stimulant drug use can fairly
rapidly induce spine changes in reward-related brain regions, however, these changes
are contingent on context, dose, and length of time the drug is administered.
In conclusion, stimulant drug use can induce morphological changes in rewardrelated brain regions. However, the changes are dependent on a number of factors,
such as length of drug administration, length of withdrawal, and brain region examined.
Overall, dendritic and spine changes are evident following acute and prolonged
stimulant administration with a short withdrawal period (Y. Kim et al., 2009; K. W. Lee et
al., 2006; Ren et al., 2010; Sarti et al., 2007), following acute stimulant administration
with a prolonged withdrawal period (Dobi et al., 2011; Y. Li et al., 2004; Mueller et al.,
2006), and following prolonged stimulant administration and withdrawal (Brown & Kolb,
2001; Y. Li et al., 2003; Robinson et al., 2001; Robinson & Kolb, 1997, 1999, 2004).
However, the mechanisms underlying the persistence of these changes are still unclear,
but they are likely produced by homeostatic mechanisms in response to drug use and
withdrawal (Kalivas, 2009; Ren et al., 2010).

Drug-induced functional changes
As discussed, fairly rapid and long-lasting morphological changes in rewardrelated brain regions are produced by stimulant drug use. These type of changes are
not unique to drug use, but instead are often produced following experiences (W. C.
Abraham & Bear, 1996; Kolb & Whishaw, 1998), such as living in an enriched
environment. However, rats with cocaine experience do not demonstrate increases in
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spine density after living in an enriched environment during withdrawal as their drugnaïve counterparts do, indicating that previous drug use blocks new experiencedependent plasticity (Kolb et al., 2003).
Experience-dependent plasticity also occurs following learning (W. C. Abraham &
Bear, 1996; Kolb & Whishaw, 1998), but previous drug use can decrease performance
on a number of tasks in rodents. For example, two weeks after rats underwent cocaine
self-administration, rats had reduced performance on the delayed alternation task using
a t-maze (Radley et al., 2015). Moreover, neonatal or early life injections of
methamphetamine result in disrupted performance in the Morris water maze during
adulthood (Skelton, Williams, Schaefer, & Vorhees, 2007; Vorhees, Ahrens, AcuffSmith, Schilling, & Fisher, 1994; Williams, Vorhees, Boon, Saber, & Cain, 2002), and
binge-like cocaine administration (multiple injections per day across several days)
during adolescence (P35-46) results in increased novelty-seeking (or reduced anxiety)
in adulthood as measured by time spent in the open arms in the elevated plus maze or
in the center of an open field test (Sillivan et al., 2011). Additionally, these rats have
attenuated context fear learning, suggesting that previous drug use increased
impulsivity, but disrupted new learning (Sillivan et al., 2011). Overall, previous drug use
can alter behavior and hinder subsequent learning.
The changes observed in learning and behavior following drug use may be due
to changes in neuronal excitability and plasticity. Depending on a number of variables,
stimulant drug use can alter synaptic and intrinsic excitability (Kauer & Malenka, 2007;
Kourrich, Calu, & Bonci, 2015; Wolf, 2010). For example, synaptic plasticity is
enhanced in VTA following a single cocaine injection for at least five days (Ungless,
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Whistler, Malenka, & Bonci, 2001), and is enhanced following prolonged cocaine
administration (5-28 days) with short or extended withdrawal (2-23 days) in NAc (Dobi
et al., 2011; Kourrich, Rothwell, Klug, & Thomas, 2007; Yao et al., 2004) and
hippocampus (Guan, Zhang, Xu, & Li, 2009). Synaptic plasticity is enhanced for a
protracted amount of time following drug cessation, suggesting enduring homeostatic
change. Indeed, glutamatergic AMPA receptors (AMPArs) lacking the GluR2 subunit
(GluR2-lacking AMPArs), which are often GluR1-containing AMPArs and have high
channel conductance and calcium permeability, are increased in NAc following
prolonged withdrawal (Wolf & Ferrario, 2010). This effect is observed progressively
following withdrawal from long-access self-administration, which consists of long daily
sessions (6+ hours versus 1-2 hours for short-access) or a longer acquisition period
(more than the usual 10-14 days for short access; X. Li & Wolf, 2015; Loweth, Tseng, &
Wolf, 2014). Moreover, following prolonged withdrawal, animals can demonstrate
“incubation” of drug seeking, which is the potentation of reward seeking (Grimm, Fyall,
& Osincup, 2005; Grimm, Hope, Wise, & Shaham, 2001; Grimm, Shaham, & Hope,
2002), and is mediated by the increase in GluR2-lacking AMPArs in NAc (Conrad et al.,
2008; Wolf & Ferrario, 2010).
Alternatively, intrinsic excitability, or how likely a neuron is to fire an action
potential, is decreased following drug administration and withdrawal. Following brief
cocaine or amphetamine injections or cocaine self-administration, intrinsic excitability is
decreased in NAc (Dong et al., 2006; Ishikawa et al., 2009; Kourrich & Thomas, 2009;
Mu et al., 2010) for at least 21 days (Ishikawa et al., 2009). However, activity is
increased in NAc following drug-associated cue presentation or drug presentation
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following 21-30 days of withdrawal from cocaine self-administration compared to one
day of withdrawal (Hollander & Carelli, 2007; Mu et al., 2010). Similar findings are also
observed in human addicts. Activity in PFC following short or prolonged withdrawal in
human addicts is reduced; however, following drug-associated cue presentation (e.g.,
videos) activity is significantly increased, which is strongly correlated with self-reported
craving (Goldstein & Volkow, 2002, 2011). Overall, these results suggest a decrease in
function in NAc and PFC following drug use, but an increase following presentation of
drug-associated cues after prolonged withdrawal.
In summary, following drug administration, animals have impaired experiencedependent plasticity, altered behavior, and disrupted new learning. Moreover, rats and
humans display decreased neuronal activity in reward-related brain regions following
prolonged drug use and withdrawal, but increased activity with drug-associated cue
presentation. These behavioral and functional adaptations are likely manifested by
drug-induced changes in synaptic and intrinsic excitability, morphology, and molecular
components.

Drug-induced molecular changes
As mentioned, structural and functional changes induced by stimulant drug use
may also be mediated by molecular changes in drug-related brain regions. Some of
these changes have been discussed already, such as alterations in AMPArs. However,
numerous other molecules are altered either directly or indirectly following drug use or
drug-associated learning, which may mediate the changes discussed previously.
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Below, I will highlight a few of the molecular changes induced by chronic drug use (see
Table 1 for summary).
One of the most extensively studied addiction-related molecules is the
transcription factor delta FosB (∆FosB), which is a highly stable splice variant of the
immediate early gene (IEG) fosB (Chen, Kelz, Hope, Nakabeppu, & Nestler, 1997;
Hope et al., 1994). ∆FosB expression is increased following administration of cocaine,
amphetamine, nicotine, morphine, phencyclidine (PCP), tetrahydrocannabinol (THC),
and ethanol in NAc (core and shell), PFC, amygdala, and hippocampus (Atkins et al.,
1999; Hiroi et al., 1997; Y. Kim et al., 2009; Larson et al., 2010; K. W. Lee et al., 2006;
Nye, Hope, Kelz, Iadarola, & Nestler, 1995; Nye & Nestler, 1996; Perrotti et al., 2008;
Pich et al., 1997; Robison & Nestler, 2011; Y. Wang et al., 2015). Mice overexpressing
∆FosB have comparable spine densities in the NAc as mice treated with repeated
cocaine, and spine density is further increased when these mice are given repeated
cocaine injections (Maze et al., 2010). Furthermore, mice overexpressing ∆FosB have
increased cocaine-induced locomotion and enhanced CPP conditioning (Kelz et al.,
1999). Moreover, ∆FosB is thought to mediate motivation, as mice overexpressing it
have facilitated acquisition of cocaine self-administration at a dose that usually results in
poor acquisition, and a higher breaking point with a progressive ratio (Colby, Whisler,
Steffen, Nestler, & Self, 2003). In summary, ∆FosB expression is increased in rewardrelated brain regions following administration of a number of abused drugs, mediates
spine density changes, and is thought to mediate the incentive properties of drugs.
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Table 1: Summary of stimulant-induced molecular changes. Acute refers to short administration of a
stimulant drug (e.g., 1 or 2 injections), and chronic refers to prolonged administration of a stimulant drug
(e.g., 14+ days). Up arrows denote an increase in expression of the corresponding protein, down arrows
denotes a decrease in expression of the corresponding protein, and blank denotes unknown changes for
the correxponding protein. (Alaghband et al., 2014; Atkins et al., 1999; Caffino, Racagni, & Fumagalli,
2011; Flores, Rodaros, & Stewart, 1998; Fumagalli, Pasquale, Racagni, & Riva, 2006; Hafenbreidel,
Twining, Rafa Todd, & Mueller, 2015; W. Y. Kim, Jang, Lee, Jang, & Kim, 2013; Kiraly, Ma, et al., 2010; J.
S. Miller et al., 2014; Nye & Nestler, 1996; Self, Choi, Simmons, Walker, & Smagula, 2004; Sutton et al.,
2003; X. Wang et al., 2013; Wolf & Ferrario, 2010; Xu et al., 2009; Yao et al., 2004).

Another IEG that is associated with stimulant-induced plasticity is activityregulated cytoskeleton-associated protein (ARC). ARC mRNA and protein expression
is increased in the mPFC following a single injection of cocaine in the mPFC, striatum,
and hippocampus (Caffino et al., 2011), but not in the VTA or NAc (Rodriguez-Espinosa
& Fernandez-Espejo, 2015). These increases in the mPFC are long-lasting as well, as
repeated cocaine injections during the adolescence period of a rat (PND28-42) results
in increased ARC mRNA expression at PND45 and increased ARC protein expression
at PND90 (Caffino et al., 2014; Giannotti et al., 2014). However, ARC expression is not
just specifically increased by injections of cocaine. Instead, ARC protein expression is
increased in the PL- and IL-mPFC, but not hippocampus, following retrieval of a cocaine
conditioned place preference or conditioned activity memory (Alaghband et al., 2014).
The increase in ARC expression following memory reactivation has also been
demonstrated following retrieval of a conditioned fear memory in the lateral amygdala
(Maddox & Schafe, 2011), indicating a specific role for ARC in associative memory
retrieval.
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Postsynaptic density protein 95 (PSD95) has also been implicated in druginduced morphological changes. PSD95 is a scaffolding protein associated with AMPAr
trafficking (Boudreau & Wolf, 2005; Schnell et al., 2002; Stein, House, Bredt, & Nicoll,
2003), and is decreased in NAc, but not cortex or hippocampus, following 3-5 or 10
days of cocaine administration plus 1-60 days of withdrawal (Yao et al., 2004). These
results suggest reorganization of dendritic and spine plasticity, instead of a decrease in
spines, which complements other data that found that the occurrence of silent synapses
(synapses that lack functional AMPArs) in NAc is increased following cocaine
administration (Huang et al., 2009). Moreover, PSD95 knockout mice demonstrate
increased responsiveness to a single injection of cocaine, but do not demonstrate
sensitization following repeated injections (Yao et al., 2004), suggesting that druginduced changes in PSD95 may underlie drug-induced behavioral changes.
Another post-synaptic protein, microtubule-associated protein-2 (MAP2), which is
associated with dendrites and drendritic growth (Gordon-Weeks, 1991; Shafit-Zagardo
& Kalcheva, 1998), has been implicated in drug-induced morphological changes. MAP2
protein expression is increased in the striatum following five days of cocaine
administration plus 14 days of withdrawal (Yao et al., 2004), which agrees with previous
findings of increased spine density following cocaine administration. However, MAP2
mRNA and protein expression in the NAc is decreased following one week of
withdrawal from cocaine self-administration (four hours sessions/12 days) compared to
naïve controls, but increased in rats that underwent extinction during the same
withdrawal period (Self et al., 2004). These results may indicate reorganization of
dendritic and spine plasticity, perhaps specific to withdrawal from self-administration,

17

similarly to postsynaptic density protein 95 (PSD95) expression following cocaine
administration.
Another example is Kalirin-7 (Kal-7), which is a brain-specific guanine-nucleotide
exchange factor (GEF) that mediates spine plasticity and excitatory transmission
(Carlisle & Kennedy, 2005; Ma et al., 2011; Penzes et al., 2000; Xie et al., 2007), and is
localized to the PSD (Kiraly, Eipper-Mains, Mains, & Eipper, 2010; Ma, Wang, Ferraro,
Mains, & Eipper, 2008). Repeated cocaine injections increased Kal-7 mRNA and
protein expression in NAc (Kiraly, Ma, et al., 2010), which is still elevated for at least 14
days (X. Wang et al., 2013), but these increases are blocked in Kal-7 knockout mice
(Kiraly, Ma, et al., 2010). Moreover, shRNA knockdown of Kal-7 blocked cocaineinduced spine and GluR1-containing AMPAr increases in NAc core following withdrawal
(X. Wang et al., 2013). Kal-7 knockout mice also have disrupted passive avoidance
learning (Kiraly, Lemtiri-Chlieh, Levine, Mains, & Eipper, 2011; Ma, Kiraly, et al., 2008),
decreased anxiety in an elevated zero maze (Ma, Kiraly, et al., 2008), disrupted
cocaine, but not food, CPP (Kiraly, Ma, et al., 2010), and knockdown in NAc reduced
acquisition of cocaine self-administration (X. Wang et al., 2013). In summary, Kal-7
mediates cocaine-induced morphological changes in NAc and mediates anxiety- and
drug-related behaviors.
Finally, downstream targets of the Wnt pathway might mediate drug-induced
plastic and behavioral changes. Wnt signaling, among other roles (e.g., Fortress &
Frick, 2016; Inestrosa & Varela-Nallar, 2014; Maguschak & Ressler, 2012; Oliva,
Vargas, & Inestrosa, 2013), is necessary for cell proliferation, differentiation (Esfandiari
et al., 2012; Hirabayashi et al., 2004; Kioussi et al., 2002; Zechner et al., 2003), and
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dendritic growth and branching (Rosso, Sussman, Wynshaw-Boris, & Salinas, 2005). In
the absence of Wnt activation, via binding to its Frizzled receptor, glycogen synthase
kinase 3 beta (GSK-3β) phosphorylates β-catenin, tagging it for degradation. However,
in the presence of Wnt, GSK-3β is phosphorylated and thus inactivated, allowing βcatenin to translocate to the nucleus and promote gene transcription (Figure 2;
MacDonald, Tamai, & He, 2009; Moon, Bowerman, Boutros, & Perrimon, 2002). These
targets, GSK-3β and β-catenin, are differentially altered following cocaine
administration.

Figure 2: Simplified diagram of bFGF signaling pathway and its interaction with the Wnt signaling
pathway. (Far left) Following binding of Wnt to its Frizzled receptor, which includes the association with
LRP (lipoprotein receptor-related protein), DSH (disheveled; among others) is activated. This results in
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the phosphorylation (p) of GSK-3β (glycogen synthase kinase 3 beta), or its inactivation, resulting in βcatenin not being tagged for degradation, and instead being translocated to the nucleus to modify
transcription (represented with a dashed line; Dailey, Ambrosetti, Mansukhani, & Basilico, 2005). (Middle)
Following binding of bFGF to its FGFR (fibroblast growth factor receptor), a number of subsequent
pathways can be activated, including Ras (Powers, McLeskey, & Wellstein, 2000; Zubilewicz et al., 2001).
Ras belongs to a superfamily that mediates a number of downstream proteins and pathways, including
the Raf/MEK (mitogen-activated protein kinase kinase)/ERK/MAPK (mitogen/extracellular-signal
regulated kinase) pathway, which can activate a number of transcription factors, including CREB (cAMP
response element binding; Graham & Richardson, 2011b; Lu, Koya, Zhai, Hope, & Shaham, 2006;
Nestler, 2013; Powers et al., 2000; Zubilewicz et al., 2001). Ras also activates the PI3K (phosphinositide
3-kinase)/AKT (also called protein kinase B, PKB) pathway, which can inhibit GSK-3β activity, among a
number of other functions (#; Dailey et al., 2005; Peineau et al., 2007; Zubilewicz et al., 2001). (Far right)
bFGF binding can also activate PLCγ (phospholipase C gamma; Gu, Seong, Lee, & Kay, 1996), which
can subsequently activate IP3 (inositol triphosphate), resulting in modified calcium activity within the cell,
as well as mediation of other pathways.

Acute or chronic stimulant drug use enhances GSK-3β activity, as shown by a
reduction of GSK-3β phosphorylation at serine 9, in the amygdala (Perrine, Miller, &
Unterwald, 2008), NAc core, but not NAc shell, after a relatively short withdrawal period
(30 minutes to 24 hours; W. Y. Kim et al., 2013; J. S. Miller et al., 2014; Xu et al., 2011;
Xu et al., 2009). Moreover, GSK-3β heterozygous mice, which have a reduction of
roughly 50% of GSK-3β in the striatum, have attenuated amphetamine-induced
increases in locomotion (Beaulieu et al., 2004); alternatively, pharmacologically blocking
GSK-3β phosphorylation in NAc core, resulting in GSK-3β remaining active, increases
cocaine-induced locomotion (W. Y. Kim et al., 2013). Similarly, blocking GSK-3β
activity systemically or in the NAc core (but not shell) attenuates sensitization
development and expression (Enman & Unterwald, 2012; J. S. Miller, Tallarida, &
Unterwald, 2009; Xu et al., 2011; Xu et al., 2009). Moreover, the development and later
reconsolidation of a cocaine CPP is blocked by inhibiting GSK-3β activity systemically,
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in NAc core, or in the basolateral amygdala (J. S. Miller et al., 2014; Shi et al., 2014; Wu
et al., 2011). In summary, stimulant drug use increases GSK-3β activity in a number of
reward-related brain regions and is necessary for drug-induced increases in locomotion,
sensitization, and drug-associative learning.
If cocaine administration results in an increase in GSK-3β activity, then it is likely
that β-catenin expression would decrease. In agreement with this, following seven
days, but not one day, of cocaine injections plus 24 hours of withdrawal, β-catenin
mRNA expression is decreased in NAc (Dias et al., 2015). However, others have
reported increased β-catenin mRNA expression in the hippocampus following 14 days
of binge-like cocaine administration, 30 minutes after the last injection (Freeman et al.,
2001), or in NAc following 10 days of withdrawal, but not after one or 100 days, from
cocaine self-administration (Freeman et al., 2010). These discrepancies might be due
to differences in cocaine administration, withdrawal length, or due to a lack of subregion
specificity in NAc. Overall, more work is needed to determine the role of β-catenin and
the Wnt pathway in cocaine-induced plastic and behavioral changes.
In summary, acute or chronic drug administration can have a profound influence
on brain morphology, function, and molecular signaling. This influence includes
increased spine density and dendritic branching in reward-related brain regions, as well
as decreased neuronal activity in these regions following withdrawal, which is reversed
and enhanced following drug-associated cue presentation. Moreover, early life drug
administration or chronic drug administration can result in disrupted experiencedependent plasticity and new learning in adulthood or after prolonged withdrawal.
Lastly, drug use or withdrawal from drug use can modify expression of a number of
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plasticity-related molecules, such as ARC, ∆FosB, GluR1, Kal-7, MAP2, PSD95, GSK3β, and β-catenin. In brief, chronic drug use and subsequent withdrawal can induce
structural, functional, and molecular changes in reward-related brain regions. These
changes are likely induced as a homeostatic mechanism to regulate the altered
neurotransmitter signaling produced by drug use or withdrawal (Kalivas, 2009),
however, it is unclear how these molecules are altered following extinction. One
potential mechanism underlying these changes might be growth factors, such as basic
fibroblast growth factor (bFGF or FGF2).

bFGF and plastic changes
As reviewed, stimulant drug administration can induce morphological, functional,
and molecular changes, and one possible mechanism mediating these changes are
growth factors, such as bFGF. bFGF is part of a large and functionally diverse
fibroblast growth factor family, which is composed of 23 different FGF types and
subfamilies (FGF1-23), ten of which are localized to the brain (Burgess & Maciag, 1989;
Powers et al., 2000; Reuss & von Bohlen und Halbach, 2003). bFGF has a broad range
of functions throughout development and adulthood. For example, during development,
bFGF is necessary for cell proliferation, migration, survival, and differentiation (Aoyagi,
Nishikawa, Saito, & Abe, 1994; Grothe et al., 2000; Ornitz & Itoh, 2001; Wagner, Black,
& DiCicco-Bloom, 1999). Throughout life, bFGF contributes to tissue repair (Schultz &
Wysocki, 2009), cancer (Haley & Kim, 2014), and angiogenesis (van Wijk & van
Kuppevelt, 2014). Furthermore, bFGF has a role in learning, memory, and mood and
anxiety disorders (Riva et al., 2005; Graham and Richardson, 2011a).
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bFGF is expressed in both neurons and glia, but preferentially in glia
(Eckenstein, Woodward, & Nishi, 1991; Gomez-Pinilla, Lee, & Cotman, 1994; Gonzalez,
Berry, Maher, Logan, & Baird, 1995; Reuss & von Bohlen und Halbach, 2003), and a
higher molecular weight form of bFGF is specifically expressed in the nucleus, though
its function is currently unclear (Arnaud et al., 1999; Bugler, Amalric, & Prats, 1991;
Coulier et al., 1997; Powers et al., 2000). Moreover, bFGF is expressed on cell
surfaces, in the extracellular matrix, and has extracellular functions (DiMario, Buffinger,
Yamada, & Strohman, 1989; Mignatti, Morimoto, & Rifkin, 1992), although it is unclear
how bFGF is transported or released to these locations. bFGF lacks a signaling
sequence and is not secreted in an endoplasmic reticulum-Golgi pathway dependent
manner (J. A. Abraham et al., 1986; D'Amore, 1990; Forget, Stewart, & Trudeau, 2006;
Ornitz & Itoh, 2001). Currently, bFGF is thought to be released by cell damage or cell
death (Friesel & Maciag, 1999; Mignatti et al., 1992; Miyake et al., 1998; Miyamoto et
al., 1993; Ohmachi et al., 2000; Ornitz & Itoh, 2001; Reuss & von Bohlen und Halbach,
2003), though this hypothesis does not explain all the roles attributed to bFGF.
FGFs can bind to four types of FGF receptors (FGFR1-4; D. E. Johnson &
Williams, 1993), each with numerous splice variants (Powers et al., 2000), and with
different expression patterns. FGFR1 and FGFR4 are preferentially expressed in
neurons, FGFR2 is preferentially expressed in oligodendrocytes, and FGFR3 is
preferentially expressed in astrocytes (Asai et al., 1993; Miyake, Hattori, Ohta, & Itoh,
1996). bFGF can bind to any FGFRs, but binds with the highest affinity to FGFR1 (P. L.
Lee, Johnson, Cousens, Fried, & Williams, 1989; Ornitz et al., 1996; Reuss & von
Bohlen und Halbach, 2003). FGFRs are a part of the tyrosine kinase receptor family (D.
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E. Johnson & Williams, 1993), and when bound by bFGF are trafficked to the nucleus
(Bikfalvi, Klein, Pintucci, & Rifkin, 1997; H. M. Johnson, Subramaniam, Olsnes, & Jans,
2004; Myers, Martins, Ostrowski, & Stachowiak, 2003; X. Zhang & Simons, 2014) where
they can alter transcription. However, bound FGFRs also initiate a number of signaling
cascades (Dailey et al., 2005), which together mediates a number of plastic changes
during development and adulthood (Figure 2).

bFGF and morphological changes during development and in vitro
Growth factors have a major role during embryonic development, and bFGF has
been implicated in proliferation, survival, migration, growth, and differentiation
(Anderson, Dam, Lee, & Cotman, 1988; Aoyagi et al., 1994; Bikfalvi et al., 1997; Grothe
et al., 2000; Wagner et al., 1999). bFGF and FGFR1 protein and mRNA are expressed
at high levels at the beginning of neurogenesis in rat and mice embryos, but expression
is reduced as neurogenesis and proliferation slows during late embryogenesis (Raballo
et al., 2000; Vaccarino et al., 1999). bFGF application to cultured cells increased
proliferation in a dose-dependent manner (Boku et al., 2013), and blocking bFGF with a
neutralizing antibody (anti-bFGF) reversed these effects (Murdoch & Roskams, 2013;
Tao, Black, & DiCicco-Bloom, 1997). Moreover, systemic injection or lateral ventricle
infusion of bFGF into newborn rat pups increased proliferation in the hippocampus,
pontine subventricular zone, and granule cells in the cerebellum (Tao, Black, & DiCiccoBloom, 1996; Wagner et al., 1999), and increased mass, volume, and cell number at
either E20.5 or 2 months, but the opposite was found when anti-bFGF was infused
(Vaccarino et al., 1999) or when bFGF was knocked out (Raballo et al., 2000; Vaccarino
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et al., 1999). Overall, these findings indicate that bFGF is necessary for cell
proliferation and neurogenesis.
bFGF also interacts with a number cell signaling pathways, such as the Wnt
signaling pathway, including GSK-3β and β-catenin, to mediate cell proliferation (Figure
2). bFGF promotes phosphorylation of GSK-3β (Israsena, Hu, Fu, Kan, & Kessler,
2004) through downstream targets, such as AKT (also called protein kinase B, PKB;
Dailey et al., 2005), resulting in increased expression of β-catenin in the nucleus and
increased cell proliferation (Boku et al., 2013; Israsena et al., 2004; Shimizu et al.,
2008). The bFGF-induced increase in proliferation is mediated through GSK-3β, as
expressing the dominant-active form of GSK-3β blocks increases in proliferation
(Shimizu et al., 2008); whereas, inhibiting GSK-3β with a small molecule increases cell
proliferation more so than when bFGF is added alone (Murdoch & Roskams, 2013).
Moreover, the increase in proliferation is through the interactions with β-catenin, as
there is only enhanced neuronal differentiation and no effect on proliferation in cell
culture overexpressing β-catenin but lacking bFGF (Israsena et al., 2004; Shimizu et al.,
2008). In summary, bFGF application increase β-catenin expression, as it inhibits GSK3β, resulting in increased proliferation.
In addition to proliferation and neurogenesis, bFGF mediates axon branching and
spine morphology. bFGF application to cultured cortical or hippocampal neurons rapidly
increases axon branching compared to control neurons (Kalil, Szebenyi, & Dent, 2000;
Patel & McNamara, 1995), and the removal of bFGF results in a reduction of axonal
branching to baseline (Aoyagi et al., 1994). Moreover, bFGF increases axonal
branching by increasing growth cone size and slowing the advancement of the growth
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cone (Szebenyi et al., 2001). During development, bFGF knockout mice have disrupted
cellular organization, differentiation, migration, and a 10 percent reduction in overall
thickness of the cortex and hippocampus (Dono, Texido, Dussel, Ehmke, & Zeller,
1998). In adulthood, bFGF knockout mice have normal dendritic spine densities in the
hippocampus, but have increased spine length (Zechel, Unsicker, & von Bohlen Und
Halbach, 2009). Long, immature, spines are associated with behavioral and learning
and memory deficits, such as those seen in mice lacking the functional fragile X mental
retardation protein, which also display no changes in spine density but an increase in
spine length (Ding, Sethna, & Wang, 2014; Grossman, Elisseou, McKinney, &
Greenough, 2006). In brief, bFGF mediates spine morphology and axon branching.
In summary, bFGF has numerous functions during embryonic and postnatal
development, but one major role is to induce cell proliferation and neurogenesis.
bFGF’s ability to induce cellular proliferation and neurogenesis persists into adulthood
(Monfils et al., 2005; Pieper et al., 2005), and can reverse age-related reductions in
neurogenesis (Jin et al., 2003; Kang & Hebert, 2015). bFGF interacts with and
stimulates a number of cell signaling pathways, and one interaction that is necessary for
proliferation and is affected by drug use (see next section) is its interaction with GSK-3β
and β-catenin. Finally, bFGF is necessary for axonal branching and can modify
dendritic spine morphology. Stimulant drug administration similarly alters some of these
functions, thus, making bFGF a potential underlying mechanism.

bFGF and drug-induced plastic changes
As reviewed, stimulant drugs induce a number of changes in reward-related brain
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regions, and these changes may underlie the perseveration of drug addiction. A
possible mechanism underlying these changes is growth factors, such as bFGF. As
discussed in the previous section, bFGF is necessary for cellular proliferation,
neurogenesis, survival, differentiation, and neurite outgrowth. Thus, bFGF might be
mediating some of the plastic changes induced by stimulant drug use.
Following stimulant drug administration, bFGF expression is increased in a
number of reward-related brain regions. A single systemic injection of nicotine
increased bFGF mRNA expression six hours later in the striatum (Maggio et al., 1998),
parietal cortex, and entorhinal cortex (Roceri et al., 2001). Drug-induced increases of
bFGF are long-lasting as well, as increased bFGF immunoreactivity in VTA and
substantia nigra (SNc) was observed following 24 hrs, 72 hrs, one week, and one month
after three days of amphetamine injections (Flores et al., 1998). Moreover, increased
bFGF mRNA expression is observed following acute or chronic injections of cocaine
(one, five, or 14 injections) in PFC and striatum, and in hippocampus in a timedependent manner following chronic injections (Fumagalli et al., 2006). Likewise, we
found a similar increase in bFGF protein expression in IL-mPFC following cocaine selfadministration plus 12 days of withdrawal (Hafenbreidel et al., 2015). In sum, a number
of stimulant drugs, given acutely or chronically, can produce relatively long-lasting
increases in bFGF mRNA or protein expression in a number of brain regions.
The increased expression is likely mediated by drug-induced increases in
extracellular neurotransmitters, such dopamine and glutamate (Flores & Stewart, 2000).
Administration of a dopamine D1 or D2 receptor antagonist can block nicotine-induced
increases in bFGF mRNA expression in the striatum (Roceri et al., 2001), whereas, a

27

non-selective dopamine agonist or a dopamine D2-selective agonist, but not a D1selective agonist, can increase bFGF mRNA expression in the striatum (Roceri et al.,
2001), PFC and hippocampus (Fumagalli et al., 2003). Likewise, bFGF mRNA
expression is increased following glutamate application to cultured cortical astrocytes
(Pechan, Chowdhury, Gerdes, & Seifert, 1993), or following a systemic injection of
kainate (to induce seizures) in the hippocampus and striatum three and six hours,
respectively, after the injection (Riva, Donati, Tascedda, Zolli, & Racagni, 1994; Van
Der Wal, Gomez-Pinilla, & Cotman, 1994). Furthermore, amphetamine-induced
increases in bFGF immunoreactivity in VTA and SNc are blocked by co-administration
of a nonselective glutamate receptor antagonist (Flores et al., 1998) and a competitive
nonselective NMDA receptor antagonist (Flores, Samaha, & Stewart, 2000). Overall,
increased bFGF expression following stimulant drug use administration is specifically
increased following dopamine and glutamate receptor activation.
As mentioned, bFGF is important for cell survival, but is also neuroprotective
during development and adulthood (Anderson et al., 1988; Gomez-Pinilla et al., 1992;
Logan et al., 1992; Chadi et al., 1993; Mark et al., 1997; Maggio et al., 1998; Flores and
Stewart, 2000a), which may underlie the increased expression following drug use (see
Figure 3 for overview). Stimulant drug exposure generates a neuroprotective response
(Flores & Stewart, 2000). For example, cocaine blocks monoamine reuptake, including
dopamine, and the autoxidation of dopamine results in free-radical byproducts
(Fornstedt, Pileblad, & Carlsson, 1990). Free radicals can induce oxidative stress and
damage cells (Riley, 1994), but also recruit bFGF (Pechan, Chowdhury, & Seifert,
1992), which can protect cells against oxidative stress (Hou, Cohen, & Mytilineou, 1997;
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Mark, Keller, Kruman, & Mattson, 1997). The oxidative stress induced by drug use may
be a sufficient injury to the cell to release bFGF, as cell injury or damage is thought to
be the mechanism by which bFGF is released (Friesel & Maciag, 1999; Mignatti et al.,
1992; Miyake et al., 1998; Miyamoto et al., 1993; Ohmachi et al., 2000; Reuss & von
Bohlen und Halbach, 2003). In brief, stimulant drug use induces oxidative stress, which
results in the recruitment, and perhaps release, of bFGF to protect the cell. However,
drug-induced increases in bFGF are long lasting in certain brain regions (Flores et al.,
1998; Fumagalli et al., 2006; Hafenbreidel et al., 2015a), and these increases may have
additional, possibly aversive, side effects.
The side effects induced by overexpression of bFGF may include some of the
long-term changes observed following drug use. For example, bFGF application to
cultured hippocampus neurons increases expression of GluR1-containing AMPArs
(Cheng et al., 1995). Moreover, amphetamine-induced increases in dendritic length of
dopaminergic neurons in VTA are blocked by inhibition of bFGF by anti-bFGF (Mueller
et al., 2006). bFGF also mediates behavioral changes induced by drug use as blocking
bFGF with anti-bFGF in VTA attenuates amphetamine-induced increases in locomotion
and blocks amphetamine-induced sensitization (Flores et al., 2000). Conversely,
systemic injections of bFGF on postnatal day (PND) one enhanced initial acquisition of
cocaine self-administration during adulthood (Turner et al., 2009). In summary, bFGF
contributes to structural and behavioral changes observed following drug use.
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Figure 3: Proposed model of the role of bFGF in drug-associated learning. (Left) Stimulant drug
administration blocks dopamine’s reuptake, which results in increased extracellular dopamine. Following
autooxidaton of dopamine, free radical byproducts are produced (Fornstedt et al., 1990; Kovacic, 2005)
that can induce oxidative stress and cell damage (Lopez-Pedrajas et al., 2015; Riley, 1994). Free
radicals recruit bFGF (Pechan et al., 1992), which can protect against oxidative stress (Hou et al., 1997;
Mark et al., 1997). Drug-induced overexpression of bFGF is long lasting, which can induce a number of
maladaptive side effects, including increased GluR1 expression (Cheng et al., 1995), increased dendritic
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length (Mueller et al., 2006), decreased excitability (Cuppini, Ambrogini, Lattanzi, Ciuffoli, & Cuppini,
2009; Hilborn, Vaillancourt, & Rane, 1998), and potentiated calcium- dependent inactivation of NMDA
receptors (Boxer, Moreno, Rudy, & Ziff, 1999). These changes may underlie the delay in new learning
and preservative drug seeking. (Right) We previously found that neutralizing bFGF in the IL-mPFC can
facilitate extinction, and extinction can reduce bFGF protein expression (Hafenbreidel et al., 2015).
However, it is unclear how neutralizing bFGF facilitates learning, or how extinction can reduce bFGF
expression.

Another possible side effect of drug-induced overexpression of bFGF is that it
affects neuronal function. Bath application of bFGF inhibits voltage-gated Na+ (Hilborn
et al., 1998) and K+ currents, and decreases the number of evoked action potentials in
the hippocampus (Cuppini et al., 2009), suggesting that cocaine-induced
overexpression of bFGF would functionally reduce intrinsic excitability of neurons. This
reduction in intrinsic excitability can have further side effects, as reduced intrinsic
excitability limits future learning (Sehgal et al., 2013). Moreover, bFGF inhibits NMDA
receptor function following excessive calcium influx (Boxer et al., 1999), which also
could impact learning and memory (e.g., McLamb, Williams, Nanry, Wilson, & Tilson,
1990; Mondadori, Weiskrantz, Buerki, Petschke, & Fagg, 1989; Thompson, Winsauer, &
Mastropaolo, 1987). In line with this, as discussed previously, stimulant drug use can
decrease intrinsic excitability following withdrawal (Kourrich & Thomas, 2009; Mu et al.,
2010), hinder later learning (Radley et al., 2015; Sillivan et al., 2011; Skelton et al.,
2007; Vorhees et al., 1994; Williams et al., 2002), and limit new experience-dependent
plasticity (Kolb et al., 2003). However, if cocaine-induced overexpression of bFGF
hinders new learning by inducing maladaptive plastic changes has yet to be directly
examined.
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In conclusion, bFGF mediates a number of processes during development and
adulthood, and in drug-associated behaviors and plasticity. Throughout life, bFGF is
neuroprotective, mediates axon, dendrite, and spine morphology, and induces
proliferation through its interactions with GSK-3β and β-catenin. However, stimulant
drug use results in increased bFGF expression in a number of reward-related brain
regions. The initial increase in bFGF expression might be a neuroprotective response,
but enduring overexpression may have lasting side effects, such as increased dendritic
growth in VTA, reduced intrinsic excitability, and the development and maintenance of
drug-associated behaviors, such as locomotor sensitization.

Extinction of drug seeking
As previously mentioned, the persistence of drug addiction is maintained by cues
associated with the rewarding properties of the drug (e.g., context or syringe), as these
cues can trigger retrieval of the original drug-cue memory, evoke craving, and promote
relapse (Epstein et al., 2006; Volkow et al., 2006). Following memory retrieval, the
memory is labile and requires restabilization into long-term storage through a process
called reconsolidation (C. A. Miller & Marshall, 2005; Misanin, Miller, & Lewis, 1968;
Nader, Schafe, & Le Doux, 2000). However, when the cue is repeatedly presented
without drug reinforcement, a new inhibitory extinction memory will be acquired and
consolidated into long-term storage (Millan et al., 2011; Quirk & Mueller, 2008).
Therefore, cue-reactivity can be reduced through extinction, leading to a reduced
likelihood of inducing craving and relapse.
As discussed, bFGF mRNA and protein expression is increased following
stimulant drug administration (Flores et al., 1998; Fumagalli et al., 2006; Maggio et al.,
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1998; Roceri et al., 2001) or cocaine self-administration (Hafenbreidel et al., 2015) in
reward-related brain regions, such as IL-mPFC and striatum. Interestingly, we found
that extinction of drug seeking following cocaine self-administration reduces bFGF
protein expression in IL-mPFC to similar expression levels as controls (Hafenbreidel et
al., 2015), and our preliminary data suggests that extinction reduces bFGF expression
in dHipp, and possibly in NAc, as well. The reduction in bFGF following extinction is
functional as well, as blocking bFGF in IL-mPFC with anti-bFGF facilitates extinction
retention following cocaine self-administration (see preliminary data; Hafenbreidel et al.,
2015). Although not directly tested, these results suggest that drug-induced
overexpression of bFGF impedes new learning, such as that required for extinction.
However, these effects are likely limited to extinction of drug seeking, as bFGF
administered systemically or infused into the amygdala enhances extinction of
conditioned fear, attenuates renewal following extinction, and attenuates shock-induced
reinstatement (Graham and Richardson, 2009a, 2010a, 2011b, a). Moreover, systemic
injections of bFGF enhances context fear conditioning in young rats (Graham &
Richardson, 2009), and early life systemic injections of bFGF (PND1-5) can enhance
later life context fear conditioning and renewal following extinction (PND16) in rats that
otherwise demonstrate poor learning at this age (Graham & Richardson, 2010).
Overall, these results suggest that bFGF administration enhances extinction of
conditioned fear, but early life administration enhances later life fear-associated
learning.
Alternatively, bFGF also has a role in anxiety-related behaviors. For example,
increased bFGF expression is associated with reduced anxiety-related behaviors and
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vice versa, in selectively bred ratlines (Graham & Richardson, 2011b; Riva, Molteni,
Bedogni, Racagni, & Fumagalli, 2005). Thus, it is unclear if bFGF simply enhances
learning in other paradigms, or if it has a unique and differential role in fear conditioning
and drug addiction. It seems likely that bFGF has a unique role in fear- and drugassociated learning, as a systemic injection of bFGF on PND one had no effect on
Morris water maze learning or food self-administration (Turner et al., 2009). However,
Graham and Richardson (2009b, 2010b) also found a single injection on PND one was
not sufficient to induce enhance learning at a young age, but when the number of
injections was increased to five and fear conditioning parameters were altered (e.g.,
more trials, stronger shock) then early life bFGF administration was sufficient to
enhance learning. Further experiments are needed to determine the overall role of
bFGF in learning and memory, particularly the differential effects of bFGF in fear
conditioning and drug-related learning.
The discrepancy in the role of bFGF during extinction of conditioned fear versus
extinction of drug seeking is likely due to changes produced by stimulant drug
administration on bFGF expression (Flores et al., 1998; Fumagalli et al., 2006;
Hafenbreidel et al., 2015; Maggio et al., 1998; Roceri et al., 2001). As discussed in the
previous section, this includes increased expression likely from drug-induced increases
in extracellular neurotransmitters, such as dopamine and glutamate, and from the
neuroprotective response initiated by drug use (Pechan et al., 1992; Pechan et al.,
1993; Riva et al., 1994; Mark et al., 1997; Flores et al., 2000; Flores and Stewart,
2000a; Roceri et al., 2001; Fumagalli et al., 2003). In further support of this, we found
that bFGF protein expression in IL-mPFC is unchanged following sucrose self-
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administration and yoked-saline administration, with or without extinction, compared to
naïve home-cage controls (see preliminary data; Hafenbreidel et al., 2015). These
results indicate that changes in bFGF expression are specifically due to cocaine
administration and subsequent extinction, and not due to operant responding, food
reward, or cue presentation. Therefore, the differences in the role of bFGF observed
between extinction of drug seeking and extinction of conditioned fear are likely due to
the maladaptive changes induced by chronic stimulant drug administration. However,
this has not been directly examined, and it is unclear how bFGF mediates these druginduced changes, or how extinction affects them.
Surprisingly little research has been conducted on the mechanisms underlying
extinction of drug seeking, as most research focuses on the development or acquisition
of drug seeking, withdrawal, or relapse or reinstatement of drug seeking. Nonetheless,
the mechanisms underlying extinction of drug seeking are beginning to be examined.
For example, spine diameter in NAc core is increased in rats that underwent extinction
of drug seeking following cocaine self-administration compared to yoked-saline controls
(Shen, Gipson, Huits, & Kalivas, 2014). Moreover, spine density was increased in ILmPFC in rats that underwent extinction of drug seeking in an ethanol self-administration
paradigm compared to rats that just underwent withdrawal (Gass et al., 2014).
Similarly, the molecular mechanisms underlying extinction have been minimally
examined. As mentioned before, ∆FosB, Kal-7, GSK-3β, or β-catenin are all modified
following cocaine use, however, it is currently unclear whether extinction modifies their
expression. Nevertheless, ∆FosB does have a role in extinction, as overexpression in
NAc shell facilitates extinction following cocaine self-administration (Y. Zhang et al.,
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2014). It seems likely that their expression would change following extinction, as they
are altered or necessary in other learning paradigms, such as classical conditioning or
spatial learning (e.g., Fortress, Schram, Tuscher, & Frick, 2013; Greenwood et al.,
2011; Kimura et al., 2008; Kiraly et al., 2011; Mandela & Ma, 2012; Mills et al., 2014;
Werme et al., 2002).
Changes in glutamatergic receptors and their associated scaffolding proteins
(e.g., PSD95) have been measured following extinction. For example, extinction of drug
seeking following cocaine self-administration results in increased expression of GluR1containing AMPAr in NAc shell, however, expression is not changed following
withdrawal of a similar passage of time (Ghasemzadeh et al., 2009b), after one day of
withdrawal, or after extinction of sucrose seeking (Self et al., 2004; Sutton et al., 2003).
Moreover, the increase in GluR1-containing AMPArs is associated with the length of
extinction training that occurred; in other words, the better rats learned extinction, the
higher their expression of GluR1-containing AMPArs (Sutton et al., 2003). Likewise,
PSD95 protein expression is increased in NAc core following extinction after longaccess cocaine self-administration compared to saline self-administration, however, no
changes were found in NAc shell, dorsomedial PFC (dmPFC, containing PL-mPFC),
ventromedial PFC (vmPFC, containing IL-mPFC), or VTA (Ghasemzadeh et al., 2009a;
Ghasemzadeh et al., 2009b; Ghasemzadeh et al., 2011). Additionally, PSD95 is
increased in PSD subfractions in NAc core following extinction after short-access
cocaine self-administration compared to yoked-saline controls (Knackstedt et al., 2010).
Changes were specific to extinguishing drug seeking, as PSD95 was not altered
following extinction of sucrose seeking or after only two days of extinction training
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(Knackstedt et al., 2010). In summary, these results indicate that additional changes
occur following extinction that are different than those that occur following withdrawal
from drug use. Understanding these changes further could help establish new methods
of strengthening extinction, and thus reduce relapse rates.
Despite the progress made regarding how stimulant drug use induces
morphological, molecular, and functional changes in a number of reward-related brain
regions, and how bFGF mediates morphological and functional changes during
development, adulthood, and following stimulant drug administration; it is unclear how
these two overlap, and in which brain regions, during extinction of drug seeking.
Specifically, little is known concerning plastic changes following extinction of drug
seeking and what mechanisms underlie our previous findings that bFGF is reduced
following extinction and reducing bFGF facilitates extinction retention. Therefore, this
dissertation aims to address these unknowns.
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PROPOSED EXPERIMENTS
The proposed experiments aimed to address four central questions: 1) are
cocaine-induced plastic changes altered by extinction, 2) in which brain regions do
these effects occur, 3) does neutralizing bFGF in the IL-mPFC prior to four 30-min
extinction sessions facilitate any extinction-induced plastic changes, and 4) what is the
functional relevance of the observed changes in bFGF expression in the NAc and
dHipp. Here, I reviewed previous work demonstrating that stimulant drug use can
induce a number of plastic changes, and growth factors, such as bFGF, might underlie
these changes. I also reviewed the limited data demonstrating that extinction might be
able to reverse some drug-induce plastic changes.
bFGF mRNA and protein expression is increased in a number of reward-related
brain regions (Flores et al., 1998; Fumagalli et al., 2006; Hafenbreidel et al., 2015;
Maggio et al., 1998; Roceri et al., 2001), but decreased following extinction
(Hafenbreidel et al., 2015), suggesting a role in both drug-induced plasticity and during
extinction. The drug-induced overexpression of bFGF might be a neuroprotective
response, as stimulant drugs increase extracellular dopamine that when it undergoes
autoxidation, it releases free radical byproducts (Fornstedt et al., 1990; Kovacic, 2005).
Free radical byproducts can induce oxidative stress (Lopez-Pedrajas et al., 2015; Riley,
1994), but they also recruit bFGF (Pechan et al., 1992), which can protect against the
oxidative stress (Hou et al., 1997; Mark et al., 1997).
The recruited bFGF, however, is long lasting, as it is still observed a long as a
month following drug administration (Flores et al., 1998; Fumagalli et al., 2006). These
long-lasting increases correspond with plastic and behavioral changes; such as,
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increased dendrite length in VTA following amphetamine administration (Mueller et al.,
2006), and bFGF in VTA is necessary for cocaine sensitization (Flores et al., 2000). In
summary, drug-induced and long-lasting overexpression of bFGF could inadvertently
lead to additional plastic changes that promote preservative drug seeking and delay
new learning. However, our preliminary data suggests that extinction can reduce bFGF
expression in IL-mPFC, dHipp, and possibly NAc, and that blocking bFGF in IL-mPFC
can facilitate extinction retention. The behavioral relevance of the reduction of bFGF in
dHipp and possibly NAc has yet to be determined. Moreover, if extinction can reverse
drug-induced plasticity is not clear.
One limitation to our previous findings is that bFGF was neutralized in IL-mPFC
following a 36-38 day withdrawal period. Conversely, we measured bFGF protein
expression after a relatively short withdrawal period (12 days) following cocaine selfadministration. As reviewed, prolonged withdrawal can induce a number of behavioral
and plastic changes in reward-related brain regions (Divac, 1971; Lu, Grimm, Hope, &
Shaham, 2004; Radley et al., 2015; Robinson & Becker, 1986; Robinson & Kolb, 1997,
1999, 2004; Sillivan et al., 2011; Skelton et al., 2007; Vorhees et al., 1994; Williams et
al., 2002). However, if bFGF expression is altered following prolonged withdrawal is
unclear. Moreover, our preliminary data suggests that extinction of drug seeking can
alter bFGF expression in a number of brain regions, but the behavioral relevance of
these changes are unknown.
Given previous work and our preliminary findings, it is likely that maladaptive
plastic and functional changes induced by drug administration are mediated, in part, by
bFGF. Extinction then reduces bFGF expression, resulting in the reversal of
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downstream consequences of stimulant-induced overexpression of bFGF and stimulantinduced plastic changes. However, one side effect of cocaine-induced overexpression
of bFGF is a delay in new learning, as demonstrated by the numerous extinction
sessions needed to reach extinction criteria and the facilitation of extinction when bFGF
is neutralized.
Aim one: To determine if extinction modifies cocaine-induced plastic changes, and if
bFGF mediates these changes.
Stimulant drug administration can induced a number of structural, functional, and
molecular changes, such as increased spine density and length, and altered spine
morphology, in reward-related brain regions (e.g., Mueller et al., 2006; Robinson & Kolb,
1997, 1999). Furthermore, extinction of drug seeking can induce plastic changes, such
as increased spine density in IL-mPFC following extinction of ethanol seeking (Gass et
al., 2014). However, if extinction of drug seeking alters stimulant-induced plasticity, and
if bFGF mediates these changes are unclear. Based on our preliminary data, the
working hypothesis for this aim is that extinction reverses cocaine-induced plasticity, in
part, by a reduction in bFGF in three reward related brain regions: IL-mPFC, NAc, and
dHipp.
Aim two: To determine the functional relevance of extinction-induced reduction of bFGF
in dHipp and NAc.
Both dHipp and NAc have been implicated in extinction. For example, lesioning
dHipp disrupts extinction of sucrose seeking (Dillon, Qu, Marcus, & Dodart, 2008)
indicating dHipp is necessary for acquiring the new extinction memory. Additionally,
inhibiting NAc activity following extinction of drug seeking in a self-administration
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paradigm will reinstate drug seeking, suggesting the NAc is necessary for the
expression of extinction of drug seeking (Peters et al., 2008). Our preliminary data
suggests that extinction of drug seeking following cocaine self-administration decreases
bFGF expression in dHipp and possibly NAc. Similarly to our findings in IL-mPFC, the
working hypothesis for this aim is that neutralizing bFGF in dHipp or NAc will facilitate
extinction retention.
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SIGNIFICANCE OF THE PROPOSED EXPERIMENTS
Our previous findings, along with others, suggest that stimulant drug use results
in a maladaptive overexpression of bFGF, which promotes plastic changes that may
underlie the persistence of drug addiction. The completion of these experiments would
determine if extinction can alter cocaine-induced plastic changes, and if these changes
are mediated by bFGF. Moreover, they would determine the underlying circuitry
mediating our preliminary results. Specifically, these experiments would determine if
neutralizing bFGF in other brain regions, such as NAc and dHipp, are also necessary to
facilitate extinction retention or if IL-mPFC is unique. Therefore, the behavioral
relevance of the observed reduction of bFGF expression in dHipp and NAc following
extinction will be determined (see preliminary data). Overall, understanding the
neuronal mechanisms by which bFGF mediates extinction at systems and molecular
levels would allow for development of new pharmacotherapeutics to enhance extinctionbased therapies for addiction.
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PRELIMINARY DATA
As described, bFGF mRNA and protein expression is increased following single
or multiple injections of cocaine, nicotine, or amphetamine (Flores et al., 1998;
Fumagalli et al., 2006; Maggio et al., 1998; Roceri et al., 2001). However, if bFGF
protein expression was altered following self-administration or extinction, and if bFGF
had a functional role during extinction of drug seeking was unknown. Therefore, we
previously conducted a serious of experiments to assess these unknowns. Tissue was
collected following an extinction retention test from a number of groups and brain
regions (Table 2), and the results demonstrate that cocaine self-administration and
extinction can alter bFGF protein expression. Furthermore, we found that blocking
bFGF in IL-mPFC facilitated extinction of drug seeking (Hafenbreidel et al., 2015).

Table 2: List of experimental groups and tissue collected for each experiment that utilized western blots
(WB) or immunohistochemistry (IHC).
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Cocaine self-administration increases bFGF protein expression in IL-mPFC and
NAc, an effect reversed by extinction
To determine if bFGF was similarly increased following cocaine selfadministration and if extinction of drug seeking had an affect on its expression, bFGF
protein expression was first measured in vmPFC and NAc after withdrawal or extinction
following cocaine self-administration. Rats were trained to lever press for cocaine or
sucrose before being matched and assigned to groups: extinction (coc-ext; suc-ext) or
no extinction (coc-noext; experiment 1, Table 2 & 3). Rats then underwent extinction of
sucrose seeking (Figure 4a) or cocaine seeking (Figure 4b), during which the rest of the
rats remained in their home cages. Following the last day of extinction, all rats were
tested for extinction retention (Figure 5c), before rats were euthanized and vmPFC and
NAc were collected for western blot analysis (see Materials and Methods).
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Table 3: Average number of active and inactive lever presses, or infusions across the last three days of
cocaine self-administration, for each experiment. There were no significant differences between groups.
Numbers in parentheses are final group sizes.

Figure 4: Cocaine self-administration increases bFGF protein expression in NAc, an effect reversed by
extinction. Active lever presses during extinction of sucrose seeking (a), cocaine seeking (b), and during
the extinction retention test (c). (d-e, top) Representative blots for each group and tissue regions
containing the vmPFC or NAc. (d) bFGF protein expression in the vmPFC was not significantly different
between groups, but there was a trend between coc-ext and coc-noext groups (t12=2.118, p=0.056). (e)
bFGF protein expression in the NAc was greater in coc-noext rats compared to coc-ext or suc-ext rats.
Error bars are ±SEM. *p<0.05. Suc-ext, n=10; coc-noext, n=7; coc-ext, n=7.

In vmPFC, bFGF protein expression was not significantly different between
groups, but there was a trend for reduced bFGF protein expression in coc-ext rats
compared to coc-noext rats (Figure 4d). However, in NAc, bFGF protein expression
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was significantly increased in coc-noext rats, replicating previous findings (Fumagalli et
al., 2006; Maggio et al., 1998; Roceri et al., 2001), but expression was reversed to
baseline following extinction (Figure 4e). Additionally, extracellular-signal-regulated
kinase (ERK; also called mitogen-signal regulated kinase, MAPK) and the activated or
phosphorylated version of ERK (pERK) were measured, as it is a downstream target of
bFGF (Figure 2; Dailey et al., 2005). Moreover, ERK is activated following acute or
prolonged cocaine administration (Valjent et al., 2000), is necessary for the
development of cocaine or amphetamine sensitization (Valjent et al., 2006b), is
increased in sensitized rats (Boudreau, Reimers, Milovanovic, & Wolf, 2007), and is
necessary for drug-associated learning (Lu et al., 2006; C. A. Miller & Marshall, 2005;
Valjent, Corbille, Bertran-Gonzalez, Herve, & Girault, 2006). Nonetheless, no significant
differences between groups were observed in vmPFC or NAc (data not shown),
possibly because rats had undergone withdrawal or extinction for over two weeks.
Differences might be detectable following the last day of self-administration or following
the first day of extinction (e.g., Ren et al., 2010). In summary, these results
demonstrated for the first time that extinction reverses cocaine-induced increases in
bFGF protein expression in NAc, and were trending in vmPFC.
However, this first preliminary experiment had a number of limitations.
Therefore, it was replicated with a number of changes, including the inclusion of
additional control groups (experiment 2, Table 1; Hafenbreidel et al., 2015), specifically
measuring protein expression in IL-mPFC, and also measuring expression of bFGF
primary receptor, fibroblast growth factor receptor-1 (FGFR1; P. L. Lee et al., 1989;
Reuss & von Bohlen und Halbach, 2003). Rats underwent sucrose or cocaine self-
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administration or yoked-saline administration, in which rats were yoked to a cocaineadministering rat throughout acquisition and extinction (if applicable), receiving identical
cues and a saline infusion when the cocaine-administering rat pressed the active lever,
but their lever presses resulted in no programmed consequences. A naïve home-cage
control group was also included (naïve; experiment 2, Table 2). Following acquisition
(experiment 2, Table 3), half of each group underwent extinction (Figure 5a, 5c, & 5e),
whereas the other half of each group remained in their home cages. Following the last
day of extinction, all rats were tested for extinction retention (Figure 5b, 5d, & 5f), before
rats were euthanized and IL-mPFC was collected for western blot analysis. NAc and
dHipp were also collected, but not analyzed.
In IL-mPFC, bFGF protein expression was not significantly different between
naïve, suc-noext, and suc-ext groups (Figure 6c), indicating that neither sucrose
reinforcement nor extinction of sucrose reinforcement altered bFGF protein expression.
Furthermore, naïve, yoked-sal-noext, and yoked-sal-ext groups were not significantly
different (Figure 6d inset), indicating that cue presentation and i.v. infusions did not
affect bFGF protein expression. Therefore, these groups were collapsed into a single
control group and compared to coc-noext and coc-ext groups (Figure 6d), and only
cocaine self-administration increased bFGF protein expression in IL-mPFC, which was
reversed to baseline by extinction. Conversely, FGFR1 protein expression was not
significantly different between any groups (Figure 6e, 6f inset, 6f). In summary, these
first two experiments indicate that bFGF protein expression was increased following
cocaine self-administration in the NAc and IL-mPFC, an effect reversed by extinction,
but FGFR1 protein expression in IL-mPFC was not changed in any condition.
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Figure 5: Extinction and extinction
retention tests prior to protein analysis.
Active lever presses during extinction
of sucrose seeking (a) and during the
extinction retention test (b). Active
lever presses during extinction of
cocaine seeking (c) and during the
extinction retention test (d). Active
lever presses during extinction
following yoked-saline (e) and during
the extinction retention test (f). Error
bars are ±SEM. *p<0.05. Suc-noext,
n=8; suc-ext, n=9; yoked-saline-noext,
n=12; yoked-saline-ext, n=11; cocnoext, n=12; coc-ext, n=12.

48

Figure 6: Cocaine selfadministration increases
bFGF protein expression in
IL-mPFC, an effect reversed
by extinction. (a)
Representative areas of
tissue collection containing
IL-mPFC. (b)
Representative blots for
each group. (c) bFGF
protein expression was not
altered between naïve (n=7),
suc-noext (n=8), or suc-ext
(n=8) groups. (d) bFGF
protein expression was
greater in coc-noext rats
(n=12) compared to coc-ext
rats (n=12) and controls
(n=30). (d, inset) Controls
are shown separately. bFGF
protein expression was not
altered between naïve (n=7),
yoked-sal-noext (n=12), or
yoked-sal-ext (n=11) groups,
and these groups were
collapsed into a single
control group. (e) FGFR1
protein expression was not
altered between naïve (n=7), suc-noext (n=7), or suc-ext (n=8) groups. (f) FGFR1 protein expression was
not altered between controls (n=28), coc-noext (n=11), or coc-ext (n=11) groups. (f, inset) Controls are
show separately. FGFR1 protein expression was not altered between naïve (n=7), yoked-sal-noext
(n=11), or yoked-sal-ext groups (n=10), and these groups were collapsed into a single control group.
*p<0.05. Error bars are ±SEM.
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Cocaine self-administration and extinction of drug seeking alters bFGF
expression in NAc and hippocampus
To further examine bFGF protein expression following cocaine self-administration
and extinction, bFGF immunoreactivity was measured in a number of brain regions
using immunohistochemistry (IHC) as it allows for precise regional specificity and
cellular expression, instead of total protein concentration as measured with western
blots. Rats were trained to lever press for cocaine before being matched and assigned
to groups: extinction (coc-ext) or no extinction (coc-noext). Additionally, a naïve homecage control group was included (naïve; experiment 3, Table 2 & 3). Rats then
underwent daily extinction sessions (Figure 7a) or remained in their home cages.
Following the last extinction day, all rats were tested for extinction retention (7b), before
being euthanized and brains were collected for IHC processing and analysis (Figure 8
and 9). The brain regions examined were selected because they are important in
addiction, learning and memory, extinction, or in combination (see Self-administration
paradigm; Fanselow & Dong, 2010; Millan et al., 2011; Quirk & Mueller, 2008), and
included PL-mPFC, IL-mPFC, NAc core, NAc shell, amygdala, dHipp, vHipp, and VTA.

Figure 7: Extinction and extinction retention
tests prior to immunohistochemical analysis.
Active lever presses during extinction of
cocaine seeking (a) and during the extinction
retention test (b). *p<0.05 Error bars are
±SEM.
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Rats were overdosed with pentobarbital and perfused with phosphate buffered
saline and paraformaldehyde. Next, slices from each treatment group that contained
mPFC, NAc, amygdala, dHipp, vHipp, and VTA were collected and processed with IHC
to measure cells expressing bFGF. Three slices were randomly selected from each rat,
imaged, and coded by a non-involved individual to ensure researchers were blind to
treatment. Next, regions of interest (ROIs) were drawn for each structure on each slice,
followed by semi-manual counting of cells expressing bFGF. After all images were
counted, images were decoded, densities per ROIs were calculated (number of cells
divided by ROI area in mm2), and averaged per rat, per treatment group.
bFGF immunoreactivity was not significantly different between groups in PLmPFC (Figure 8e, left) or in IL-mPFC (Figure 8e, right). However, in IL-mPFC there
was a trend for reduced bFGF immunoreactivity in coc-ext rats compared to naïve,
suggesting that bFGF immunoreactivity is reduced following extinction. In NAc core
(Figure 8g, right), bFGF immnoreactivity was significantly higher in coc-ext rats
compared to coc-noext rats, indicating an increase in bFGF immunoreactivity following
extinction. However, in NAc shell, there were no significant differences between groups
(Figure 8g, left), but there was a trend for a reduction in coc-noext rats compared to
naïve rats and coc-ext rats, suggesting that extinction normalizes bFGF
immunoreactivity. Overall, no differences were observed in PL-mPFC, but there was a
trend in IL-mPFC that extinction reduced bFGF expression. Alternatively, in NAc core
and trending in the shell, extinction from drug seeking appears to increase bFGF
immnoreactivity compared to undergoing withdrawal.
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Figure 8: Cocaine self-administration decreased bFGF immunoreactivity in NAc core, an effect reversed
by extinction. Representative region of interest (ROI) analyzed, and representative image from each
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group, from PL-mPFC and IL-mPFC (a, d), NAc core and shell (b, f), and amygdala (c, h). (e) bFGF
immunoreactivity was not significantly different between groups in the PL-mPFC (naïve, n=6; coc-noext,
n=5; coc-ext, n=4) or IL-mPFC (naïve, n= 7; coc-noext, n=5; coc-ext, n=4). (g) bFGF immunoreactivity in
the NAc was increased in coc-ext (n=4) compared to coc-noext (n=6) rats, but was not different than
naïve (n=7) rats. There were no differences between groups in the NAc shell, but there was a trend
(F2,14=3.319, p=0.066; naïve, n= 7; coc-noext, n=6; coc-ext, n=4). (i) bFGF immunoreactivity was not
significantly different between groups in the amygdala (naïve, n= 11; coc-noext, n=7; coc-ext, n=7).
*p<0.05. Error bars are ±SEM.

Unfortunately, due to procedural limitations, group sizes and tissue quality likely
limited our analysis of these forebrain regions. The trends observed in IL-mPFC
moderately match our previous findings that bFGF protein expression is reduced
following extinction (Hafenbreidel et al., 2015). However, the increase in bFGF
following withdrawal (coc-noext) was not observed when examining cell
immunoreactivity. Interestingly, the significant findings and trends observed in NAc core
and shell, respectively, are opposite of previous results. Using western blots, bFGF
protein expression was increased following withdrawal, an effect reversed by extinction;
however, using IHC, there was a reduction in bFGF immnoreactivity following
withdrawal (coc-noext), but this was returned to control levels following extinction.
These differences may be due to small group sizes and poor tissue quality, or they may
be due to examining cellular expression of bFGF with more precisely defined brain
regions versus total protein expression in larger, less precisely defined, brain regions.
Further experiments are needed to determine how bFGF expression changes in these
brain regions, specifically in NAc, following self-administration and extinction.
bFGF expression was also examined in the amygdala, hippocampus, VTA, and
PBP (parabrachial pigmented nucleus of VTA; a subregion of VTA). In the amygdala,
bFGF immnoreactivity was not significantly different between groups (Figure 9i). In
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dHipp, bFGF immnoreactivity was significantly lower in coc-ext rats compared to naïve
and coc-noext rats (Figure 9e), demonstrating a reduction in bFGF expression following
extinction, which agrees with previous findings in IL-mPFC and NAc with western blots.
Alternatively, in vHipp, bFGF immunoreactivity was significantly lower in coc-noext rats
compared to naïve (Figure 9g), suggesting that cocaine self-administration reduces
bFGF immnoreactivity in vHipp, but extinction mitigates this effect. Finally, bFGF
immunoreactivity was not significant different between groups in the VTA (Figure 9i, left)
or PBP (Figure 9i, right).
The dHipp and vHipp are thought to regulate different functions, with dHipp
mediating cognitive processes associated with learning, memory, and spatial
navigation, and vHipp mediating processes associated with emotions and motivation
(Fanselow & Dong, 2010). Withdrawal from cocaine is associated with depression and
increased anxiety (Aston-Jones & Harris, 2004; Chartoff & Carlezon, 2014; Erb, 2010;
Gawin & Kleber, 1986; Koob, 2009), therefore vHipp might be mediating these affective
processes during acquisition and withdrawal. However, further investigation is needed
to determine the role of bFGF in the hippocampus following cocaine self-administrating
and extinction.
Alternatively, bFGF immnoreactivity was unchanged in PL-mPFC, amygdala, and
VTA. Results in PL-mPFC may also be limited by procedures, but PL-mPFC and
amygdala are necessary for stress- or cue-induced reinstatement (Erb et al., 2001;
Hiranita et al., 2006; Kantak et al., 2002; Leri et al., 2002; McFarland et al., 2004;
McFarland & Kalivas, 2001; McLaughlin & See, 2003; Peters et al., 2008), therefore,
changes in bFGF immnoreactivity might be detectable following reinstatement.
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Figure 9: Cocaine self-administration and extinction differentially affects bFGF immunoreactivity in dHipp
and vHipp. Representative ROI analyzed, and representative image from each group, from dHipp (a, d),
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vHipp (b, f), and VTA (c, h). (e) bFGF immunoreactivity in dHipp was significantly reduced in coc-ext rats
(n=9) compared to coc-noext (n=9) and naïve (n=13) rats. (g) bFGF immunoreactivity in vHipp was
reduced in coc-noext (n=9) compared to naïve (n=14) rats, but not compared to coc-ext rats (n=9). (i)
bFGF immunoreactivity was not significantly different between groups in VTA (naïve, n= 7; coc-noext,
n=7; coc-ext, n=6) or PBP (naïve, n= 7; coc-noext, n=7; coc-ext, n=6). *p<0.05. Error bars are ±SEM.

Moreover, VTA is necessary for the development of sensitization (Kalivas & Weber,
1988; Perugini & Vezina, 1994; Vezina & Stewart, 1990), but not for the maintenance or
longevity of sensitization (X. F. Zhang, Hu, White, & Wolf, 1997). Similarly, changes in
bFGF immnoreactivity in the VTA might have been observed had expression been
measured during initial acquisition.
In summary, these results demonstrate that cocaine self-administration and
extinction can influence bFGF expression in a number of reward-related brain regions.
Significant changes were observed in NAc core, dHipp, and vHipp, but not in mPFC,
NAc shell, amygdala, or VTA. Unfortunately, procedural limitations might have limited
the results in the mPFC and NAc, but overall, these results suggest subsequent
structures to examine for the role of bFGF in drug addiction and extinction learning.

Neutralizing bFGF in IL-mPFC facilitates extinction of drug seeking
Our previous findings indicate that bFGF protein expression in the IL-mPFC is
increased following cocaine self-administration, and extinction can reverse this effect.
To directly test the function of bFGF during extinction of drug seeking following selfadministration, rats were infused with vehicle or anti-bFGF prior to four 30-min
extinction sessions and retention was tested on subsequent 90-min extinction sessions.
Rats were first trained to self-administer cocaine, before being matched and assigned to
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groups: vehicle (veh) or anti-bFGF (experiment 4, Table 2 & 3). Daily extinction training
began 38 days after the last day of cocaine self-administration to maximize drug
seeking through prolonged withdrawal (as opposed to three days with all previous
preliminary experiments; Pickens et al., 2011). Overall, little extinction was observed
across the first four 30-min extinction sessions (Figure 10b, left), but anti-bFGF-infused
rats showed a robust reduction in lever pressing during the first 90-min extinction
session compared to vehicle-infused rats (Figure 10b, right). These results indicate that
both groups demonstrated extinction of lever pressing across days, but that neutralizing
bFGF in IL-mPFC prior to four 30-min sessions significantly facilitated extinction
compared to controls.
Furthermore, a control experiment was conducted to determine if a reduction in
bFGF in the IL-mPFC was sufficient to reduce drug seeking, or if an interaction between
extinction learning and reduced bFGF was necessary. Rats were trained to selfadminister cocaine before being matched and assigned to groups: veh or anti-bFGF
(experiment 5, Table 2 and 3). Daily extinction training began 36 days after the last day
of cocaine self-administration. Rats were then infused for four days with either vehicle
or anti-bFGF into IL-mPFC, and then immediately placed back in their home cages.
Overall, both groups extinguished across the 90-min extinction sessions, with no
differences between groups (Figure 10e, right). Thus, neutralizing bFGF in IL-mPFC
without extinction training (immediately returning rats to their home cages) did not affect
subsequent extinction. Therefore, extinction training in combination with bFGF
neutralization in IL-mPFC is necessary to facilitate extinction.

57

Figure 10: Neutralizing bFGF in IL-mPFC facilitates extinction. (a) Injector tip locations for vehicle (open
circles; n=7) and anti-bFGF (closed circles; n=8) in IL-mPFC. (b) Pre-extinction session infusions of antibFGF into IL-mPFC (arrows) during the 30-min extinction sessions facilitated extinction retention
compared to vehicle infusions. (c) Inactive lever presses during extinction. (d) Injector tip locations for
vehicle (open circles; n=10) and anti-bFGF (closed circles; n=10) in IL-mPFC. (e) Infusions of either
vehicle or anti-bFGF into IL-mPFC for four days (arrows), during which rats were returned immediately to
their home cages, did not affect subsequent extinction. (f) Inactive lever presses during extinction.
*p<0.05 Error bars are ±SEM.
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MATERIALS AND METHODS
Aim one: To determine if extinction modifies cocaine-induced plastic changes,
and if bFGF mediates these changes.
Subjects
Male Long-Evans rats (Harlan) weighing 250-300g at the start of the experiment
were individually housed and handled on a 14/10 hour light/dark cycle as previously
described (Hafenbreidel, Rafa Todd, Twining, Tuscher, & Mueller, 2014). Rats had
unlimited water access, but were food restricted (13-25g rat chow/day) throughout
experiments except during surgery and recovery. Protocols were approved by the
Institutional Animal Care and Use Committee at the University of Wisconsin-Milwaukee
in accordance with National Institutes of Health guidelines.

Drugs
Cocaine HCl (National Institute of Drug Abuse) was dissolved in sterile 0.9%
saline and administered intravenously (i.v.) at 0.25mg/infusion. For some rats, vehicle
(IgG) or a neutralizing antibody against bFGF (anti-bFGF; Millipore, 05-117) was
infused into IL-mPFC (0.35µg/0.35µl/side at a rate of 0.15µl/minute) one hour prior to
extinction. This neutralizing antibody against bFGF blocks the biological function of
bFGF, is highly selective for bFGF with no cross-reactivity to acidic FGF (aFGF or
FGF1; Matsuzaki, Yoshitake, Matuo, Sasaki, & Nishikawa, 1989; Tao et al., 1997), and
has been used previously (Flores et al., 2000; Hafenbreidel et al., 2015; Mueller et al.,
2006).
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Self-administration
Apparatus. Sucrose and cocaine self-administration procedures were conducted
using 12 standard sound-attenuated operant conditioning chambers (MED Associates)
as previously described (Hafenbreidel et al., 2014). Briefly, each chamber (30.5 cm
long x 24.1 cm wide x 21.0 cm high) had two retractable levers, two stimulus lights
located above each lever, a food hopper placed between the two levers, a house light
(25 W), a rod grid floor (23 4.8-mm stainless steel bars spaced 1.3 cm apart), and a
speaker/tone generator (65 Hz, 65 dB). Each chamber was located within a sound- and
light-attenuating enclosure with a ventilation fan. A syringe pump was located outside
of the enclosure and is connected to a single channel swivel (Instech Solomon) by
tygon tubing and connector cannula (Plastics One; a metal spring attached to a metal
spacer with PE50 tubing inserted down the center) that was connected to the catheter
anchored in the rat’s back (see Surgery).
Lever press training. For overall timeline of methods, see Figure 11. One week
after arrival, rats were food restricted for three days prior to a 10-hour sucrose training
session on a FR1 schedule of reinforcement. At the beginning of each session, the
house light and right stimulus light turned on, and the right lever was extended. Active
lever presses resulted in delivery of a 20mg sucrose pellet. When criteria were met
(100+ responses), sessions were shortened to 90 min on a FR1 schedule, with the
criteria of 50+ responses per session.
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Figure 11: Timeline of methods for Aim one, experiment one (a) and two (b), and Aim two (c).

Surgery. Rats assigned to the yoked-saline or cocaine self-administration
conditions were anesthetized with a mixture of ketamine/xylazine (87/13 mg/kg, i.p.) and
implanted with chronic intravenous catheters (assembled by Access Technologies) as
described previously (Hafenbreidel et al., 2014). Briefly, two incisions were made on
the back of the rat for placement of the catheter, and another incision was made over
the right jugular vein. A small polyurethane tube was inserted into the jugular vein. The
tube was attached to a larger polyurethane tube that was connected to a backmount
pedestal (Plastics One), which was implanted behind the shoulder blades. Following
catheter implantation, some rats were place in a stereotaxic instrument and implanted
with a 26-gauge double barrel guide cannula aimed bilaterally at IL-mPFC (AP, +2.8,
ML, ±0.6, DV, -4.4mm relative to bregma), as previously described (Hafenbreidel et al.,
2015; Otis, Fitzgerald, & Mueller, 2014). Following surgery, rats received the antibiotic
penicillin g procaine (75,000 units/0.35ml, s.c.) and the inflammation and pain reliever
carprofen (5mg/0.1ml, s.c.). Rats recovered for a minimal of five days before catheter
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patency was verified with 0.3ml of 1% Propofol (i.v.), a short acting anesthetic that
causes immediate loss of muscle tone. Rats recovered for a minimum of seven days
prior to behavioral testing. Catheter patency was maintained daily with heparinized
saline (~0.2 cc of 60 i.u./ml).
Acquisition of cocaine self-administration. Rats in the cocaine self-administration
condition were trained to self-administer cocaine daily for 90-min sessions on a FR1
schedule or until the progressive daily cap is achieved (20-35 infusions/session). At the
beginning of each session, the house light and right stimulus light turned on, and the
right and left lever extended. Following a lever press on the active lever (right), the
stimulus light turned off for 20 seconds, a tone (65 dB) sounded for five seconds, and a
cocaine infusion was initiated for three seconds. To reduce the risk of overdose,
another infusion was not be available until the stimulus light turned on again (time-out
period). All lever presses, reinforced or not, were reported as active lever presses
during acquisition, extinction, and cocaine-induced reinstatement. Responding on the
inactive lever (left) was recorded, but did not have any programmed consequences. For
experiment one, a yoked-saline control group was included. These rats were yoked to a
cocaine-administering rat throughout acquisition and extinction (if applicable), receiving
identical cues, but a saline infusion when the cocaine-administering rat pressed the
active lever, and lever presses resulted in no programmed consequences. Rats were
trained to self-administer cocaine for 18 sessions when stable drug seeking was
achieved. In order to obtain stable drug seeking across rats, some rats received a
priming infusion at the start of the session or additional acquisition sessions. Groups
were matched on total number of infusions during self-administration, the average
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number of infusions over the last three days of self-administration, and if rats receive
priming infusions or extra sessions.
To control for motor activity, a separate group of rats continued to lever press for
sucrose (FR1), as during initial lever press training, for 90-min daily session or until the
progressive daily cap is achieved (50-95 presses/session). At the beginning of each
session, the house light and right stimulus light turned on, and the right lever extended.
Active lever presses resulted in the delivery of a 20mg sucrose pellet. These rats did
not receive catheters or cannula implants, but were trained on the same days as the
cocaine and yoked-saline self-administration rats. Groups were matched on the
average number of active lever presses.

Experimental manipulations
Experiment one. For overall timeline of methods, see Figure 11a. To determine
if extinction alters plasticity following drug self-administration in IL-mPFC, NAc, or
dHipp, protein expression was examined following withdrawal or extinction. Specifically,
protein expression of ARC, β-catenin (total or phosphorylated form; pβ-catenin), bFGF,
∆-FosB, GluR1, GSK-3β (total or phosphorylated form; pGSK-3β), Kal-7, MAP2, and
PSD95 was measured.
Following acquisition, rats were matched and assigned to groups: extinction (cocext, yoked-sal-ext, and suc-ext) or no extinction (coc-noext, yoked-sal-noext, and sucnoext). Extinction of sucrose seeking, cocaine seeking, or yoked-saline administration
was conducted identical to acquisition, except that no reinforcement was delivered
following a lever press. A naïve home-cage control was included that was neither
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manipulated nor handled (naïve; experiment 2, Table 1). Rats were given a three-day
break before coc-ext, yoked-sal-ext, and suc-ext rats underwent daily 90-min extinction
sessions. Coc-noext, yoked-sal-noext, and suc-noext rats remained in their home
cages during these sessions. Following the last day of extinction, all groups (except
naïve) were tested for extinction retention with the same extinction procedure used
throughout the experiment. Immediately after testing, rats were anesthetized with
isoflurane gas and their brains were extracted and frozen at -80°C for western blot
analysis.
Experiment two. For overall timeline of methods, see Figure 11b. To determine
if extinction or bFGF alters plasticity following prolonged withdrawal from cocaine selfadministration, protein expression was examined in a number of groups in reward- and
learning-related brain regions (IL-mPFC, NAc, and dHipp). The same proteins that
were examined in experiment one were examined here.
Following acquisition, rats were matched and assigned to groups: extinction (cocveh-ext or coc-anti-bFGF-ext) or no extinction (coc-veh-noext or coc-anti-bFGF-noext).
Based on preliminary findings (Figure 6), a few controls were excluded, including
sucrose self-administration and yoked-saline, but a naïve home cage control was
included (Table 4). Rats underwent 36 days of withdrawal before rats were adapted to
microinfusion procedures, which included gently restraining rats on the first day
(withdrawal day 36), lowering injectors extending 1.0mm past the guide cannula on the
second day (withdrawal day 37), and infusing saline at the same rate and volume as
during drug manipulation on the third day (withdrawal day 38).
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Table 4: List of experimental groups and tissue collected for each experiment in Aim one.

On the following day, vehicle (IgG) or anti-bFGF was infused into IL-mPFC one
hour before four daily 30-min extinction sessions. Another group of rats also received
vehicle or anti-bFGF infusions, but were immediately placed back in their home cages
and were not exposed to the operant chambers. Thirty-min sessions were used, as
previously described (see Self-administration paradigm section), to better manipulate
initial extinction learning. Rats received a two-day break for drug-washout before
extinction retention was tested during a 90-min extinction session (extinction day five).
During all extinction sessions, lever presses resulted in the same programmed
consequences as during self-administration, but no cocaine was administered, in order
to model exposure therapy. Immediately following extinction day five, coc-veh-ext, cocanti-bFGF-ext, coc-veh-noext, coc-anti-bFGF-noext, and half of the naïve rats were
anesthetized, and their brains were extracted and frozen at -80˚C.
Additionally, two groups of rats (coc-ext and coc-noext; Table 3) did not receive
cannula implants or microinfusions, but did receive the same 38-day withdrawal period
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before undergoing extinction (90-min sessions) or remaining in their home cages as
described in experiment one. Following the last day of extinction, both groups were
tested for extinction retention with the same extinction procedure used throughout the
experiment. Immediately after testing, all rats (coc-ext, coc-noext, and half of naïve)
were anesthetized with isoflurane gas and their brains were extracted and frozen at 80˚C.

Western blots
To determine the effect of extinction and bFGF on extinction following cocaine
self-administration, expression of a number of plasticity-related proteins were measured
in reward- and learning-related brain regions: IL-mPFC, NAc, and dHipp. These
included ARC, β-catenin (total and phosphorylated), bFGF, ∆-FosB, GluR1, GSK-3β
(total and phosphorylated), Kal-7, MAP2, and PSD95. Tissue was collected and
processed as previously described (Fortress, Heisler, & Frick, 2015; Hafenbreidel et al.,
2014). Briefly, IL-mPFC, NAc, and dHipp was quickly dissected from frozen blocked
tissue, and stored at -80˚C until they were re-suspended at 1:25w/v in lysis buffer,
homogenized using a probe sonicator (Branson Sonifier 250). Samples were
electrophoresed on 18% or 4-15% Tris-HCl gels (Bio-Rad), and transferred to PVDF
membranes using a TransBlot Turbo system (Bio-Rad). Membranes were blocked in
5% or 8% (bFGF only) milk for one hour at room temperature, followed by overnight
incubation at 4˚C in primary antibodies for ARC (1:100; Santa Cruz), β-Actin (1:5000;
Cell Signaling), β-catenin, pβ-catenin (both 1:1000; Cell Signaling), bFGF (1:1000;
Millipore), ∆-FosB (1:1000; Santa Cruz), GluR1 (1:1000; Pierce), GSK-3β, pGSK-3β,
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(both 1:1000; Cell Signaling), Kal-7 (1:500; Millipore), MAP2 (1:2000; Millipore), and
PSD95 (1:1000; Cell Signaling). Next, membranes were incubated in secondary
antibodies and developed using West Dura chemiluminescence (Pierce). Protein
expression was imaged (ChemiDocMP gel imager, BioRad) and quantified by
densitometry using Carestream software. To determine changes in expression,
proteins were normalized to β-Actin levels or total protein levels. There were no
significant differences between groups in β-Actin protein expression in IL-mPFC, NAc or
dHipp (Fs<3.250, ps>0.05). Data is expressed as percent immunoreactivity relative to
naïve controls.

Data analysis
Lever presses and infusions during acquisition were analyzed by comparing the
average of the last three days of cocaine self-administration between groups using ttests or one-way analysis of variance (ANOVA). For extinction, lever presses were
analyzed across days using an repeated-measures ANOVA or across days and
between groups using two-way repeated-measures ANOVA. During the extinction
retention test, lever presses were analyzed using t-tests between groups. For Western
blot analysis, mean optical densities were analyzed using a one-way ANOVA. All posthoc tests were conducted, when appropriate, using Fisher’s least significant difference
(LSD) test.
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Aim two: Determine the functional relevance of extinction-induced reduction of
bFGF in NAc and dHipp.
Subjects
Same as in Aim one.

Drugs
Same as in Aim one. For some rats, vehicle (0.1% BSA/sterile PBS) or bFGF
(R&D Systems, 3339-FB) was infused into IL-mPFC (200ng/0.75µl/side at a rate of
0.25µl/minute) one hour prior to extinction of sucrose seeking. This dose, volume,
infusion rate, and time point were based off of previous research (Graham &
Richardson, 2011a; Turner et al., 2009; Wagner et al., 1999).

Self-administration
Apparatus. Same as in Aim one.
Lever press training. For overall timeline of methods, see Figure 11c. Training
was the same as in Aim one.
Surgery. Rats were anesthetized and implanted with a catheter followed by a 26gauge double barrel guide cannula aimed bilaterally at NAc (AP, +1.5, ML, ±0.6, DV, 7.0mm relative to bregma) or two single-barrel guide cannula aimed bilaterally at dHipp
(AP, -3.5, ML, ±2.6, DV, -3.0mm relative to bregma), as described in Aim one. A
separate group of rats did not receive catheters, but were implanted with a 26-gauge
double barrel guide cannula aimed bilaterally at IL-mPFC, as described in Aim one.
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Post-surgical care, recovery times, and catheter patency and maintenance were
conducted the same as in Aim one.
Acquisition of cocaine self-administration. Rats that were implanted with
catheters were trained to self-administer cocaine, and groups were subsequently
matched as in Aim one. Rats only implanted with cannula were trained to selfadminister sucrose, and subsequently matched, as in Aim one.

Experimental manipulations
Experiment three. To determine the role of bFGF in NAc and dHipp during
extinction, bFGF was neutralized one hour before four daily 30-min extinction sessions
and retention was tested on the following 90-min drug-free extinction session.
Following acquisition, rats were matched and assigned to groups (Table 5): extinction
(coc-veh-ext, or coc-anti-bFGF-ext) or no extinction (coc-veh-noext or coc-anti-bFGFnoext) for each brain region. Rats underwent a 36-day withdrawal period before being
adapted to microinfusion procedures as described in Aim one (injectors extended
1.0mm for NAc or 0.5mm for dHipp past the guide cannula). Similarly to Aim one,
vehicle or anti-bFGF was infused one hour before four 30-min extinction sessions or
rats were immediately returned to their home cages, which was followed by a two-day
break before extinction retention was tested during 90-min extinction sessions (all
groups). Extinction was conducted the same as in Aim one.
Experiment four. To determine if overexpression of bFGF in IL-mPFC was
sufficient to disrupt new learning, bFGF was infused one hour before four daily 90-min
extinction sessions and retention was tested on the following 90-min drug-free extinction
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sessions. Short 30-min extinction sessions were not used here because bFGF has a
long half-life (overexpressed is still observed in the spinal fluid 24 h after a systemic
injection; Wagner et al., 1999), and because the overall rate of extinction was being
examined and not initial extinction learning.

Cocaine-induced reinstatement
Following extinction, rats received a priming injection of cocaine (10 mg/kg; i.p.)
before undergoing normal extinction procedures to test for cocaine-induced
reinstatement.

Locomotion
To determine if anti-bFGF infusion into IL-mPFC, NAc, or dHipp affected general
motor activity, rats were infused with vehicle or anti-bFGF one hour prior to being
placed in locomotion activity chambers for 20 min.

Table 5: List of experimental groups for Aim two.
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Data analysis
Data was analyzed the same as in Aim one. For locomotor activity, total
photobeam breaks between groups were analyzed using a t-test. After behavioral
procedures, verification of injector tip location was performed on cresyl violet-stained
coronal sections, and rats with incorrect placements were removed from analysis.
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AIM ONE
RESULTS
Behavioral results
Stimulant drug administration can induce a number of long- immediate early
gene lasting plastic changes, including increased bFGF expression in a number of
reward-related brain regions. The increase in bFGF may be a neuroprotective
response, but prolonged overexpression may induce maladaptive changes that underlie
the preservation of drug seeking. However, we previously demonstrated that extinction
of drug seeking can reverse the increase in bFGF. In order to determine if extinction or
bFGF mediates other drug-induced plasticity changes, we obtained tissue from rats that
had undergone cocaine self-administration with or without extinction, in addition to a
number of controls, from three brain regions implicated from our preliminary data,
including the IL-mPFC, NAc, and dHipp.
Rats first acquired sucrose (Suc), yoked-saline (Y-sal), or cocaine (Coc) selfadministration. Active or inactive lever presses and number of infusions (where
applicable) were equivalent between Suc, Y-sal, or Coc groups across the average of
the last three days of self-administration (Table 3 and 6). Following acquisition, some
rats (Coc-ext), Y-sal-ext, Suc-ext) underwent extinction (E), while other rats (Coc-noext,
Y-sal-noext, and Suc-noext) remained in their home cages (no extinction; NE). For
active lever presses during extinction of sucrose seeking (Figure 5a), ANOVA revealed
a significant effect of day (F7,56=34.561, p<0.0001), indicating that rats reduced lever
presses across days. After the last day of extinction, both groups were tested for
extinction retention (Figure 5b). For active lever presses, Suc-ext rats pressed less
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than Suc-noext rats (t15=-6.031, p<0.0001), demonstrating good extinction retention for
the Suc-ext group. Likewise, ANOVA revealed a significant effect of active lever
presses in the Coc-ext group across extinction days (F7,77=23.731, p<0.0001), indicating
rats learned extinction (Figure 5c). For inactive lever presses (data not shown), ANOVA
revealed a significant reduction in lever pressing across days for Coc-ext rats
(F7,77=9.660, p<0.0001). Comparing active and inactive lever presses across extinction
days for Coc-ext rats revealed a significant effect of lever (F1,176=154.796, p<0.0001),
indicating that Coc-ext rats lever pressed significantly more on the active lever than the
inactive lever throughout (data not shown). Active (Figure 5e) and inactive (data not
shown) lever presses in the Y-sal-ext group did not differ throughout extinction (active:
F7,70=1.446, p=0.201; inactive: F7,70=0.469, p=0.854). Following the last day of
extinction, all rats were tested for extinction retention. Coc-ext rats pressed less than
Coc-noext rats on active levers (t22=-3.208, p=0.004), demonstrating good extinction
retention (Figure 5d). However, Y-sal-ext rats and Y-sal-noext rats did not differ on
lever pressing (t21=-1.161, p=0.259; Figure 5f), as expected. Inactive lever presses
(data not shown) during the extinction retention test did not differ between Coc-ext and
Coc-noext (t22=-1.981, p=0.060) or Y-sal-ext and Y-sal-noext rats (t21=1.267, p=0.219).
Following the extinction retention test, rats were sacrificed and IL-mPFC, NAc, and
dHipp tissue was collected for analysis (Figures 6, 14, 15, 17, and 18).
To further determine the role of bFGF in drug-associated plasticity, another group
of rats were trained to self-administer cocaine. Active or inactive lever presses and
number of infusions were equivalent between groups across the average of the last
three days of self-administration (Table 6).
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Table 6: Average number of active and inactive lever presses, or infusions across the last three days of
cocaine self-administration, for each experiment. There were no significant differences between groups.

Following acquisition, rats underwent 38 days of withdrawal in their home cages.
Next, some rats received vehicle or anti-bFGF (Veh E, Ant-bFGF E) infusions into ILmPFC one hour before four 30-min extinction sessions. Across the 30-min sessions
(days 1-4, active lever presses; Figure 12b), ANOVA revealed a significant effect of day
(F3,68=17.213, p<0.0001), but no significant effect of treatment (F1,68=3.687, p=0.059) or
day by treatment interaction (F3,68=0.922, p=0.435). During the 90-min extinction
retention test (day 5; Figure 12c), anti-bFGF-infused rats lever pressed significantly less
than veh-infused rats (t17=-2.433, p=0.026). These results indicate that both groups
demonstrate extinction during extinction days 1-4, but that neutralizing bFGF in ILmPFC significantly reduced lever pressing compared to controls when extinction
retention was tested.

74

Figure 12: Extinction and extinction retention tests prior to protein analysis in veh- or anti-bFGF infused
rats. (a) Representative area for injector tip locations in IL-mPFC; veh: n= 9, anti-bFGF: n=10. (b) Preextinction session infusions of anti-bFGF into IL-mPFC (arrows) during the 30-min extinction sessions
facilitated extinction retention compared to vehicle infusions (c). (d) Representative area for injector tip
locations in IL-mPFC; veh: n= 11, anti-bFGF: n=10. (e) Infusions of either vehicle or anti-bFGF into ILmPFC for four days (arrows), during which rats were returned immediately to their home cages, did not
affect subsequent extinction (f). (g) Veh-infused rats that underwent four 30-min extinction sessions lever
pressed less than Veh-infused rats that did not undergo extinction. *p<0.05 Error bars are ±SEM.

For inactive lever presses during extinction days 1-4 (data not shown), ANOVA
revealed a significant effect of treatment (F1,68=5.582, p=0.021), but no effect of day
(F3,68=2.631, p=0.057) or day by treatment interaction (F3,68=0.370, p=0.775).
Comparing active and inactive lever presses across extinction days revealed a
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significant effect of lever (F1,136=539.379, p<0.0001), indicating that rats pressed
significantly more on the active lever than the inactive lever throughout, which
demonstrates goal-directed behavior (data not shown). For inactive lever presses
during the extinction retention test, anti-bFGF-infused rats lever pressed less on the
inactive lever than veh-infused rats (t17=-2.696, p=0.015), but a subsequent ANOVA
comparing active and inactive lever presses revealed a significant effect of lever
(F1,34=109.792, p<0.0001), indicating that rats pressed significantly more on the active
lever than the inactive lever (data not shown). Following the extinction retention test,
rats were sacrificed and IL-mPFC, NAc, and dHipp tissue was collected for analysis
(Figures 6, 14, 15, 17, and 18).
Additionally, to control for infusions of anti-bFGF, another groups of rats received
infusions of veh or anti-bFGF into IL-mPFC, but were returned to their home cages
without exposure to the operant chamber (Veh NE, Anti-bFGF NE). Active or inactive
lever presses and number of infusions were equivalent between groups across the
average of the last three days of self-administration (Table 6). Following acquisition,
rats underwent 38 days of withdrawal in their home cages, before being infused with
veh or anti-bFGF in IL-mPFC for four days, and being immediately returned to their
home cages without exposure to the operant chamber (Figure 12e). Following a twoday wash out period, rats then underwent a 90-min extinction test. During the 90-min
extinction retention test (day 5; Figure 12f), there were no significant differences
between groups (t19=0.587, p=0.564), indicating that neutralizing bFGF in the IL-mPFC
without extinction for four days did not affect subsequent extinction. Inactive lever
presses were also not significantly different between groups during the extinction
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retention test (t19=1.134, p=0.271). Finally, veh-infused rats that did undergo four 30min extinction sessions lever pressed significantly less than veh-infused rats that did not
undergo the four 30-min extinction sessions (t18=4.573, p<0.0001; Figure 12g), which
indicates that four 30-min extinction sessions are sufficient for extinction learning to
occur. Following the extinction retention test, rats were sacrificed and IL-mPFC, NAc,
and dHipp tissue was collected for analysis (Figures 6, 14, 15, 17, and 18).
Finally, an additional group of rats were not implanted with cannula and did not
receive veh or anti-bFGF infusions, but instead underwent 38 days of withdrawal
following acquistion before undergoing daily 90-min extinction sessions or remaining in
their home cages. These rats were included to control for the limitation that prolonged
withdrawal can alter plasticity and potentate drug seeking (e.g., Lu et al., 2004; Pickens
et al., 2011), as our preliminary behavioral data included a 38-day withdrawal period,
but our bFGF protein analysis data did not. For clarity, rats that underwent extinction
without the prolonged withdrawal period are referred to as Coc E(3) and rats that did not
undergo extinction or the prolonged withdrawal period are referred to as Coc NE(3);
whereas, rats that did undergo the prolonged withdrawal period, with or without
extinction, are referred to as Coc E(38) and Coc NE(38), respectively (Table 4). Active
or inactive lever presses and number of infusions were equivalent between groups
across the average of the last three days of self-administration (Table 6).
Following acquisition, rats underwent 38 days of withdrawal in their home cages
before undergoing daily 90-min extinction sessions (Coc E(38)), or remaining in their
home cages (Coc NE(38)). For active lever presses during extinction of cocaine
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seeking (Figure 13a), ANOVA revealed a significant reduction in lever pressing across
days (F11,77=30.878, p<0.0001), indicating that rats learned extinction.
Figure 13: Extinction and extinction retention
tests prior to protein analysis in rats that
underwent 38 days of withdrawal, but did not
receive microinfusions. Active lever presses
during extinction of cocaine seeking (a) and
during the extinction retention test (b). *p<0.05
Error bars are ±SEM.

For inactive lever presses during extinction (data not shown), ANOVA revealed a
significant reduction in lever pressing across days (F11,77=3.059, p=0.002). A
subsequent ANOVA revealed a significant effect of lever (F1,168 =177.692, p<0.0001),
which indicates that rats pressed the active lever significantly more than the inactive
lever across days (data not shown). During the extinction retention test (Figure 13b),
rats that underwent extinction lever pressed significantly less on the active lever than
rats that remained in their home cages and did not undergo extinction (t16=-5.279,
p<0.0001). For inactive lever presses during the extinction retention test, rats that
underwent extinction lever pressed significantly less than rats that remained in their
home cages and did not undergo extinction (t16=-3.716, p=0.002; data not shown).
However, a subsequent ANOVA revealed a significant effect of lever (F1, 32=57.303,
p<0.0001), which indicates that rats pressed the active lever significantly more than the
inactive lever across days (data not shown). Following the extinction retention test, rats
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were sacrificed and IL-mPFC, NAc, and dHipp tissue was collected for analysis (Figures
6, 14, 15, 17, and 18).

Cocaine self-administration induces plastic changes in IL-mPFC, which is partly
attenuated by extinction
To determine if extinction alters cocaine-induced plastic changes in IL-mPFC, we
used western blots to analyze expression of a number of plasticity-related proteins in
rats that underwent cocaine self-administration, followed by a short or long withdrawal
period and extinction or no extinction (remained in their home cages). Additionally, if
neutralizing bFGF in IL-mPFC had an effect on cocaine-induced plastic changes in rats
that underwent four 30-min extinction sessions or remained in their home cages, was
examined. We first examined bFGF protein expression to determine the time course of
its expression. We next examined a number of plasticity-related proteins, including
ARC, GluR1, PSD95, Kal-7, MAP2, β-catenin, and GSK3β, to examine the effect of
extinction and bFGF on cocaine-induced plasticity. Figure 14a shows a representative
area of tissue collection from IL-mPFC (bregma 3.00 mm; Paxinos & Watson, 2007).
Additionally, efforts were made to examine the protein expression of bFGF’s high
affinity receptor, FGFR1, in each brain region. However, despite having a functional
protocol (e.g., Hafenbreidel et al., 2015), no bands were produced that were viable
enough to analyze. Likewise, efforts were made to examine all proteins in each brain
region, but due to certain limitations, some proteins were not examined in all brain
regions (see Table 7 for summary of all results).
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Table 7: Summary of western blot results.

bFGF protein expression
We previously found that cocaine self-administration increased bFGF protein
expression in the IL-mPFC, an effect reversed by extinction (Figure 6), after a relatively
short withdrawal period. Next, to determine if self-administration and extinction altered
bFGF protein expression in IL-mPFC following a prolonged withdrawal period, we
analyzed expression between groups. There were no significant differences in bFGF
protein expression between naïve, Coc NE(38), and Coc E(38) rats (F2,23=0.788,
p=0.466; Figure 14b) indicating that bFGF protein expression is returned to naïve
control levels following a prolonged withdrawal period after cocaine self-administration,
and extinction does not alter this expression further.
Next, to determine if bFGF protein expression in IL-mPFC is altered following the
extinction retention test on day 5, following four days of vehicle or anti-bFGF infusions
with or without 30 min extinction sessions (Figure 12), expression was examined
between groups. There were no significant differences between groups (F4,47=2.138,
p=0.091; Figure 14c), but there was a trend for increased expression in groups that
underwent cocaine self-administration. These results agree with previous results that
bFGF protein expression is not significantly increased following a prolonged withdrawal
period. However, they do suggest an increase in bFGF expression when expression is
examined during initial extinction learning, even though extinction overall does not
appear to affect bFGF protein expression at this time point. Moreover, these results
demonstrate that neutralizing bFGF in the IL-mPFC does not persist for three days, as
expression is similar between veh- and anti-bFGF infused groups.
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Figure 14: bFGF protein expression is not altered following a prolonged withdrawal period. (a)
Representative areas of tissue collection containing IL-mPFC. (b) bFGF protein expression was not
altered between naïve (n=13), Coc NE(38) (n=8), or Coc E(38) (n=5) groups. (c) bFGF protein
expression was not altered between naïve (n=13), Veh NE (n=11), Anti-bFGF NE (n=10), Veh E (n=9), or
Anti-bFGF E (n=9) groups. Representative blots are located above each graph. Error bars are ±SEM.

ARC protein expression
Next, we examined the expression of five proteins associated with cocaineinduced plastic changes, including ARC, GluR1, PSD95, MAP2, and Kal-7 (See Druginduced Plastic changes section). ARC is an IEG that is increased following stimulant
drug administration and increases in its expression are associated with memory
retrieval (Alaghband et al., 2014; Caffino et al., 2014; Caffino et al., 2011; Giannotti et
al., 2014). To determine if natural reward reinforcement and extinction of reward
seeking altered ARC protein expression in IL-mPFC, tissue from naïve, Suc NE, and
Suc E groups were compared. ANOVA revealed significant differences between groups
(F2,34=4.461, p=0.019; Figure 15a). Post hoc tests confirmed that Suc NE rats
(p=0.021) and Suc E rats (p=0.023) had higher ARC protein expression than naïve rats,
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but Suc NE rats were not significantly different than Suc E rats (p=0.911). These results
indicated that ARC protein expression was increased following operant conditioning, but
extinction of sucrose seeking does not alter this expression. Next, to determine if cue
presentation or i.v. infusions altered ARC protein expression in IL-mPFC, tissue from
naïve, Y-Sal-NE, and Y-Sal-E groups were compared. There were no significant
differences, but there was a trend, in ARC protein expression between naïve, Y-Sal-NE,
and Y-Sal-E rats (F2,39=2.986, p=0.062; Figure 15b), indicating that cue presentation
and i.v. infusions does not significantly affect ARC protein expression.
Subsequently, to determine if cocaine self-administration with a short or long
withdrawal period or extinction of drug seeking altered ARC protein expression in ILmPFC, expression was examined between groups (Figure 15c). ANOVA revealed
significant differences in ARC protein expression between groups (F4,56=10.199,
p<0.0001). Post hoc tests confirmed that Coc NE(3) rats (p<0.0001), Coc NE(38) rats
(p<0.0001), Coc E(38) rats (p=0.003), but not Coc E(3) rats (p=0.415), had higher ARC
protein expression than naïve rats. Moreover, Coc NE(3) rats (p=0.012), Coc NE(38)
rats (p<0.0001), and Coc E(38) rats (p<0.0001) had higher ARC protein expression than
Coc E(3) rats. Finally, there was a trend for decreased ARC expression in Coc E(38)
rats compared to Coc NE(38) rats (p=0.068), but it was not significantly different. These
results indicate that cocaine self-administration increases ARC protein expression,
which is still elevated following a prolonged 38-day withdrawal period. Extinction can
reverse this increase following a short 3-day withdrawal period, and is only trending
after a longer 38-day withdrawal period.
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Finally, to examine ARC protein expression in IL-mPFC after an extinction
retention test (day 5) following four days of veh or anti-bFGF infusions with or without
30-min extinction sessions, expression was compared between groups (Figure 15d).
ANOVA revealed significant differences in ARC protein expression between groups
(F4,54=3.537, p=0.012). Post hoc tests confirmed that Veh E rats (p=0.026) and AntibFGF NE rats (p=0.001) had significantly increased ARC expression compared to naïve
rats, and there was a strong trend for Veh NE (p=0.051). Anti-bFGF E rats were not
significantly different than naïve rats (p=0.101), and there were no further significant
differences between groups (all ps>0.05). These results agree that cocaine selfadministration with a 38-day withdrawal period increases ARC protein expression in the
IL-mPFC, but suggest that neutralizing bFGF in the IL-mPFC before four 30-min
extinction sessions may attenuate ARC protein expression, which matches with lever
pressing observed in the behavioral data.
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Figure 15: Cocaine self-administration induces plastic changes in IL-mPFC, which are partly attenuated
by extinction. (a) Sucrose seeking with or without extinction increased ARC protein expression (naïve,
n=20; Suc NE, n=8; Suc E, n=9). (b) ARC protein expression was not altered between naïve (n=20), YSal-NE (n=12), and Y-Sal-E (n=10) rats. (c) ARC protein expression was increased in all groups except
Coc E(3) (n=11; Coc NE(3), n=12; Coc NE(38), n=10; Coc E(38), n=8) compared to naïve rats (n=20).
(d) ARC protein expression was increased in Anti-bFGF NE (n=10) and Veh E (n=9) rats compared to
naïve rats (n=20; Veh NE, n=10; Anti-bFGF E, n=10). (e) GluR1 protein expression was not different
between naïve (n=19), Suc NE (n=8), and Suc E (n=8) rats. (f) GluR1 protein expression was decreased
in Y-Sal-NE (n=11) and Y-Sal-E (n=10) rats compared to naïve rats (n=19). (g) GluR1 protein expression
was increased in rats that underwent cocaine self-administration and long withdrawal (naïve, n=19; Coc
NE(3), n=11; Coc E(3), n=12; Coc NE(38), n=10; Coc E(38), n=8). (h) GluR1 protein expression was not
different between naïve (n=19), Veh NE (n=11), Anti-bFGF NE (n=10), Veh E (n=8), and Anti-bFGF E
(n=10) rats. (i) PSD95 protein expression was not different between naïve (n=19), Suc NE (n=8), and Suc
E (n=9) rats. (j) PSD95 protein expression was not different between naïve (n=19), Y-Sal-NE (n=12), and
Y-Sal-E (n=10) rats. (k) PSD95 protein expression was increased in rats that underwent cocaine selfadministration and long withdrawal (naïve, n=19; Coc NE(3), n=11; Coc E(3), n=11; Coc NE(38), n=10;
Coc E(38), n=8). (l) PSD95 protein expression was not different between naïve (n=19), Veh NE (n=11),
Anti-bFGF NE (n=9), Veh E (n=8), and Anti-bFGF E (n=10) rats. (m) pGSK3β protein expression was not
different between naïve (n=20), Suc NE (n=8), and Suc E (n=8) rats. (n) pGSK3β protein expression was
not different between naïve (n=20), Y-Sal-NE (n=12), and Y-Sal-E (n=10) rats. (o) pGSK3β protein
expression was decreased only in Coc NE(38) rats (n=9; naïve, n=20; Coc NE(3), n=11; Coc E(3), n=12;
Coc E(38), n=8). (p) pGSK3β protein expression was not different between naïve (n=20), Veh NE (n=11),
Anti-bFGF NE (n=10), Veh E (n=9), and Anti-bFGF E (n=9) rats. *p<0.05, **p<0.01, ***p<0.001 compared
to naïve, #p<0.05, ##p<0.01, ###p<0.001 compared to CNE(3), *p<0.05, **p<0.01, ***p<0.001
compared to CE(3). Error bars are ±SEM.
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GluR1 protein expression
GluR1 expression is increased following stimulant drug administration plus a
prolonged withdrawal period and increases in its expression are associated with
potentiated drug seeking in NAc (Loweth et al., 2014; Wolf & Ferrario, 2010). To
determine if natural reward reinforcement and extinction of reward seeking altered
GluR1 protein expression in IL-mPFC, tissue from naïve, Suc NE, and Suc E groups
were compared. There were no significant differences between groups (F2,32=0.958,
p=0.394; Figure 15e), which indicates that GluR1 protein expression was not altered
following sucrose self-administration with or without extinction. Next, to determine if cue
presentation or i.v. infusions altered GluR1 protein expression in IL-mPFC, tissue from
naïve, Y-Sal-NE, and Y-Sal-E groups were compared. ANOVA revealed significant
differences in GluR1 protein expression between groups (F2,37=8.699, p=0.001; Figure
15f). Post hoc tests confirmed that Y-Sal-NE rats (p=0.003) and Y-Sal-E rats (p=0.001)
had lower GluR1 protein expression than naïve rats, but Y-Sal-NE rats were not
different than Y-Sal-E rats (p=0.609). These results indicate that cue presentation and
i.v. infusions reduced GluR1 protein expression.
Subsequently, to determine if cocaine self-administration with a short or long
withdrawal period or extinction of drug seeking altered GluR1 protein expression in ILmPFC, expression was examined between groups (Figure 15g). ANOVA revealed
significant differences in GluR1 protein expression between groups (F4,55=5.801,
p=0.001). Post hoc tests confirmed that Coc NE(38) rats (p=0.002) had significantly
increased GluR1 protein expression compared to naïve rats. There was a trend for
increased expression in Coc NE(3) rats compared to naïve rats (p=0.085), but Coc E(3)

87

rats (p=0.451) and Coc E(38) rats (p=0.241) were not significantly different than naïve
rats. Moreover, Coc NE(38) rats (p<0.0001) and Coc E(38) rats (p=0.015) had
significantly higher GluR1 protein expression compared to Coc NE(3) rats. Coc NE(38)
rats (p=0.001), and a trend for Coc E(38) rats (p=0.093), had significantly higher GluR1
protein expression than Coc E(3) rats. Finally, there were no significant differences
between Coc NE(3) rats and Coc E(3) rats (p=0.362), or between Coc NE(38) rats and
Coc E(38) rats (p=0.112). These results indicate that GluR1 protein expression is
increased following prolonged withdrawal from cocaine self-administration, and
extinction may attenuate some of these increases.
Finally, to examine GluR1 protein expression in IL-mPFC after an extinction
retention test (day 5), following four days of veh or anti-bFGF infusions with or without
30-min extinction sessions, expression was compared between groups (Figure 15h).
ANOVA revealed no significant differences between groups (F4,55=1.048, p=0.391.
Interestingly, these rats also underwent a 38-day withdrawal period following cocaine
self-administration, but do not demonstrate the same significant increase in GluR1
protein expression as Coc NE(38) rats do.

PSD95 protein expression
PSD95 expression is decreased following stimulant drug administration in NAc,
and is thought to underlie the reorganization of dendritic spines following drug use
(Huang et al., 2009; Yao et al., 2004). To determine if natural reward reinforcement and
extinction of reward seeking altered PSD95 protein expression in IL-mPFC, tissue from
naïve, Suc NE, and Suc E groups were compared. There were no significant
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differences between groups (F2,33=0.603, p=0.553; Figure 15i), which indicate that
PSD95 protein expression was not altered following sucrose self-administration, with or
without extinction. Next, to determine if cue presentation or i.v. infusions altered PSD95
protein expression in IL-mPFC, tissue from naïve, Y-Sal-NE, and Y-Sal-E groups were
compared. There were no significant differences between groups (F2,38=0.680, p=0.513;
Figure 15j), which indicates cue presentation and i.v. infusions does not significantly
affect PSD95 protein expression
Subsequently, to determine if cocaine self-administration with a short or long
withdrawal period or extinction of drug seeking altered PSD95 protein expression in ILmPFC, expression was examined between groups (Figure 15k). ANOVA revealed
significant differences in PSD95 protein expression between groups (F4,54=4.248,
p=0.005). Post hoc tests confirmed that Coc E(38) rats (p=0.010) had significantly
increased PSD95 protein expression compared to naïve rats, but Coc NE(3) rats
(p=0.520), Coc E(3) rats (p=0.119), and Coc NE(38) rats (p=0.192) were not
significantly different than naïve rats. Moreover, Coc E(38) rats had significantly higher
PSD95 protein expression than Coc NE(3) rats (p=0.005) and Coc E(3) rats (p<0.0001).
Coc NE(38) rats had significantly higher PSD95 protein expression than Coc E(3) rats
(p=0.014) and were trending to be higher than Coc NE(3) rats (p=0.087). Finally, there
were no significant differences between Coc NE(3) rats and Coc E(3) rats (p=0.410), or
between Coc NE(38) rats and Coc E(38) rats (p=0.205). These results indicate that
cocaine self-administration increased PSD95 protein expression in IL-mPFC after a
prolonged withdrawal period, but not a short withdrawal period. Moreover, extinction
does not appear to significantly effect PSD95 protein expression.
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Finally, to examine PSD95 protein expression in IL-mPFC after an extinction
retention test (day 5) following four days of veh or anti-bFGF infusions with or without
30-min extinction sessions, expression was compared between groups (Figure 15l).
ANOVA revealed no significant differences between groups (F4,52=0.336, p=0.853).
Interestingly, these rats also underwent a 38-day withdrawal period, but do not
demonstrate the same significant increase in PSD95 protein expression as the COC
E(38) rats do.

Kal-7 and MAP2 protein expression
Kal-7 is increased following cocaine administration, and has a role in cocaineinduced increases in spine density (Kiraly, Ma, et al., 2010; X. Wang et al., 2013).
MAP2 is associated with dendritic growth (Gordon-Weeks, 1991; Shafit-Zagardo &
Kalcheva, 1998), and is decreased one week following cocaine self-administration, but
increased following extinction (Self et al., 2004). However, there were no significant
differences between any groups in Kal-7 or MAP2 protein expression in IL-mPFC (all
Fs<2.075, ps>0.05; data not shown). These results indicate that neither Kal-7 nor
MAP2 protein expression, at the selected time points, was altered by cocaine selfadministration, extinction of drug seeking, or neutralizing bFGF in IL-mPFC.

β-Catenin and GSK3β protein expression
Lastly, we examined the expression of two proteins, β-catenin and GSK3β, that
are known to interact with bFGF signaling to mediate plastic changes, such as
proliferation, during development (Boku et al., 2013; Israsena et al., 2004; Shimizu et
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al., 2008), and are altered by stimulant drug administration. GSK3β activity is increased
(as demonstrated through decreased pGSK3β protein expression) following stimulant
drug administration (W. Y. Kim et al., 2013; J. S. Miller et al., 2014; Perrine et al., 2008),
which should result in decreased β-catenin activity (as demonstrated through increased
pβ-catenin protein expression) though these findings are unclear currently (Dias et al.,
2015; Freeman et al., 2001). Therefore, we examined expression of each between
groups.
There were no significant differences between any groups in pβ-catenin protein
expression (all Fs<2.353, ps>0.05; data not shown), but there were significant
differences in pGSK3β expression between groups in IL-mPFC. To determine if natural
reward reinforcement and extinction of reward seeking altered pGSK3β protein
expression in IL-mPFC, tissue from naïve, Suc NE, and Suc E groups were compared.
ANOVA revealed no significant differences between groups (F2,33=1.474, p=0.244;
Figure 15m). These results indicated that pGSK3β protein expression was not altered
by sucrose self-administration, with or without extinction. Next, to determine if cue
presentation or i.v. infusions altered pGSK3β protein expression in IL-mPFC, tissue
from naïve, Y-Sal-NE, and Y-Sal-E groups were compared. There were no significant
differences between groups (F2,40=0.016, p=0.984; Figure 15n), indicating that cue
presentation and i.v. infusions does not significantly affect pGSK3β protein expression.
Subsequently, to determine if cocaine self-administration with a short or long
withdrawal period or extinction of drug seeking altered pGSK3β protein expression in ILmPFC, expression was examined between groups (Figure 15o). ANOVA revealed
significant differences in pGSK3β protein expression between groups (F4,55=3.042,
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p=0.025). Post hoc tests confirmed that Coc NE(38) rats (p=0.008), but not Coc NE(3)
rats (p=0.525), Coc E(3) rats (p=0.401), or Coc E(38) rats (p=0.226), had lower pGSK3β
protein expression than naïve rats. Moreover, Coc NE(38) rats had lower pGSK3β
protein expression than Coc E(3) rats (p=0.002), were trending to have lower
expression than Coc NE(3) rats (p=0.058), but were not different than Coc E(38) rats
(p=0.222). Finally, Coc NE(3) rats were not significantly different than Coc E(3) rats
(p=0.194). These results indicate that cocaine self-administration decreased pGSK3β
protein expression, but only after a prolonged 38-day withdrawal period. Extinction may
be able to attenuate this decrease, though not significantly.
Finally, to examine pGSK3β protein expression in IL-mPFC after an extinction
retention test (day 5) following four days of veh or anti-bFGF infusions with or without
30-min extinction sessions, expression was compared between groups (Figure 15p).
There were no significant differences between groups (F4,54=0.713, p=0.587).
Interestingly, these rats also underwent 38 days of withdrawal following cocaine selfadministration, yet they do no demonstrate the same decrease in pGSK3β protein
expression as Coc NE(38) rats do.

Cocaine self-administration induces plastic changes in NAc
The NAc has been extensively studied for its role in drug seeking and the longterm plastic changes induced by drug use (see Self-administration paradigm or Druginduced plastic changes section), however its role in extinction learning is less well
characterized. Our preliminary data suggested that bFGF protein expression in the NAc
is altered by cocaine self-administration and extinction. Therefore, to determine if
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extinction alters cocaine-induced plastic changes in NAc, we used western blotting to
analyze protein expression changes following cocaine self-administration with or with
extinction. Additionally, if neutralizing bFGF in IL-mPFC had a downstream effect on
cocaine-induced plastic changes with or without extinction in the NAc was examined.
Similarly to IL-mPFC, we first examined bFGF protein expression to determine
the time course of its expression. Next, we examine ARC, Kal-7, MAP2, GluR1,
PSD95, ∆FosB, β-catenin, and GSK3β to examine the effect of extinction and bFGF on
cocaine-induced plasticity. Figure 16a shows a representative area of tissue collection
from NAc (bregma 2.52 mm; Paxinos & Watson, 2007).

Figure 16: Representative regions of
collection containing (a) NAc and (b)
dHipp.

bFGF protein expression
Our preliminary data suggested two alternatives for bFGF protein expression in
the NAc. When protein expression was examined with western blots, we found that
cocaine self-administration increased bFGF protein expression and this was reversed
by extinction (Figure 5), which is similar to our findings in IL-mPFC (Figure 6).
Alternative, using IHC, we found that extinction increased bFGF immunoreactivity in
NAC core and a trend in NAc shell (Figure 8). Due to a number of limitations for each
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method, here we attempted to determine how bFGF protein expression was altered in
NAc with the inclusion of a number of groups.
To determine if natural reward reinforcement and extinction of reward seeking
altered bFGF protein expression in NAc, tissue from naïve, Suc NE, and Suc E groups
were compared. ANOVA revealed significant differences between groups (F2,16=5.025,
p=0.020; Figure 17a). Post hoc tests confirmed that Suc E rats (p=0.006), but not Suc
NE rats (p=0.360), had higher bFGF protein expression than naïve rats. There was a
trend for Suc E rats to have higher bFGF protein expression than Suc NE rats
(p=0.098), but it was not significant. These results indicate that bFGF protein
expression was increased following extinction of sucrose seeking in NAc. Next, to
determine if cue presentation or i.v. infusions altered bFGF protein expression in NAc,
tissue from naïve, Y-Sal-NE, and Y-Sal-E groups were compared. There were no
significant differences in bFGF protein expression between naïve, Y-Sal-NE, and Y-SalE rats (F2,22=2.114, p=145; Figure 17b), which indicate that cue presentation and i.v.
infusions does not significantly affect bFGF protein expression.
Subsequently, to determine if cocaine self-administration with a short or long
withdrawal period or extinction of drug seeking altered bFGF protein expression in NAc,
expression was examined between groups (Figure 17c). There were no significant
differences between groups (F4,29=1.044, p=0.402). These results indicate that bFGF
protein expression was unchanged in NAc following cocaine self-administration with or
without a prolonged withdrawal period, and with or without extinction training. These
results do not confirm either preliminary finding.
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Next, to determine if bFGF protein expression was altered following the
extinction retention test on day 5, following four days of vehicle or anti-bFGF infusions
with or without 30 min extinction sessions (Figure 12), expression was examined
between groups. There were no significant differences between groups (F4,32=1.092,
p=0.377; Figure 17d). These results further confirm the previous findings that bFGF
protein expression was not changed following prolonged withdrawal or following
abridged extinction training. Furthermore, bFGF protein expression in NAc was not
affected by neutralizing bFGF in IL-mPFC three days earlier.

ARC protein expression
To determine if natural reward reinforcement and extinction of reward seeking
altered ARC protein expression in NAc, tissue from naïve, Suc NE, and Suc E groups
were compared. There were no significant differences between groups (F2,27=2.486,
p=0.102; Figure 17e). These results indicated that ARC protein expression was not
altered by sucrose self-administration or extinction of sucrose seeking. Next, to
determine if cue presentation or i.v. infusions altered ARC protein expression in NAc,
tissue from naïve, Y-Sal-NE, and Y-Sal-E groups were compared. There were no
significant differences, but there was a trend, in ARC protein expression between naïve,
Y-Sal-NE, and Y-Sal-E rats (F2,37=2.564, p=0.091; Figure 17f), indicating that cue
presentation and i.v. infusions does not significantly affect ARC protein expression.
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Figure 17: Cocaine self-administration induces plastic changes in NAc. (a) Extinction of sucrose seeking
increased bFGF protein expression (naïve, n=10; Suc NE, n=4; Suc E, n=5). (b) bFGF protein
expression was not altered between naïve (n=10), Y-Sal-NE (n=8), and Y-Sal-E (n=7) rats. (c) bFGF
protein expression was not altered between naïve (n=10), Coc NE(3) (n=7), Coc E(3) (n=7), Coc NE(38)
(n=6), and Coc E(38) (n=4) rats. (d) bFGF protein expression was not different between naïve (n=10),
Veh NE (n=7), Anti-bFGF NE (n=7), Veh E (n=6), and Anti-bFGF E (n=7) rats. (e) ARC protein
expression was not different between naïve (n=18), Suc NE (n=7), and Suc E (n=5) rats. (f) ARC protein
expression was not different between naïve (n=18), Y-Sal-NE (n=11), and Y-Sal-E (n=11) rats. (g) ARC
protein expression was increased in all groups, except for Coc E(3) rats (n=10), compared to naïve rats
(n=18; Coc NE(3), n=11; Coc NE(38), n=8; Coc E(38), n=8). (h) ARC protein expression was increased
in Veh NE (n=11) and Anti-bFGF E (n=7) rats, but not Anti-bFGF NE (n=9) or Veh E (n=8) rats, compared
to naïve rats (n=18). (i) Kal-7 protein expression was not different between naïve (n=18), Suc NE (n=6),
and Suc E (n=6) rats. (j) Kal-7 protein expression was increased in Y-Sal-NE rats (n=12), but not Y-Sal-E
(n=11) rats, compared to naïve rats (n=18). (k) Kal-7 protein expression was not altered between naïve
(n=18), Coc NE(3) (n=11), Coc E(3) (n=10), Coc NE(38) (n=8), and Coc E(38) (n=8) rats. (l) Kal-7 protein
expression was not different between naïve (n=18), Veh NE (n=11), Anti-bFGF NE (n=9), Veh E (n=8),
and Anti-bFGF E (n=7) rats. (m) MAP2 protein expression was not different between naïve (n=17), Suc
NE (n=6), and Suc E (n=6) rats. (n) MAP2 protein expression was not different between naïve (n=17), YSal-NE (n=12), and Y-Sal-E (n=11) rats. (o) MAP2 protein expression was increased in rats that
underwent cocaine self-administration and long withdrawal (naïve, n=17; Coc NE(3), n=11; Coc E(3),
n=10; Coc NE(38), (n=8); Coc E(38), n=8). (p) MAP2 protein expression was not different between naïve
(n=17), Veh NE (n=10), Anti-bFGF NE (n=9), Veh E (n=8), and Anti-bFGF E (n=7) rats. *p<0.05, **p<0.01
compared to naïve, #p<0.05, ##p<0.01 compared to CNE(3), *p<0.05, **p<0.01 compared to CE(3).
Error bars are ±SEM
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Subsequently, to determine if cocaine self-administration with a short or long
withdrawal period or extinction of drug seeking altered ARC protein expression in NAc,
expression was examined between groups (Figure 17g). ANOVA revealed significant
differences in ARC protein expression between groups (F4,50=3.705, p=0.010). Post
hoc tests confirmed that Coc NE(3) rats (p=0.027), Coc NE(38) rats (p=0.001), Coc
E(38) rats (p=0.037), and trending in Coc E(3) rats (p=0.081), had increased ARC
protein expression compared to naïve rats. However, there were no further differences
between groups (all ps>0.05). These results indicate that cocaine self-administration
increased ARC protein expression after a short or prolonged withdrawal period, but
extinction does not appear to have an affect on ARC protein expression in NAc.
Finally, to examine ARC protein expression in NAc after an extinction retention
test (day 5) following four days of veh or anti-bFGF infusions with or without 30-min
extinction sessions, expression was compared between groups (Figure 17h). ANOVA
revealed significant differences in ARC protein expression between groups (F4,48=3.357,
p=0.017). Post hoc tests confirmed that Veh NE rats (p=0.002), Anti-bFGF E rats
(p=0.014), and a trend for Veh E rats (p=0.096), had significantly increased ARC protein
expression compared to naïve rats, but no change in expression for Anti-bFGF NE rats
(p=0.159). There were no further significant differences between groups (all ps>0.05).
These results partly agree that cocaine self-administration followed by a 38-day
withdrawal period increases ARC protein expression in the NAc. However, veh-infused
rats that underwent four 30-min extinction sessions or anti-bFGF-infused rats that did
not undergo four 30 min extinction sessions had similar ARC expression that was not
significantly different from naïve rats.
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Kal-7 protein expression
To determine if natural reward reinforcement and extinction of reward seeking
altered Kal-7 protein expression in NAc, tissue from naïve, Suc NE, and Suc E groups
were compared. There were no significant differences between groups (F2,26=1.061,
p=0.361; Figure 17i). These results indicated that Kal-7 protein expression was not
altered by sucrose self-administration or extinction of sucrose seeking. Next, to
determine if cue presentation or i.v. infusions altered Kal-7 protein expression in NAc,
tissue from naïve, Y-Sal-NE, and Y-Sal-E groups were compared. ANOVA revealed
significant differences in KAL-7 protein expression between naïve, Y-Sal-NE, and Y-SalE rats (F2,36=3.758, p=0.033; Figure 17j). Post hoc test confirm that Y-Sal-NE rats had
higher Kal-7 protein expression than naïve rats (p=0.012) and were trending to have
higher Kal-7 protein expression than Y-Sal-E rats (p=0.054). Y-Sal-E rats were not
different than naïve rats (p=0.724). These results indicate that Kal-7 was increased
following yoked-saline administration.
Subsequently, to determine if cocaine self-administration with a short or long
withdrawal period or extinction of drug seeking altered KAL-7 protein expression in NAc,
expression was examined between groups (Figure 17k). There were no significant
differences between groups (F4,49=0.282, p=0.888). Moreover, to examine KAL-7
protein expression in NAc after an extinction retention test (day 5) following four days of
veh or anti-bFGF infusions with or without 30-min extinction sessions, expression was
compared between groups (Figure 17l). There were no significant differences between
groups (F4,46=0.900, p=0.472). In summary, Kal-7 protein expression was not altered
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following cocaine self-administration with a short or long withdrawal point, following
extinction, or after bFGF is neutralized in IL-mPFC at the selected time points.

MAP2 protein expression
To determine if natural reward reinforcement and extinction of reward seeking
altered MAP2 protein expression in NAc, tissue from naïve, Suc NE, and Suc E groups
were compared. There were no significant differences between groups (F2,26=0.301,
p=0.743; Figure 17m). These results indicated that MAP2 protein expression was not
altered by sucrose self-administration or extinction of sucrose seeking. Next, to
determine if cue presentation or i.v. infusions altered MAP2 protein expression in NAc,
tissue from naïve, Y-Sal-NE, and Y-Sal-E groups were compared. There were no
significant differences in MAP2 protein expression between naïve, Y-Sal-NE, and Y-SalE rats (F2,37=0.630, p=0.538; Figure 17n), which indicates that cue presentation and i.v.
infusions does not significantly affect MAP2 protein expression.
Subsequently, to determine if cocaine self-administration with a short or long
withdrawal period or extinction of drug seeking altered MAP2 protein expression in NAc,
expression was examined between groups (Figure 17o). ANOVA revealed significant
differences in MAP2 protein expression between groups (F4,49=4.448, p=0.004). Post
hoc tests confirmed that Coc E(38) rats (p=0.027), trending in Coc NE(3) rats (p=0.077),
but not Coc E(3) rats (p=0.283) or Coc NE(38) rats (p=0.167), had increased MAP2
protein expression compared to naïve rats. Furthermore, Coc NE(38) rats (p=0.007;
p=0.034) and Coc E(38) rats (p=0.001; p=0.005) had significantly higher MAP2 protein
expression than Coc NE(3) rats and Coc E(3) rats, respectively. Finally, Coc NE(3) rats
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were not different than Coc E(3) rats (p=0.545), and Coc NE(38) rats were not different
than Coc E(38) rats (p=0.453), Overall, these results demonstrate that MAP2 protein
expression was increased following cocaine self-administration with a prolonged
withdrawal, but not a short withdrawal, period in NAc. Additionally, extinction does not
affect MAP2 protein expression in NAc at the selected time points.
Finally, to examine MAP2 protein expression in NAc after an extinction retention
test (day 5) following four days of veh or anti-bFGF infusions with or without 30-min
extinction sessions, expression was compared between groups (Figure 17p). There
were no differences between groups (F4,46=1.060, p=0.387). Interestingly, the rats in
these groups also underwent a 38-day withdrawal period, but do not demonstrate the
same significant increase in MAP2 protein expression as the COC E(38) rats do.

GluR1, PSD95, and ∆FosB protein expression
∆FosB expression is increased following administration of most commonly
abused substances in a number of brain regions (e.g., Atkins et al., 1999; Y. Kim et al.,
2009; Larson et al., 2010; Nye et al., 1995; Nye & Nestler, 1996; Perrotti et al., 2008;
Pich et al., 1997), and is thought to mediate the motivation to drug seek (Colby et al.,
2003). However, there were no significant differences between any groups in ∆FosB,
as well as GluR1 or PSD95, protein expression in NAc (all Fs<2.015, ps>0.05; data not
shown). These results indicate that GluR1, PSD95, and ∆FosB protein expression in
NAc was not altered at the selected time points by cocaine self-administration with a
short or long withdrawal period, extinction of drug seeking, or neutralizing bFGF in ILmPFC.
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β-Catenin and GSK3β protein expression
There were no significant differences between any groups in pβ-catenin or
pGSK3β protein expression in NAc (all Fs<2.398, ps>0.05; data not shown). These
results indicate that pβ-catenin and pGSK3β protein expression in the NAc was not
altered at any of the selected time points by cocaine self-administration with a short or
long withdrawal period, extinction of drug seeking, or neutralizing bFGF in IL-mPFC.

Cocaine self-administration induces plastic changes in dHipp
Less research is conducted on the role of the dHipp in drug addiction; however,
substantial research is conducted on its role in learning and memory (e.g., Fanselow &
Dong, 2010; Pergola & Suchan, 2013). Our preliminary data suggested that extinction
of cocaine seeking could reduce bFGF protein expression in the dHipp. Therefore, we
targeted this region to determine if cocaine self-administration induced plastic changes,
and if extinction could mediate these changes. To determine these changes, we
analyzed protein expression changes following cocaine self-administration after a short
or prolonged withdrawal period, with or with extinction. Additionally, if neutralizing bFGF
in IL-mPFC had an indirect effect on cocaine-induced plastic changes with or without
extinction in the dHipp was examined. Similarly, to IL-mPFC and NAc, we first
examined bFGF protein expression to determine the time course of its expression.
Next, we examine ARC, GluR1, PSD95, MAP2, β-catenin, and GSK3β to examine the
effect of extinction and bFGF on cocaine-induced plasticity. Figure 16b shows a
representative area of tissue collection from dHipp (bregma -3.24 mm; Paxinos &
Watson, 2007).
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bFGF protein expression
Our preliminary data suggested that extinction of drug seeking following cocaine
self-administration reduced bFGF protein expression (Figure 9). Here, we examine
bFGF protein expression in dHipp with the addition of a number of treatment groups.
To determine if natural reward reinforcement and extinction of reward seeking altered
bFGF protein expression in dHipp, tissue from naïve, Suc NE, and Suc E groups were
compared. There were no differences between groups (F2,24=0.18, p=0.864; Figure
18a), which suggests that bFGF protein expression was not altered following sucrose
self-administration or extinction of sucrose seeking in dHipp. Next, to determine if cue
presentation or i.v. infusions altered bFGF protein expression in dHipp, tissue from
naïve, Y-Sal-NE, and Y-Sal-E groups were compared. There were no significant
differences in bFGF protein expression between naïve, Y-Sal-NE, and Y-Sal-E rats
(F2,27=0.229, p=796; Figure 18b), which indicates that cue presentation and i.v.
infusions does not significantly affect bFGF protein expression in dHipp.
Subsequently, to determine if cocaine self-administration with a short or long
withdrawal period or extinction of drug seeking altered bFGF protein expression in
dHipp, expression was examined between groups (Figure 18c). ANOVA revealed
significant differences between groups (F4,42=1.044, p=0.402). Post hoc tests confirmed
that Coc NE(38) rats (p=0.027) had increased bFGF protein expression compared to
naïve rats, but Coc NE(3) rats (p=0.218), Coc E(3) rats (p=0.193), and Coc E(38) rats
(p=0.424) were not different than naïve rats. Additionally, Coc NE(38) rats had
significantly higher bFGF protein expression than Coc NE(3) rats (p=0.026) and Coc
E(3) rats (p=0.003), but were not different than Coc E(38) rats (p=0.245). These results
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indicate that bFGF protein expression was increased in dHipp following cocaine selfadministration with a prolonged withdrawal, but not short withdrawal, period and
extinction may attenuate this increase.

Figure 18: Cocaine self-administration induces plastic changes in dHipp. (a) bFGF protein expression
was not different between naïve (n=15), Suc NE (n=6), and Suc E (n=6) rats. (b) bFGF protein
expression was not altered between naïve (n=15), Y-Sal-NE (n=8), and Y-Sal-E (n=7) rats. (c) bFGF
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protein expression was increased in Coc NE(38) (n=9), but not Coc NE(3) (n=8), Coc E(3) (n=8), or Coc
E(38) (n=7) rats, compared to naïve rats (n=15). (d) bFGF protein expression was not different between
naïve (n=15), Veh NE (n=11), Anti-bFGF NE (n=9), Veh E (n=9), and Anti-bFGF E (n=8) rats. (e) ARC
protein expression was not different between naïve (n=19), Suc NE (n=8), and Suc E (n=9) rats. (f) ARC
protein expression was not different between naïve (n=19), Y-Sal-NE (n=11), and Y-Sal-E (n=11) rats.
(g) ARC protein expression was only increased in Coc NE(38) rats (n=10; Coc NE(3), n=12; Coc E(3),
n=11; Coc E(38), n=8; naïve, n=19). (h) ARC protein expression was increased in all groups (Veh NE,
n=11; Anti-bFGF NE, n=10; Veh E, n=9; and Anti-bFGF E, n=10) compared to naïve rats (n=19). (i)
pGSK3β protein expression was not different between naïve (n=18), Suc NE (n=6), and Suc E (n=5) rats.
(j) pGSK3β protein expression was not different between naïve (n=18), Y-Sal-NE (n=11), and Y-Sal-E
(n=10) rats. (k) pGSK3β protein expression was decreased in rats that underwent cocaine selfadministration and prolonged withdrawal (naïve, n=18; Coc NE(3), n=10; Coc E(3), n=10; Coc NE(38),
n=10; Coc E(38), n=8). (l) pGSK3β protein expression was not different between naïve (n=18), Veh NE
(n=11), Anti-bFGF NE (n=8), Veh E (n=9), and Anti-bFGF E (n=10) rats. *p<0.05, **p<0.01 compared to
naïve, #p<0.05, ##p<0.01 compared to CNE(3), *p<0.05, **p<0.01 compared to CE(3). Error bars are
±SEM.

Next, to determine if bFGF protein expression was altered following the extinction
retention test on day 5, following four days of vehicle or anti-bFGF infusions with or
without 30 min extinction sessions (Figure 12), expression was examined between
groups. There were no significant differences between groups (F4,48=1.605, p=0.188;
Figure 18d). Interestingly, these rats also underwent 38 days of withdrawal following
cocaine self-administration, but do not demonstrate significantly increased bFGF protein
expression as Coc NE(38) rats do. Furthermore, these results demonstrate that bFGF
protein expression in dHipp was not affected by neutralizing bFGF in IL-mPFC three
days earlier.
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ARC protein expression
To determine if natural reward reinforcement and extinction of reward seeking
altered ARC protein expression in dHipp, tissue from naïve, Suc NE, and Suc E groups
were compared. There were no differences between groups (F2,33=1.908, p=0.165;
Figure 18e). These results indicated that ARC protein expression was not altered
following sucrose self-administration or extinction of sucrose seeking. Next, to
determine if cue presentation or i.v. infusions altered ARC protein expression in dHipp,
tissue from naïve, Y-Sal-NE, and Y-Sal-E groups were compared. There were no
differences in ARC protein expression between naïve, Y-Sal-NE, and Y-Sal-E rats
(F2,38=2.115, p=0.135; Figure 18f), which indicates that cue presentation and i.v.
infusions does not affect ARC protein expression.
Subsequently, to determine if cocaine self-administration with a short or long
withdrawal period or extinction of drug seeking altered ARC protein expression in dHipp,
expression was examined between groups (Figure 18g). ANOVA revealed significant
differences in ARC protein expression between groups (F4,55=3.658, p=0.010). Post
hoc tests confirmed that Coc NE(38) rats (p=0.001) had significantly higher ARC protein
expression compared to naïve rats. There was a trend for increased ARC protein
expression in Coc NE(3) rats (p=0.099) and Coc E(38) rats (p=0.083) compared to
naïve rats, but Coc E(3) rats (p=0.665) were not different. Moreover, Coc NE(38) rats
had higher ARC protein expression than Coc E(3) rats (p=0.007), and were trending to
be higher than Coc NE(3) rats (p=0.075). Finally, there were no differences in ARC
protein expression between Coc E(3) rats and Coc NE(3) rats (p=0.282), and between
Coc E(38) and Coc NE(38) rats (p=0.176). These results indicate that cocaine self-
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administration with a long withdrawal period, but not short, increased ARC protein
expression in dHipp, and extinction may attenuate this increase.
Finally, to examine ARC protein expression in dHipp after an extinction retention
test (day 5), following four days of veh or anti-bFGF infusions with or without 30-min
extinction sessions, expression was compared between groups (Figure 18h). ANOVA
revealed significant differences in ARC protein expression between groups (F4,54=4.324,
p=0.004). Post hoc tests confirmed that Veh NE rats (p=0.007), Anti-bFGF NE rats
(p=0.001), Veh E rats (p=0.028), and Anti-bFGF E rats (p=0.006) had significantly
increased ARC expression compared to naïve rats. However, there were no further
significant differences between groups (ps>0.05). These results agree that cocaine
self-administration with a 38-day withdrawal period increased ARC protein expression in
dHipp, but here there was no effect of extinction on expression.

GluR1, PSD95, and MAP2 protein expression
There were no significant differences between any groups in GluR1, PSD95, or
MAP2 protein expression in dHipp (all Fs<2.061, ps>0.05; data not shown). These
results indicate that GluR1, PSD95, and MAP2 protein expression in dHipp was not
altered at the selected time points by cocaine self-administration following a short or
long withdrawal period, extinction of drug seeking, or neutralizing bFGF in IL-mPFC.

β-Catenin and GSK3β protein expression
There were no significant differences between any groups in pβ-catenin
expression (all Fs<1.568, ps>0.05; data not shown); however, there were differences in
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pGSK3β in dHipp. To determine if natural reward reinforcement and extinction of
reward seeking altered pGSK3β protein expression in dHipp, tissue from naïve, Suc NE,
and Suc E groups were compared. There were no differences between groups
(F2,26=0.395, p=0.678; Figure 18i). These results indicated that pGSK3β protein
expression was not altered by sucrose self-administration or extinction of sucrose
seeking. Next, to determine if cue presentation or i.v. infusions altered pGSK3β protein
expression in dHipp, tissue from naïve, Y-Sal-NE, and Y-Sal-E groups were compared.
There were no differences between groups (F2,36=0.026, p=0.974; Figure 18j), which
indicates that cue presentation and i.v. infusions did not significantly affect pGSK3β
protein expression.
Subsequently, to determine if cocaine self-administration with a short or long
withdrawal period or extinction of drug seeking altered pGSK3β protein expression in
dHipp, expression was examined between groups (Figure 18k). ANOVA revealed
significant differences in pGSK3β protein expression between groups (F4,51=3.552,
p=0.012). Post hoc tests confirmed that Coc NE(38) rats (p=0.005) and Coc E(38) rats
(p=0.027), but not Coc NE(3) rats (p=0.733) and Coc E(3) rats (p=0.787), had lower
pGSK3β protein expression than naïve rats. Moreover, Coc NE(38) rats had lower
pGSK3β protein expression than Coc NE(3) rats (p=0.028) and Coc E(3) rats (p=0.007),
and CE(38) rats had significantly lower pGSK3β protein expression than Coc E(3) rats
(p=0.027). Finally, Coc NE(3) rats were not significantly different than Coc E(3) rats
(p=0.590), and Coc NE(38) rats were not different than Coc E(38) rats (p=0.709).
These results indicate that cocaine self-administration decreased pGSK3β protein
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expression, but only after a prolonged 38-day withdrawal period, and extinction does not
appear to effect pGSK3β protein expression at this time point in dHipp.
Finally, to examine pGSK3β protein expression in dHipp after an extinction
retention test (day 5), following four days of veh or anti-bFGF infusions with or without
30-min extinction sessions, expression was compared between groups (Figure 18l).
There were no significant differences between groups, though there was a trend
(F4,51=2.150, p=0.088). Interestingly, these rats also underwent 38 days of withdrawal
following cocaine self-administration, yet they do no demonstrate the same decrease in
pGSK3β protein expression as Coc NE(38) rats and Coc E(38) rats do.
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DISCUSSION
The current experiments aimed to determine if extinction could reverse cocaineinduced plastic changes, and if neutralizing bFGF in IL-mPFC before four extinction
sessions could facilitate extinction-induced plastic changes. We observed a number of
plastic changes following cocaine self-administration, predominantly following a
prolonged withdrawal period, in IL-mPFC, NAc, and dHipp (Table 7). In the IL-mPFC,
extinction reversed cocaine-induced increases in bFGF and ARC protein expression,
but only after the short withdrawal period. However, in the other proteins of interest,
extinction only attenuated some changes. Moreover, specifically neutralizing bFGF in
the IL-mPFC before four 30-min extinction sessions did not significantly alter protein
expression in any brain region. Overall, these results give insights into proteins to
target that could enhance extinction and ultimately reduce relapse rates.
Overall, cocaine self-administration resulted in increased expression of ARC,
bFGF, and GluR1 and decreased expression of GSK3β in IL-mPFC; increased
expression of ARC in the NAc; and increased expression of ARC and bFGF, and
decreased expression of GSK3β in dHipp, compared to naïve controls. Cocaine selfadministration, however, had no effect on expression of ∆FosB, Kal-7, and pβ-catenin,
in any brain region examined at the selected time points. Alternatively, rats that
underwent extinction were not different than naïve in their expression of ARC (after
short withdrawal period), bFGF, GluR1, and GSK3β in IL-mPFC; ARC (after short
withdrawal period) in NAc; and ARC and bFGF in dHipp. Moreover, PSD95 (IL-mPFC)
and MAP2 (NAc) were increased in Coc E(38) rats compared to naïve controls.
However, with the exception of ARC and bFGF in IL-mPFC after the short withdrawal
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period, Coc NE(3) rats were not significantly different than Coc E(3) rats and Coc
NE(38) rats were not significantly different than Coc E(38) rats in any protein of interest,
but there were trends. Therefore, extinction does result in changes in protein
expression, but these changes may be subtle at the selected time points or reduced
after prolonged withdrawal.
Interestingly, in a region-specific manner, cocaine self-administration induced
increases in GluR1, PSD95, pGSK3β, MAP2, and bFGF that were observed following a
prolonged withdrawal period, but were not observed in rats that were euthanized after
extinction day 5 (extinction retention test) in rats that previously received veh- or antibFGF infusions, with or without 30 min extinction sessions, for four days. ARC
expression, however, was increased in nearly all groups that underwent prolonged
withdrawal in all three brain regions. Veh E, Anti-bFGF E, Veh NE, Anti-bFGF NE rats
underwent equal acquisition and withdrawal days as the animals that underwent
extinction to criteria (Coc E(38)) or remained in their home cages (Coc NE(38)), and
therefore they would have been expected to have similar protein expression.
These rats differ from the “full” extinction groups in a few ways. They were
implanted with cannula, underwent four days of microinfusions, did not extinguish to
criteria, and they were euthanized after 45-days of withdrawal compared to 51-days of
withdrawal (Coc NE(38) and Coc E(38) rats). Coc NE(38), Veh NE, and Anti-bFGF NE
rats all only underwent one extinction day (extinction retention test), but similar changes
between groups were not observed. Therefore, the number of days and amount of time
undergoing extinction is unlikely to explain the differences in expression.

111

The number of withdrawal days may be able to explain the differences, however,
the opposite results would be expected (e.g., changes at the early time point). Others
have reported that the number of days of stimulant drug treatment, route of
administration, and number of withdrawal days can result in differences in spine density
and morphology (Dobi et al., 2011; Dumitriu et al., 2012; K. W. Lee et al., 2006), and
protein expression such as GluR1, β-catenin, and MAP2 (Dias et al., 2015; Freeman et
al., 2010; Self et al., 2004; Wolf, 2010; Wolf & Ferrario, 2010; Yao et al., 2004).
Moreover, one experiment even found an inverted “u” shaped curved for β-catenin
expression in NAC when expression was examined at 1, 10, or 100 days of withdrawal
following 10 continuous days of cocaine self-administration, with expression peaking at
10 days (Freeman et al., 2010). However, in most experiments, protein expression is
compared after 24 hours of withdrawal to 14 days. We examined protein expression
after 12, 45, or 51 days of withdrawal (from the last day of acquisition), and might have
missed changes in protein expression only observed during early withdrawal periods.
Another limitation to our design is that all groups underwent an extinction
retention test prior to being euthanized. In groups that did not undergo extinction, one
90-min extinction session might have been sufficient to induce plastic changes in certain
brain regions. Alternatively, being placed in the operant chamber prior to being
euthanized would reactive the original drug-cue memory and therefore could have
induced changes that way. For example, ARC protein expression was increased
following retrieval of a cocaine conditioned place preference memory in IL-mPFC and
PL-mPFC (Alaghband et al., 2014) and following retrieval of conditioned fear memory in
the lateral amygdala (Maddox & Schafe, 2011).
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The retrieval of the original drug-cue memory may explain the increase in ARC
protein expression in all three brain regions observed in some groups following an
extinction retention test. In the IL-mPFC and NAc, ARC protein expression was
increased in Coc NE(3), Coc NE(38), and Coc E(38) rats, but not in Coc E(3) rats,
compared to naïve. In dHipp, ARC protein expression was only increased in Coc
NE(38) rats compared to naïve. These results might be demonstrating a difference in
memory retrieval, which differs depending on the withdrawal length. In other words,
Coc NE(3) rats retrieved the original drug cue memory resulting in higher ARC protein
expression, but Coc E(3) rats retrieved the extinction memory which did not result in
higher ARC protein expression. However, after a prolonged withdrawal period, which
also corresponded with increased drug seeking compared to a short withdrawal period
(see Figure 23), ARC protein expression was increased with or without extinction.
Further research needs to be conducted to confirm these findings, but the results
are interesting when considering how protein expression corresponds with differences
in active lever pressing during extinction day one and the retention test. To my
knowledge, little work has been conducted on the mechanisms underlying retrieval of an
extinction memory. In comparison, extinction and reconsolidation share similar, but
distinct, underlying mechanisms (Suzuki et al., 2004; Tronson & Taylor, 2007), with
some research suggesting they compete at the molecular level (Nader, 2003). Perhaps
extinction and retrieval of the original drug-cue memory also compete at the molecular
level. This competition could explain why differences in IL-mPFC and NAc are
observed in ARC protein expression in Veh NE, Anti-bFGF NE, Veh E, and Anti-bFGF E
rats that does not correspond with length of extinction undergone by the rats.
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Interestingly, ARC protein expression was increased in all four groups in dHipp, which is
important for memory retrieval in a number of paradigms (S. A. Thomas, 2015).
To control for withdrawal length and memory reactivation, future experiments
should include a group of rats that are euthanized shortly following the last day of
acquisition (e.g., 30 min or 24 hours). This time point would act as a baseline for
cocaine-induced changes, and allow comparisons to be made at any addition time
points after a withdrawal point (e.g., if expression increases or decreases relative to
immediately at the cessation of drug use). Additionally, another group should be
included that does not undergo the extinction retention test, which would control for the
original memory reactivation and any extinction that might occur.
Implanting cannula might also have altered protein expression, particularly in the
IL-mPFC. bFGF has a role in tissue repair (Schultz & Wysocki, 2009), and possibly
could have been recruited to the area following surgery. Moreover, scar tissue likely
forms around the cannula, which could also alter protein expression in the area. To
control for this variable, an additional control group that is treated identically as the other
four groups could be included, but that do not receive cannula or microinfusions.
One final limitation to these results is the manner by which the western blots
were conducted. Due to limited time and resources, the western blots were conducted
simultaneously, with all proteins of interest per structure being examined at once or
following numerous strips and reprobes of the membrane. Each brain region was
conducted in this manner in immediate succession. Conducting the western blots in this
manner likely and greatly increased the risk of human error. Thus, to confirm the results
presented here, replication of each protein of interest per structure is warranted.
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Extinction of drug seeking alters drug-induced plasticity
Overall, there was some evidence that extinction could attenuate cocaineinduced plastic changes in IL-mPFC, NAC, and dHipp, as rats that underwent extinction
had changes in protein expression when compared to naïve or rats that had different
length of withdrawal. However, rats that underwent extinction were not different than
rats that remained in their home cages throughout, when the length of withdrawal was
equal, with the exception of ARC and bFGF in IL-mPFC. Thus, extinction does alter
cocaine-induced plastic changes, but reversal was only observed in IL-mPFC with
bFGF and ARC protein expression.
These findings are not surprising when reinstatement and relapse is considered.
Rats will reliability reinstate drug seeking following a priming injection of cocaine, a
stressful event, or following presentation of a cue previously not extinguished (Epstein
et al., 2006; Shaham, Shalev, Lu, De Wit, & Stewart, 2003). This is not unique to rats,
as most addicts relapse following treatment (McLellan et al., 2000), and extinctionbased exposure therapy is not particularly effective (Conklin & Tiffany, 2002). It is
thought that prolonged stimulant use induces long-lasting maladaptive changes to the
brain, specifically to the reward pathway, that makes abstinence difficult (Hyman,
Malenka, & Nestler, 2006; Kalivas, 2009). In conjunction, stimulant drugs are a potent
reinforcer that can become associated with cues, which can trigger craving and promote
relapse in an abstinent addict (Childress et al., 1986).
Extinction is the formation of a new memory wherein the cues are no longer
associated with the reward (Millan et al., 2011; Quirk & Mueller, 2008). However, as
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discussed, extinction alone is not sufficient to prevent relapse. Considerable work has
been conducted to find pharmacological adjuncts to pair with exposure based extinction
therapy (Chesworth & Corbit, 2015), in hopes that if extinction was strengthened, it
could prevent subsequent relapse. Progress has been made with opiates and alcohol
treatment (Aboujaoude & Salame, 2016; Rodriguez-Arias, Aguilar, & Minarro, 2015), but
there is no FDA approved medication for cocaine addiction.
Extinction of drug seeking is less well characterized than reinstatement or
relapse. However, in order to strengthen extinction learning, the mechanisms
underlying extinction should be determined. If stimulant drug use is promoting a state
that makes it difficult to form new memories, then methods to reverse this state should
be determined. Therefore, the goal of these experiments was to determine if extinction
could alter cocaine-induced plasticity. None of the proteins of interest, except for bFGF
in our preliminary data (Hafenbreidel et al., 2015) and ARC in IL-mPFC, reversed
cocaine-induced plasticity. However, extinction did alter the expression of ARC, bFGF,
GluR1, MAP2, pGSK3β, and PSD95 at either the early or late withdrawal period in at
least one brain region. These changes give new directions for ways to being
strengthening extinction to ultimately reduce drug seeking and prevent relapse.

The role of bFGF in extinction of drug seeking
The second central question Aim 1 was trying to address was if neutralizing
bFGF in IL-mPFC prior to four 30-min extinction sessions facilitated any extinctioninduced plastic changes. With the exception of ARC (see above), no other protein of
interest was significantly different between groups that received veh- or anti-bFGF
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infusions, in any brain region. Thus, at the time point selected, neutralizing bFGF in ILmPFC did not affect cocaine-induced plasticity.
In addition to the aforementioned limitations, the limited number of extinctioninduced changes in cocaine-induced plasticity made any conclusions from these groups
difficult. There were no significant changes in bFGF protein expression in IL-mPFC in
rats that received infusions of anti-bFGF, which indicates that neutralizing bFGF is not
long lasting. Therefore, it is possible that any plastic changes induced by bFGF during
the first four 30-min extinction sessions were also reversed by extinction day five.
Moreover, learning induced changes may not have been evident either, as animals
were euthanized immediately following the retention test, and rats had not fully
extinguished drug seeking. Our findings do not explain the differences in behavior
observed on extinction day five, but it is possible that western blotting is not sensitive
enough to detect the changes that mediated the facilitated extinction observed in antibFGF infused rats during the extinction retention test (extinction day five).
A more robust technique to determine the mechanisms underlying the effect of
neutralizing bFGF on extinction of drug seeking would be to conduct
electrophysiological recordings. bFGF reduces intrinsic excitability when bath applied to
hippocampal neurons (Cuppini et al., 2009; Hilborn et al., 1998), and blocks calciumdependent inactivation of NMDA receptors (Boxer et al., 1999). Therefore, the first step
would be to determine if neutralizing bFGF could reverse these effects. Next, stimulant
drug use can decrease intrinsic excitability in NAc (Dong et al., 2006; Ishikawa et al.,
2009; Kourrich & Thomas, 2009; Mu et al., 2010). Thus, the following step would be to
determine if cocaine self-administration also decreased excitability in IL-mPFC and if
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neutralizing bFGF could reverse these changes. Finally, the last step would be
determining if extinction could also reverse these changes in excitability and if
neutralizing bFGF potentiated this reversal.
Another potential way to examine the mechanisms underlying the effect of
neutralizing bFGF on extinction would be to systematically block targets down stream
from bFGF (Figure 2), either pharmacologically or genetically (e.g., siRNA). One
additional approach would be to examine epigenetic modifications following extinction of
drug seeking. Epigenetic modifications have emerged as a potent regulator of
neuroplasticity in drug addiction (Nestler, 2014). Epigenetic modifications are changes
made to the DNA or proteins associated with the DNA (histones) that alter transcription.
One type is histone methylation, which is associated with a closed chromatin state and
reduced transcription. bFGF is regulated through histone methylation; specifically the
expression of H3K9me3 on bFGF is associated with decreased expression of bFGF in
the NAc (Chaudhury et al., 2014). However, the extent that H3K9me3 regulates the
differential bFGF expression following self-administration or extinction is unknown.
Therefore, a future investigation could test the hypothesis that cocaine selfadministration decreases H3K9me3 at the bFGF promoter resulting in increased bFGF
expression, but the opposite occurs following extinction in IL-mPFC.
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AIM 2
RESULTS
To determine the behavioral relevance of our previous findings that indicated that
extinction of cocaine seeking also modified bFGF protein expression in the NAc and
dHipp, rats were infused with vehicle or anti-bFGF one hour before four 30-min
extinction sessions or were immediately returned their home cages without being
exposed to the operant chambers. Extinction retention was then tested, after a two-day
drug wash out period, during a 90-min extinction session. Finally, the long-term effects
of neutralizing bFGF in NAc and dHipp were examined by inducing reinstatement with a
priming injection of cocaine.

Neutralizing bFGF in NAc before four 30-min extinction sessions disrupted initial
extinction retention
Active or inactive lever presses and number of infusions were equivalent
between groups across the average of the last three days of self-administration (Table
8). Rats infused with vehicle in NAc of dHipp that did undergo 30-min extinction
sessions were not significantly different during acquisition (Table 8; active lever
presses, all t13=0.875, p=0.397), extinction (Figures 19 and 20; active lever presses, all
Fs<3.467, p>0.05), or reinstatement (Figures 19 and 20; active lever presses,
F1,24=1.879, p=0.183) and therefore were collapsed into a single vehicle group.
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Table 8: Average number of active and inactive lever presses, or infusions across the last three days of
cocaine self-administration. There were no significant differences between groups.

Figure 19: Neutralizing bFGF in NAc before four 30-min extinction sessions disrupts initial extinction, but
neutralizing bFGF without extinction facilitates subsequent extinction. (a) Representative area for injector
tip locations in NAc. (b) Pre-extinction session infusions of anti-bFGF into NAc (arrows) during the 30-min
extinction sessions disrupted extinction retention compared to vehicle infusions. (c) All rats reinstated
following a priming injection of cocaine. (d) Representative area for injector tip locations in NAc. (e)
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Infusions of either vehicle or anti-bFGF into NAc for four days (arrows), during which rats were returned
immediately to their home cages, facilitated subsequent extinction. (f) All rats reinstated following a
priming injection of cocaine, but anti-bFGF-infused rats were attenuated. *p<0.05, ***p<0.0001 Error bars
are ±SEM.

Following acquisition, rats underwent 38 days of withdrawal in their home cages.
Next, rats received vehicle or anti-bFGF infusions into NAc one hour before four 30-min
extinction sessions. Across the 30-min extinction sessions (days 1-4, active lever
presses; Figure 19b, left), ANOVA revealed a significant effect of treatment
(F1,88=4.769, p=0.032), but no effect of day (F3,88=2.305, p=0.082) or day by treatment
interaction (F3,88=0.031, p=0.993). During the 90-min extinction sessions (days 5-14;
Figure 19b, right), ANOVA revealed a significant effect of treatment (F1,220=15.051,
p<0.0001), day (F9,220=5.187, p<0.0001), but no day by treatment interaction
(F9,220=0.442, p=0.911). These results indicate that both groups demonstrate little
extinction during the first four 30-min extinction days, but anti-bFGF-infused rats lever
pressed more. Moreover, anti-bFGF-infused rats lever pressed more during the 90-min
extinction sessions, suggesting impaired extinction retention, but both groups
demonstrate extinction across days. Inactive lever presses (data not shown) did not
differ across days or treatment regardless of extinction session duration (all Fs<3.367,
ps>0.05). Thus, neutralizing bFGF in the NAc disrupted initial extinction retention.
Following extinction, all rats were tested for cocaine-induced reinstatement of
drug seeking. Rats were given a non-contingent priming injection of cocaine (Figure
19c) prior to a 90-min extinction session. ANOVA revealed a significant increase in
active lever pressing during the reinstatement test as compared to the last extinction

121

test (F1,42=28.690, p<0.0001), but no effect of treatment (F1,42=0.694, p=0.410) or day
by treatment interaction (F1,42=0.001, p=0.975). Inactive lever presses did not differ
across days or treatment (all Fs<2.504, ps>0.05; data not shown). Therefore,
neutralizing bFGF in the NAc during the first four extinction days did not affect cocaineinduced reinstatement.

Neutralizing bFGF in NAc for four days, without extinction training, enhanced
extinction retention
Active or inactive lever presses and number of infusions were equivalent
between groups across the average of the last three days of self-administration (Table
8). Rats infused with vehicle in NAc of dHipp that did not undergo 30-min extinction
sessions were not significantly different during acquisition (Table 8; active lever
presses, all t13=0.881, p=0.394), extinction (Figures 19 and 20; active lever presses, all
F1,130=0.740, p=0.391), or reinstatement (Figures 19 and 20; active lever presses,
F1,26=0.224, p=0.640) and therefore were collapsed into a single vehicle group.
Following acquisition, rats underwent 38 days of withdrawal in their home cages.
Next, rats received vehicle or anti-bFGF infusions into NAc and were immediately
returned to their home cages, without being exposed to the operant chambers, for four
days (Figure 19e, left). Next, rats underwent daily 90-min extinction sessions. During
the 90-min extinction sessions (days 5-14; Figure 19e, right), ANOVA revealed a
significant effect of treatment (F1,210=16.597, p<0.0001), day (F9,210=14.256, p<0.0001),
but no day by treatment interaction (F9,210=0.417, p=0.925). These results indicate that

122

both groups demonstrate extinction across days, but anti-bFGF-infused rats extinguish
at a quicker rate than vehicle-infused rats.

Figure 20: Neutralizing bFGF in dHipp, with or without four 30-min extinction sessions, facilitates
subsequent extinction. (a) Representative area for injector tip locations in dHipp. (b) Pre-extinction
session infusions of anti-bFGF into dHipp (arrows) during the 30-min extinction sessions facilitates
extinction retention compared to vehicle infusions. (c) All rats reinstated following a priming injection of
cocaine. (d) Representative area for injector tip locations in dHipp. (e) Infusions of either vehicle or antibFGF into dHipp for four days (arrows), during which rats were returned immediately to their home cages,
facilitated subsequent extinction. (f) All rats reinstated following a priming injection of cocaine. *p<0.05,
***p<0.0001 Error bars are ±SEM.
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For inactive lever presses during extinction days 5-14 (data not shown), ANOVA
revealed a significant effect of treatment (F1,210=8.971, p=0.003), day (F9,210=2.285,
p=0.018), but no day by treatment interaction (F9,210=0.340, p=0.961). A subsequent
ANOVA between active and inactive lever presses revealed a significant effect of lever
(F1,420=430.918, p<0.0001), which demonstrates that rats pressed the active lever more
than the inactive lever. Finally, veh-infused rats that underwent four 30-min extinction
sessions lever pressed significantly less than veh-infused rats that did not undergo the
four 30-min extinction sessions during extinction day five (t13=-3.635, p=0.003; data not
shown), which indicates that four 30-min extinction sessions are sufficient for extinction
learning to occur. In summary, neutralizing bFGF in the NAc, without four 30-min
extinction sessions, facilitated subsequent extinction across days.
Following extinction, all rats were tested for cocaine-induced reinstatement of
drug seeking. Rats were given a non-contingent priming injection of cocaine (Figure
19f) prior to a 90-min extinction session. ANOVA revealed a significant increase in
active lever pressing during the reinstatement test as compared to the last extinction
test (F1,42=24.980, p<0.0001), and a significant effect of treatment (F1,42=4.826,
p=0.034), but no day by treatment interaction (F1,42=0.984, p=0.327). Inactive lever
presses did not differ across days or treatment (all Fs<1.153, ps>0.05). In summary,
previously veh- or anti-bFGF-infused rats reinstated cocaine seeking following a priming
injection of cocaine, however, previously anti-bFGF-infused rats appear to have
attenuated seeking. These results suggest that neutralizing bFGF in the NAc, without
30-min extinction sessions, may help protect against cocaine-induced reinstatement.
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Neutralizing bFGF in dHipp before four 30-min extinction sessions facilitates
extinction
Active or inactive lever presses and number of infusions were equivalent
between groups across the average of the last three days of self-administration (Table
8). Following acquisition, rats underwent 38 days of withdrawal in their home cages.
Next, rats received vehicle or anti-bFGF infusions into dHipp one hour before four 30min extinction sessions. Across the 30-min extinction sessions (days 1-4, active lever
presses; Figure 20b, left), ANOVA revealed a significant effect of day (F3,88=3.764,
p=0.014), but no effect of treatment (F1,88=2.108, p=0.150) or day by treatment
interaction (F3,88=1.132, p=0.341). During the 90-min extinction sessions (days 5-14;
Figure 20b, right), ANOVA revealed a significant effect of treatment (F1,230=4.903,
p=0.028), day (F9,220=7.476, p<0.0001), but no day by treatment interaction
(F9,220=0.542, p=0.843). These results indicate that both groups reduced lever pressing
during the first four 30-min extinction and during the 90-min extinction days indicating
both groups demonstrated extinction across days, but anti-bFGF-infused rats extinguish
at a quicker rate than vehicle-infused rats during the 90-min extinction days. Inactive
lever presses (data not shown) did not differ across days regardless of extinction
session duration (all Fs<1.443, ps>0.05), but ANOVA did reveal a significant treatment
effect (extinction days 1-4: F1,88=4.498, p=0.037; extinction days 5-15: F1,220=14.759,
p<0.0001). Subsequent ANOVAs between active and inactive levers demonstrated a
significant effect of lever (extinction days 1-4: F1,176=521.859, p<0.0001; extinction days
5-15: F1,440=456.583, p<0.0001), which demonstrates that rats pressed significantly
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more on the active lever than the inactive. Overall, neutralizing bFGF in the dHipp
before four 30-min extinction sessions facilitated subsequent extinction across days.
Following extinction, all rats were tested for cocaine-induced reinstatement of
drug seeking. Rats were given a non-contingent priming injection of cocaine (Figure
20c) prior to a 90-min extinction session. ANOVA revealed a significant increase in
active lever pressing during the reinstatement test as compared to the last extinction
test (F1,42=40.724, p<0.0001), but no effect of treatment (F1,42=0.032, p=0.859) or day
by treatment interaction (F1,42=0.099, p=0.754). Inactive lever presses did not differ
across days or treatment (all Fs<0.891, ps>0.05). Therefore, neutralizing bFGF in the
dHipp during the first four extinction days did not affect cocaine-induced reinstatement.

Neutralizing bFGF in dHipp for four days, without extinction training, facilitates
subsequent extinction across days
Active or inactive lever presses and number of infusions were equivalent
between groups across the average of the last three days of self-administration (Table
8). Following acquisition, rats underwent 38 days of withdrawal in their home cages.
Next, rats received vehicle or anti-bFGF infusions into dHipp and were immediately
returned to their home cages, without being exposed to the operant chambers, for four
days. Next, rats underwent daily 90-min extinction sessions. During the 90-min
extinction sessions (days 5-14), ANOVA revealed a significant effect of treatment
(F1,210=12.406, p<0.0001), day (F9,210=14.546, p<0.0001), but no day by treatment
interaction (F9,210=0.347, p=0.958). These results indicate that both groups
demonstrate extinction across days, but anti-bFGF-infused rats extinguish at a quicker
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rate than vehicle-infused rats. For inactive lever presses during extinction days 5-14
(data not shown), ANOVA revealed a significant effect of day (F9,210=2.930, p=0.003),
but no effect of day or day by treatment interaction (all Fs<2.046, ps>0.05). Finally,
veh-infused rats that underwent four 30-min extinction sessions lever pressed
significantly less than veh-infused rats that did not undergo the four 30-min extinction
sessions during extinction day five (t13=-3.069, p=0.009; data not shown), which
indicates that four 30-min extinction sessions are sufficient for extinction learning to
occur. Overall, neutralizing bFGF in the dHipp, without four 30-min extinction sessions,
facilitated subsequent extinction across days.
Following extinction, all rats were tested for cocaine-induced reinstatement of
drug seeking. Rats were given a non-contingent priming injection of cocaine (Figure
20f) prior to a 90-min extinction session. ANOVA revealed a significant increase in
active lever pressing during the reinstatement test as compared to the last extinction
test (F1,42=31.706, p<0.0001), but no effect of treatment (F1,42=1.153, p=0.289) or day
by treatment interaction (F1,42=0.081, p=0.778). Inactive lever presses did not differ
across days or treatment (all Fs<2.317, ps>0.05). Therefore, neutralizing bFGF in the
dHipp for four days, without 30-min extinction sessions, did not affect cocaine-induced
reinstatement.

Infusing bFGF in IL-mPFC was not sufficient to disrupt extinction of sucrose
seeking
We previously found that neutralizing bFGF in IL-mPFC facilitates extinction of
cocaine seeking (Hafenbreidel et al., 2015), however, if overexpression of bFGF in IL-
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mPFC was sufficient to prolong extinction was unknown. Extinction of sucrose seeking
does not alter bFGF expression in IL-mPFC (Hafenbreidel et al., 2015), so infusing
bFGF into this region would result in overexpression. Thus, to determine if
overexpression of bFGF in IL-mPFC is sufficient to disrupt extinction, rats received
infusions of bFGF one hour before four 90-min extinction of sucrose seeking sessions.
Active lever presses were equivalent between groups across the average of the
last three days of sucrose self-administration (t(21)=-0.001, p=0.999). Following
acquisition, rats received vehicle or bFGF infusions into IL-mPFC one hour before four
90-min extinction sessions. Across the 90-min sessions (days 1-8, active lever presses;
Figure 21b), ANOVA revealed a significant effect of day (F7,168=57.160, p<0.0001), but
no significant effect of treatment (F1,168=1.056, p=0.306) or day by treatment interaction
(F7,168=0.413, p=0.893). Overall, these results demonstrate that brief bFGF
overexpression prior to extinction training is not sufficient to prolong extinction of
sucrose seeking.
Figure 21: Infusing
bFGF in IL-mPFC is
not sufficient to disrupt
extinction of sucrose
seeking, (a)
Representative area
for injector tip
locations in IL-mPFC.
(b) Pre-extinction
session infusions of bFGF into IL-mPFC (arrows) did not affect extinction. Error bars are ±SEM.
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Neutralizing bFGF in IL-mpFC and dHipp does not affect locomotion, but does in
NAc
To determine if neutralizing bFGF in IL-mPFC, NAc, or dHipp affected general
motor activity, rats were infused with vehicle or anti-bFGF one hour prior to being
placed in locomotor activity chambers for 20 minutes (Figure 22). No difference in
photobeam breaks between groups in IL-mPFC (t5=0.565, p=0.597) or dHipp (t14=0.869, p=0.400) were observed, demonstrating that locomotor activity was not affected
by neutralizing bFGF. However, neutralizing bFGF in NAc significantly increased
locomotion (t13=2.649, p=0.020), demonstrating a region specific effect of anti-bFGF on
locomotion. This increase in general motor activity may explain the increase in lever
pressing observed in rats infused with anti-bFGF that did receive 30-min extinction
sessions that was not observed in anti-bFGF-infused rats that did not receive 30-min
sessions. To control for this effect, anti-bFGF could be infused immediately after the
30-min session, and this would also determine if neutralizing bFGF affects extinction
acquisition or extinction consolidation.
Figure 22: Neutralizing
bFGF in IL-mPFC and
dHipp does not affect
locomotion, but does in
NAc. (a) Neutralizing bFGF
in IL-mPFC does not affect
locomotion. (b) Neutralizing
bFGF in NAc increases
locomotion. (c) Neutralizing bFGF in dHipp does not affect locomotion. *p<0.05 Error bars are ±SEM.
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Cannula placement does not affect drug seeking, but withdrawal duration does
To determine if lowering cannula into specific brain regions affected drug seeking
following acquisition, an additional analysis was conducted on the number of active
lever presses made during the first 90-min extinction session. Additionally, to determine
if our particular acquisition paradigm induced potentiated drug seeking following a
withdrawal period, the number of lever presses made during the first 90-min extinction
session was examined in rats that underwent either a short or long withdrawal period.
Rats that underwent 30-min extinction sessions were excluded from this analysis, and
the number of withdrawal days indicates the number of days that elapsed between the
final day of acquisition and the first 90-min extinction day. First, rats that were not
implanted with cannula, but did undergo different number of withdrawal days were
compared (Figure 23a). A one-way ANOVA revealed a significant difference in active
lever pressing between rats that underwent three, 11, 38, or 50 withdrawal days
(F3,38=4.790, p=0.006). Post hoc analysis confirmed that rats that underwent 38 days of
withdrawal lever pressed significantly more than rats that underwent three (p=0.014) or
11 (p=0.024) days of withdrawal, but were not significantly different than rats that
underwent 50 days of withdrawal (p=0.854). Likewise, rats that underwent three or 11
days of withdrawal lever pressed similarly (p=0.800). Finally, rats that underwent 50
days of withdrawal lever pressed significantly more than rats that underwent three
(p=0.005) or 11 days of withdrawal (p=0.010). These results demonstrate that drug
seeking is potentiated after a prolonged withdrawal period after acquisition when using
our specific parameters (i.e., 18 days, 90 min a day, 4-5 days in a row followed by 2-3
day breaks).
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Figure 23: Drug seeking is potentiated after
a prolonged withdrawal period. (a) Rats
lever press significant more during the first
90-min extinction session after a prolonged
withdrawal period. (b) Rats with IL-mPFC
cannula lever press more than rats with no
cannula or NAc cannula, but all rats that
underwent a prolonged withdrawal period (L)
lever pressed more than rats that underwent a short withdrawal period (S). **p<0.001 compared to 50
days, * p<0.05 compared to 38 days, * p<0.05 compared to No cannula-S, # p<0.05 compared to IL-L
Error bars are ±SEM.

Next, because rats that underwent three or 11 days of withdrawal were not
significantly different, they were collapsed into a single “short” withdrawal group (wholeS). Similarly, rats that underwent 38 or 50 days of withdrawal were collapsed into a
single “long” withdrawal group (whole-L) as they were not significantly different. These
two groups were then compared to rats that received IL-mPFC, NAc, or dHipp cannula
that also underwent 38-days of withdrawal (IL-L, NAc-L, dHipp-L, respectively; Figure
23b). A one-way ANOVA revealed a significant difference in active lever pressing
between groups (F4,63=9.190, p<0.0001). Post hoc analysis confirmed that whole-S rats
lever pressed significantly less than whole-L rats (p=0.001), IL-L rats (p<0.0001), NAc-L
rats (p=0.030), and dHipp-L rats (p=0.006). These results indicate that regardless of
cannula placement or no cannula, a long withdrawal period will potentiate drug seeking
following self-administration. However, post hoc analysis also revealed that IL-L rats
lever pressed significantly more than whole-L rats (p=0.016) and NAc-L rats (p=0.013),
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but not dHipp-L rats (p=0.078). Overall, these results suggest that a long withdrawal
period will result in potentiated drug seeking, but cannula placement may also affect
drug seeking.
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Discussion
The current experiments aimed to determine the functional relevance of our
preliminary findings that extinction altered bFGF protein expression in the NAc and
dHipp. We found that neutralizing bFGF in NAc before four 30-min extinction sessions
disrupted extinction retention, initially. However, when bFGF was neutralized in NAc for
four days, without rats undergoing four 30-min extinction sessions, subsequent
extinction was facilitated and cocaine-induced reinstatement was attenuated.
Moreover, neutralizing bFGF in dHipp, with or without 30-min extinction sessions,
facilitated subsequent extinction. Finally, we found that infusing bFGF into IL-mPFC, to
mimic drug-induced overexpression, before four 90-min extinction of sucrose seeking
sessions was not sufficient to prolong extinction.
We previously found that neutralizing bFGF in IL-mPFC before four 30-min
extinction sessions was necessary for facilitated extinction retention, as rats pressed
similarly throughout extinction when they were infused without undergoing four 30-min
extinction sessions (Figure 10). Alternatively, neutralizing bFGF in NAc only facilitated
extinction when rats did not received four 30-min extinction sessions. Moreover,
neutralizing bFGF in dHipp facilitated extinction with or without the four 30 min sessions.
These results suggest that neutralizing bFGF without extinction is sufficient to enhance
subsequent extinction in NAc and dHipp. Rats lever press similarly on the first 90-min
extinction sessions, but the rate by which anti-bFGF-infused rats reduce lever pressing
across days is quicker than vehicle-infused rats. These results indicate that neutralizing
bFGF does not simply impair the rat’s ability to retrieve the original drug-cue memory or
supplant an extinction memory, but instead that they are able to learn extinction at a
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faster rate than vehicle-infused rats over days. Moreover, in the NAc, neutralizing bFGF
without four 30-min extinction sessions appears to have attenuated cocaine-induced
reinstatement.
The use of the shortened extinction sessions allows for the possibility that the rat
does not have sufficient time to begin learning the new contingencies that the cues are
no longer associated with drug administration, and thus would serve only as a memory
reactivation session. If that were the case, then the reduction of lever pressing by antibFGF-infused rats would be due to either retrieval or reconsolidation disruption,
because bFGF is neutralized before the session, and not due to enhanced extinction
acquisition or consolidation. However, because neutralizing bFGF in NAc and dHipp
without undergo four 30 min extinction sessions resulted in facilitated rate of
subsequent extinction, it does not seem likely that the original drug-cue memory was
affected. Moreover, veh-infused rats that underwent the four 30-min extinction sessions
lever press less than veh-infused rats that did not undergo extinction during the first 90min extinction session (IL-mPFC, NAc, and dHipp), which demonstrates that the four 30
min extinction sessions were sufficient for rats to learn extinction. Overall, these results
suggest that neutralizing bFGF is affecting extinction, and not the retrieval or
reconsolidation of the original drug-cue memory.
Finally, it is interesting that opposite effects were observed in the NAc depending
on whether or not rats underwent 30-min extinction sessions. A possible explanation for
these contrasting results is that a drug-state effect may have affected behavior during
the 30-min extinction sessions. We found that infusing vehicle or anti-bFGF into IL-
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mPFC or dHipp one hour before locomotion testing did not alter general motor activity,
but infusing anti-bFGF into NAc did increased general motor activity.

The diverse role of bFGF in learning and plasticity
One possible explanation for our results is that blocking the biological function of
bFGF primes the region for subsequent plasticity, such as what is necessary for new
learning. As discussed previously, stimulant drug administration can induce a number
of structural and functional changes in reward related brain regions. Particularly,
stimulant drug administration decreases intrinsic excitability in the NAc (Dong et al.,
2006; Ishikawa et al., 2009; Kourrich & Thomas, 2009; Mu et al., 2010). The effect of
bFGF application on intrinsic excitability in NAc has not been determined, but bFGF
reduces intrinsic excitability in dHipp (Cuppini et al., 2009). Thus, when bFGF was
neutralized, this could limit its effect on excitability, perhaps allowing for subsequent
new plasticity and learning to occur, such as extinction. In agreement with this, bFGF
protein expression was increased in Coc NE(38) rats in dHipp (Figure 18c), and there
was a trend for increased expression in IL-mPFC (Figure 14b) and NAc (Figure 17c),
but blocking bFGF expression in any of these brain regions, under certain parameters,
can enhance subsequent extinction.
These results are interesting considering that infusing bFGF into the amygdala
can enhance extinction of conditioned fear (Graham & Richardson, 2011a, 2011b). It is
unclear if this is a region specific effect, or if bFGF has unique roles in extinction of drug
seeking and extinction of conditioned fear. It is unknown if fear conditioning alters
bFGF protein expression, but increased bFGF is associated with lower anxiety-related
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behaviors and decreased bFGF is associated with higher anxiety-related behaviors in
selectively bred ratlines (Graham & Richardson, 2011b; Riva et al., 2005). Fear
conditioning can induce anxiety, and thus may decrease bFGF expression, but this has
not been tested yet. bFGF may function optimally in a very narrow and specific range.
Thus, when expression is decreased by an anxiety-provoking event, perhaps like fear
conditioning, then infusions of bFGF would increase it back into its optimal range and
allow for enhanced learning. Alternatively, when expression is increased by stimulant
drug administration, then infusions of anti-bFGF would reduce it back into its optimal
range and allow for enhanced learning.
In agreement with this notion, bFGF also has a role in glutamate signaling.
Besides inhibiting NMDA receptors (Boxer et al., 1999), bFGF can induce glutamate
release through interactions with voltage-gated calcium channels and the MAPK
pathway in culture neurons (Graham & Richardson, 2011b; Numakawa et al., 2002).
Increased glutamate could explain the enhancement in learning, and NMDA receptor
activation is necessary for learning in a number of paradigms (Fiorenza, Rosa,
Izquierdo, & Myskiw, 2012; Hafenbreidel et al., 2014; Hammond, Seymour, Burger, &
Wagner, 2012; Kelamangalath, Seymour, & Wagner, 2009; Langton & Richardson,
2008; Nic Dhonnchadha et al., 2010).
However, in disagreement, we found that infusing bFGF into IL-mPFC before
four extinction of sucrose seeking sessions had no effect on the rate of extinction. The
dose used was based off of previous research (Graham & Richardson, 2011a; Turner et
al., 2009; Wagner et al., 1999), but the dose may not have been high enough to match
the increase observed following stimulant drug administration. Another possibility is that
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cocaine-induced overexpression does not induce maladaptive changes quickly, but
instead requires prolonged over expression.

The role of bFGF in extinction of drug seeking circuitry
Overall, we found that neutralizing bFGF in IL-mPFC before four 30-min
extinction sessions facilitated extinction retention, neutralizing bFGF in NAc for four
days without extinction facilitated subsequent extinction, and neutralizing bFGF in dHipp
before four 30-min extinction sessions or without extinction facilitated subsequent
extinction. The most robust finding was in the IL-mpFC, which agrees with previous
research that it is necessary for extinction (LaLumiere et al., 2010; Peters et al., 2008).
The IL-mPFC sends projections to the NAc shell (Groenewegen et al., 1999; Sesack et
al., 1989), which is necessary for inhibiting drug seeking following extinction, but if it is
necessary for extinction acquisition is unclear (Peters et al., 2009; Peters et al., 2008).
The NAc is thought to regulate the motor outputs that drive drug seeking (Peters et al.,
2009), which may explain why this was the only brain region that had increased
locomotion following infusions of anti-bFGF, and had attenuated cocaine-induced
reinstatement.
The dorsal hippocampus may not have any direct projections to the IL-mPFC or
NAc, but does have indirect projections, such as one projection to the NAc core through
the vHipp (Figure 1; Fanselow & Dong, 2010; Groenewegen, Wright, & Beijer, 1996;
Naber & Witter, 1998). It is not clear what role the vHipp may have in extinction of drug
seeking. We previously found that rats that did not undergo extinction had reduced
bFGF immunoreactivity in vHipp compared to naïve rats, which was slightly attenuated
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in rats that did undergo extinction (Figure 9). However, if this brain region, or some
other region, is a critical link between the NAc and dHipp during extinction of drug
seeking is unknown. Future experiments should assess the role of the vHipp during
extinction, but also the role that bFGF may have in that region during extinction or
withdrawal from cocaine self-administration.
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FUTURE DIRECTIONS
In the current experiments, we demonstrate that extinction of drug seeking
attenuates some plastic changes induced by chronic cocaine use. Moreover, we
demonstrate that neutralizing bFGF in NAc and dHipp can facilitate subsequent
extinction of drug seeking, and neutralizing bFGF in NAc can attenuate cocaine-induced
reinstatement. These results provide new insights to the mechanisms underlying
extinction of drug seeking, which provide new directions for future research examining
how to strengthen extinction learning in order to reduce relapse rates.
Extinction of drug seeking is not well characterized, and these experiments
provided some of the first insights into how extinction, itself, could alter cocaine-induced
plastic changes in IL-mPFC, NAc, and dHipp. These results suggest new targets to
examine for their behavioral relevance in extinction, or in the case of ARC, possibly in
retrieval of the original drug-cue memory. However, as mentioned, the mechanisms
underlying the effect of neutralizing bFGF on extinction are still unclear. As discussed,
electrophysiological recordings or examining epigenetic modification may begin to
explain how neutralizing bFGF in IL-mPFC, NAc, and dHipp results in facilitated
extinction.
bFGF could be affecting learning and memory through a number of mechanisms
(Graham & Richardson, 2011b), including those suggested in Figure 1. Another
possible mechanism could be through its subsidiary interactions with NMDA receptors
and the growth factor BDNF (brain derived neurotrophic factor). bFGF has opposing
effects on extinction compared to BDNF. An infusion of BDNF into IL-mPFC facilitates
extinction (Otis et al., 2014; Peters, Dieppa-Perea, Melendez, & Quirk, 2010; Xin et al.,
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2014) and endogenous BDNF mRNA expression increases in IL-mPFC during
extinction of a conditioned taste aversion (Xin et al., 2014). Furthermore, reducing
BDNF activity in the basolateral amygdala and dHipp disrupts learning and extinction
(Heldt, Stanek, Chhatwal, & Ressler, 2007; Sakata et al., 2013). In contrast, our results
show that endogenous bFGF is reduced in IL-mPFC following extinction and blocking
bFGF in this region facilitates extinction, suggesting that BDNF and bFGF have inverse
roles during extinction. These opposing roles could be mediated by interactions with
NMDA receptors. For example, BDNF facilitates extinction of drug seeking through its
interaction with NMDA receptors (Otis et al., 2014). However, bFGF diminishes the
function of these receptors (Boxer et al., 1999). NMDA receptor activation is necessary
for learning in a number of paradigms (Fiorenza et al., 2012; Hafenbreidel et al., 2014;
Hammond et al., 2012; Kelamangalath et al., 2009; Langton & Richardson, 2008; Nic
Dhonnchadha et al., 2010). Therefore, future experiments should determine the
interaction between NMDA receptors and bFGF, and how they mediate extinction.
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Conclusions
Drug addiction is a complex disorder characterized by compulsive drug seeking,
increased impulsivity, and chronic relapse. Nearly 25 million people are reported as
needing treatment for drug abuse in the United States (Substance Abuse and Mental
Health Services Administration, 2014), and of those that receive treatment, 30-60%
relapse within one year (McLellan et al., 2000). The altered behavior and resistance to
long-term treatment suggests persistent plastic changes, and these are evident in such
instances as modified dendritic and spine morphology and density (Brown & Kolb, 2001;
Kolb et al., 2003; Y. Li et al., 2003; Mueller et al., 2006; Robinson & Kolb, 1997, 1999,
2004), and altered expression of molecular markers for neuronal structure and function
in reward-related brain regions (e.g., Kauer & Malenka, 2007; Kiraly, Eipper-Mains, et
al., 2010; Kourrich et al., 2015; Robison & Nestler, 2011; Wolf, 2010). Determining the
mechanisms that underlie each of the characteristics of addiction, and how they
interact, is essential to developing new therapeutic strategies.
Drug addiction is also a disorder of learning, as cues become associated with the
rewarding properties of the drug. These cues can later trigger craving and withdrawallike symptoms, which promotes relapse (Childress et al., 1986). Reducing the salience
of these cues would therefore reduce the induction of craving and the likelihood of
relapse. Alone, however, extinction-based exposure therapy has had limited success
(Conklin & Tiffany, 2002). This may be due to another long-term effect of drug use,
which is a reduced ability for subsequent experience-dependent plasticity (Kolb et al.,
2003) and learning (Divac, 1971; Radley et al., 2015; Sillivan et al., 2011; Skelton et al.,
2007; Vorhees et al., 1994; Williams et al., 2002). Therefore, determining the plasticity-
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related changes underlying extinction and if they can ameliorate the changes induced
by drug use, would allow new targets to be modified, resulting in enhanced learning and
better long-term treatment results.
Finally, based off previous work and our preliminary findings, the growth factor
bFGF appears to be a key link between drug-induced maladaptive changes and
resistance to extinction. bFGF mediates changes in axonal and dendritic morphology
(Kalil et al., 2000; Patel & McNamara, 1995; Zechel et al., 2009), intrinsic excitability
(Cuppini et al., 2009; Hilborn et al., 1998), is neuroprotective (Anderson et al., 1988;
Logan et al., 1992; Mark et al., 1997; Flores and Stewart, 2000a), and contributes to
drug-associated behavioral and plastic changes (Flores et al., 2000; Mueller et al.,
2006; Turner et al., 2009). Thus, determining the interactions between bFGF, druginduced plastic changes, and extinction could help identify new targets for
pharmacotherapeutrics to enhance treatment for drug addiction.
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reconsolidation of cocaine self-administration memory. Poster presented at the annual
meeting of Society for Neuroscience and meeting of Molecular and Cellular Cognition
Society, Washington, DC.
Hafenbreidel, M., Rafa Todd, C., Twining, R. C., & Mueller, D. (2013, November).
NMDA receptors mediate extinction of cocaine self-administration, and enhancing
receptor function facilitates extinction. Poster presented at the annual meeting of
Society for Neuroscience and meeting of Molecular and Cellular Cognition Society, San
Diego, CA.
Hafenbreidel, M., Rafa Todd, C., Twining, R. C., & Mueller, D. (2013, May). NMDA
receptors bidirectionally mediate extinction of cocaine self-administration. Poster
presented at the meeting of Milwaukee Society for Neuroscience, University of
Wisconsin-Milwaukee, Milwaukee, WI.
Hafenbreidel, M., Twining, R. C., & Mueller, D. (2012, October). Neutralizing bFGF in
the infralimbic medial prefrontal cortex facilitates extinction of cocaine selfadministration. Poster presented at the annual meeting of Society for Neuroscience and
meeting of Molecular and Cellular Cognition Society, New Orleans, LA.
Hafenbreidel, M., Twining, R. C., Schneider, J., & Mueller, D. (2011, November). NMDA
and β-adrenergic receptor antagonists impair extinction of cocaine seeking. Poster
presented at the annual meeting of Society for Neuroscience and meeting of Molecular
and Cellular Cognition Society, Washington, DC.
Hafenbreidel, M., Twining, R. C., Schneider, J., & Mueller, D. (2011, September).
NMDA and β-adrenergic receptor antagonists impair extinction of cocaine seeking.
Poster presented at the meeting of Pavlovian Society, Milwaukee, WI.
Hafenbreidel, M., Twining, R. C., Schneider, J., & Mueller, D. (2011, May). NMDA and
β-adrenergic receptor antagonists impair extinction of cocaine seeking. Poster
presented at the meeting of Milwaukee Society for Neuroscience, Medical College of
Wisconsin, Milwaukee WI.
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ORAL PRESENTATIONS:
Mechanisms underlying the role of bFGF (FGF2) in extinction of drug seeking. Oral
presentation at the Association for Graduate Students in Psychology Annual Seminar,
University of Wisconsin- Milwaukee, Milwaukee, WI, April 8, 2016.
Infralimbic NR2A-containing NMDA receptors are necessary for the reconsolidation of
cocaine self-administration memory. Abstract was selected of three from all abstracts
submitted to present an oral research talk at UWM-Neuroscience Mini-symposium, a
collaboration between Department of Biological Sciences and Department of
Psychology, University of Wisconsin- Milwaukee, Milwaukee, WI, March 11, 2016.
The role of NR2A-containing NMDA receptors in cocaine-associated learning. Oral
presentation at Department of Psychology Neuroscience Seminar, University of
Wisconsin- Milwaukee, Milwaukee, WI, November 20, 2015.
Reduction in infralimbic bFGF (FGF2) facilitates extinction of drug seeking. Oral
presentation at the Association for Graduate Students in Psychology Annual Seminar,
University of Wisconsin- Milwaukee, Milwaukee, WI, April 10, 2015.
Reduction of bFGF (FGF2) facilitates extinction of drug seeking. Oral presentation at
Department of Biological Sciences and Department of Psychology Neuroscience
Seminar, University of Wisconsin- Milwaukee, Milwaukee, WI, February 6, 2015.
The role of NR2A-containing NMDA receptors in cocaine self-administration. Oral
presentation at the Association for Graduate Students in Psychology Annual Seminar,
University of Wisconsin- Milwaukee, Milwaukee, WI, April 4, 2014.
The role of NR2A-containing NMDA receptors in cocaine self-administration. Oral
presentation at Department of Biological Sciences and Department of Psychology
Neuroscience Seminar, University of Wisconsin- Milwaukee, Milwaukee, WI, March 14,
2014.
The role of NMDA receptors in extinction of cocaine self-administration. Oral
presentation at the Association for Graduate Students in Psychology Annual Seminar,
University of Wisconsin- Milwaukee, Milwaukee, WI, April 5, 2013.
The role of NMDA receptors in extinction of cocaine self-administration. Oral
presentation at Department of Biological Sciences and Department of Psychology
Neuroscience Seminar, University of Wisconsin- Milwaukee, Milwaukee, WI, February
1, 2013.
bFGF and extinction of cocaine self-administration. Oral presentation at the Association
for Graduate Students in Psychology Annual Seminar, University of WisconsinMilwaukee, Milwaukee, WI, April 20, 2012.
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Glutamate and extinction of cocaine self-administration: Mechanisms and caveats. Oral
presentation at Department of Biological Sciences and Department of Psychology
Neuroscience Seminar, University of Wisconsin- Milwaukee, Milwaukee, WI, March 16,
2012.
NMDA and β-adrenergic receptors antagonist disrupt extinction of cocaine seeking. Oral
presentation at the Association for Graduate Students in Psychology Annual Seminar,
University of Wisconsin- Milwaukee, Milwaukee, WI, April 8, 2011.
HONORS, AWARDS, AND GRANTS:
o UWM Department of Psychology Summer Research Fellowship (2015).
o UWM Student Association Travel Grant to the annual meeting for Society for
Neuroscience in New Orleans, LA (2012), San Diego, CA (2013), Washington,
DC (2015), Chicago IL (2015), and San Diego, CA (2016).
o Featured in the Spring 2014 issue of PsychNews, a newsletter for the
undergraduate psychology program.
o 2nd place award for data presentation at the Annual Association of Graduate
Students in Psychology Seminar (2013).
o Graduate School Graduate Student Travel Award, University of WisconsinMilwaukee, Fall 2011, Fall 2012, Fall 2013.
o Lucky Waller Scholarship, University of Minnesota-Twin Cities, 2008-2009.
o Vivian V. Volstorff Scholarship, South Dakota State University, 2006-2007.
o Opportunity Scholarship, South Dakota State University, 2006-2007.
o University of Minnesota-Twin cities Dean’s List, 2007-2008; 2010.
o South Dakota State University Dean’s List, 2006-2007.
RESEARCH EXPERIENCE:
June 2010-Current:
Graduate research assistant, Psychology department,
UWM. Faculty advisor: Dr. Devin Mueller.
Master’s Thesis: The role of NMDA receptors in extinction
of cocaine self-administration (2013)
Ph.D. Thesis: The mechanisms underlying cocaine-induced
over-expression of basic fibroblast growth factor (bFGF,
FGF2), an effect reversed by extinction (2016)
August 2009-May 2010:

Undergraduate research assistant, Psychology
department, University of Minnesota-Twin Cities. Graduate
supervisor: Yanna Weisberg. Faculty advisor: Dr. Colin
DeYoung.

January 2009-May 2009: Undergraduate research assistant, Psychology
department, University of Minnesota-Twin Cities. Graduate
supervisor: Jenny Filson. Faculty advisor: Dr. Mark Snyder.
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August 2006-August 2008: Undergraduate research assistant, Economics
department, South Dakota State University. Faculty advisor:
Dr. Scott Fausti
TEACHING EXPERIENCE:
o Associate Lecturer, University of Wisconsin-Milwaukee
• Introduction to Conditioning and Learning (online) – Spring 2015, Fall
2015
o Teacher Assistant, University of Wisconsin-Milwaukee, Fall 2010 to Spring 2015.
• Physiological Psychology, discussion – Fall 2010, Spring 2011, Fall 2011
• Advanced Physiological Psychology, lab – Spring 2012, Fall 2012, Fall
2013, Spring 2014, Fall 2014, Spring 2015
• Introduction to Psychological Statistics, discussion and lab – Spring 2013
POSITIONS HELD:
o Laboratory Manager, University of Wisconsin-Milwaukee, 2012 to current.
o Laboratory Safety Coordinator, University of Wisconsin-Milwaukee, Fall 2015 to
current
o Graduate Research Assistantship, University of Wisconsin-Milwaukee, Fall 2015
to current.
o President, Graduate Students in Behavioral Neuroscience, Fall 2014-current
o Vice President, Graduate Students in Behavioral Neuroscience, Spring 2010Spring 2014
o Treasurer, Psi Chi, Spring 2008-Spring 2010
MEMBERSHIPS:
o Society for Neuroscience, Student member, 2011-current
o Molecular and Cellular Cognition Society, 2011-current
o Pavlovian Society, 2011, 2015
o Association of Graduate Students in Psychology, 2010-current
o Graduate Students in Behavioral Neuroscience, 2010-current
o Psi Chi National Honor Society in Psychology, 2008-current
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